CEimpact Podcast - SoundSage

View Details

Skin conditions are among the most common reasons patients seek advice from healthcare professionals, creating frequent opportunities for pharmacist intervention and support. This course reviews common dermatologic conditions encountered in pharmacy practice, including eczema, poison ivy, and other minor skin conditions and infections, while exploring the pharmacist's role in screening, triage, treatment selection, patient counseling, and prevention. You will be better prepared to support evidence-based management of common skin conditions and help patients access appropriate dermatologic care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Jamie McConaha, PharmD, BCACP, CDCES, FCCP
Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe clinical features and management considerations for common skin conditions encountered in pharmacy practice.

Explain the pharmacist's role in screening, triage, treatment selection, patient counseling, and prevention of dermatologic conditions.

Rachel Maynard and Jamie McConaha have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-307-H01-P
Initial release date: 8/10/2026
Expiration date: 8/10/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Pediatric irritable bowel syndrome with constipation (IBS-C) can significantly affect quality of life and presents unique treatment and counseling challenges for patients and families. This course reviews evolving management strategies for pediatric IBS-C, including newly approved treatment options and practical considerations for therapy selection. You will be better prepared to evaluate treatment approaches and counsel families on the safe and appropriate use of therapy for pediatric IBS-C.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Christopher Hartley, PharmD, BCPPS
Pediatric Clinical Pharmacy Specialist,
The Johns Hopkins Hospital

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current treatment considerations for pediatric IBS-C, including recently approved pharmacologic options.
2. Compare factors that influence treatment selection and family counseling for pediatric IBS-C.

Rachel Maynard and Christopher Hartley have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-300-H01-P
Initial release date: 8/3/2026
Expiration date: 8/3/2029
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Skin cancer remains one of the most common cancers in the United States, making effective sun protection an important component of preventive care. This course reviews sunscreen best practices, common patient questions, and recent updates affecting sunscreen products, including the addition of a new active ingredient to the OTC sunscreen monograph. You will be better prepared to provide evidence-based recommendations on sunscreen selection, sun safety, and skin cancer prevention.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Kendall Guthrie, PharmD, BCACP
Director of Co-Curriculum/Clinical Professor,
UMKC School of Pharmacy

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current recommendations for sunscreen use and sun protection to reduce the risk of skin cancer.
2. Explain pharmacist-relevant considerations for sunscreen selection, including formulation differences, active ingredients, and patient counseling.

Rachel Maynard and [Speaker] have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-289-H01-P
Initial release date: 7/27/2026
Expiration date: 7/27/2029
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Primary open-angle glaucoma is a progressive eye disease that can lead to irreversible vision loss without timely treatment and ongoing monitoring. This course reviews practical approaches to glaucoma management, including treatment goals, common medication options, and factors that influence adherence and long-term disease control. You will be better prepared to support patients receiving glaucoma therapy through medication counseling, adherence support, and reinforcement of appropriate follow-up care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Stephanie Conway-Allen, PharmD
Associate Professor of Pharmacy Practice,
Massachusetts College of Pharmacy and Health Sciences -Worcester/Manchester

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe treatment goals and common management strategies for primary open-angle glaucoma.
2. Explain pharmacist-relevant considerations for counseling and supporting patients receiving glaucoma therapy.

Rachel Maynard and Stephanie Conway-Allen have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-252-H01-P
Initial release date: 7/20/2026
Expiration date: 7/20/2029
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

International travel exposes patients to a range of infectious disease risks, making pre-travel planning and vaccination an important part of patient care. This course reviews recent travel health updates, including vaccine recommendations, emerging safety considerations, and prevention strategies for common travel-related illnesses. You will be better prepared to provide evidence-based recommendations, assess patient risk, and counsel travelers on vaccines and preventive measures before international travel.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Lana Saad Sherr, PharmD
Assistant Dean for Professional Affairs,
University of Maryland Eastern Shore

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1.Describe key vaccine recommendations and safety considerations for patients traveling internationally.
2. Describe prevention strategies for common travel-related infectious diseases, including mosquito-borne illnesses.

Rachel Maynard and Lana Sherr have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-251-H01-P
Initial release date: 7/13/2026
Expiration date: 7/13/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Deprescribing is an important component of patient care as medication regimens are reassessed to ensure ongoing appropriateness, safety, and alignment with patient goals. This course reviews key deprescribing principles, including when it may be appropriate to discontinue therapy and important considerations for patient monitoring and follow-up. You will be better prepared to support evidence-based deprescribing decisions and collaborate with patients and providers to optimize medication use.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Kristin S. Meyer, PharmD, BCGP, FASCP
Professor of Pharmacy Practice,
Drake University College of Pharmacy and Health Sciences

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss key principles and clinical considerations for deprescribing.
2. Compare patient-specific factors that influence evidence-based deprescribing decisions, including risks, benefits, and treatment goals.

Rachel Maynard and Kristin Meyer have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-249-H01-P
Initial release date: 7/6/2026
Expiration date: 7/6/2029
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Beta-blockers have long been considered a foundational therapy following myocardial infarction, yet emerging data are challenging their routine use in all patients. This course discusses recent evidence on outcomes associated with beta-blocker therapy after MI, particularly in patients without reduced ejection fraction, and explores the ongoing debate over the benefits, risks, and duration of therapy. You will gain practical insight to support evidence-based decision-making and individualized pharmacotherapy recommendations in post-MI care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUESTS
Anna Crider, PharmD, BCCP
Clinical Pharmacy Specialist,
Emory University Hospital

Taylor Merritt, PharmD
PGY2 Internal Medicine Pharmacy Resident, Chief Pharmacy Resident,
Emory University Hospital

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize contemporary evidence regarding beta-blocker therapy after myocardial infarction.
2. Describe clinical considerations that may influence the decision to initiate, continue, or deprescribe beta-blocker therapy following myocardial infarction.

Rachel Maynard, Anna Crider, and Taylor Merritt have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-242-H01-P
Initial release date: 6/29/2026
Expiration date: 6/29/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Sexually transmitted infection (STI) management continues to evolve, with new treatment options, prevention strategies, and practice considerations that are important for pharmacists to understand. This course reviews recent updates in STI care, including newly approved oral therapies for gonorrhea and doxycycline post-exposure prophylaxis. You will be better prepared to recognize practice-relevant changes and support evidence-based STI prevention, treatment, and patient counseling.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Francisco Franco, PharmD, MS, AAHIVP
Registered Store Manager,
Walgreens

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent updates in STI treatment and prevention that are relevant to pharmacy practice.
2. Compare emerging strategies for managing gonorrhea and STI post-exposure prophylaxis.

Rachel Maynard and Francisco Franco have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-241-H01-P
Initial release date: 6/22/2026
Expiration date: 6/22/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Well-designed rotation experiences are essential to developing competent and confident student pharmacists and residents. This course discusses how to structure rotations, align with institutional expectations, and create meaningful schedules, activities, and deliverables that balance service and learning, while introducing principles of deliberate practice to support ongoing skill development. You will gain practical strategies for designing engaging, well-organized, high-impact experiential learning experiences

Host
Kate Newman PharmD,
Director of Experiential Education
Clinical Associate Professor, Pharmacy Practice
Southern Illinois University - Edwardsville

Guest
Mayank Amin, PharmD, RPH, MBA
Pharmacist
Owner, Skippack Pharmacy

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Describe key elements of effective rotation design, including structure, expectations, and learning activities.
2. Identify strategies to create engaging and high-impact rotation experiences for pharmacy learners.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-246-H99-P
Initial release date: 6/17/2026
Expiration date: 6/17/2029
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

The examples shared in this episode are intended to illustrate approaches to experiential learning, service development, and patient care innovation and are not endorsements of any specific service, product, or practice model. Certain examples discussed may no longer be viable, appropriate, or permissible under current regulatory requirements. Pharmacists should exercise professional judgment and ensure compliance with applicable laws, regulations, payer requirements, and evidence-based standards when evaluating or implementing patient care services.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Interest in peptide therapies has grown rapidly, with increasing patient questions driven by social media, wellness trends, and evolving access through compounding and online sources. This course reviews what peptides are, the current state of evidence supporting their use, and key safety and regulatory considerations relevant to patient care. You will be better prepared to apply an evidence-based approach when discussing peptides, including evaluating risks, addressing misconceptions, and guiding patients toward safe and informed decisions.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Nicolette Mathey, PharmDFounder & CEO,
Atrium24

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the role of peptides in human physiology and the current evidence supporting their therapeutic use.
2. Identify safety, regulatory, and patient-specific considerations relevant to the use of peptides in clinical practice.

Rachel Maynard and Nicolette Mathey have no relevant financial relationships to disclose.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-240-H01-P
Initial release date: 6/15/2026
Expiration date: 6/15/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Antibiotics are frequently prescribed in dental care, yet evidence suggests they are often unnecessary and can expose patients to significant risks, including Clostridioides difficile infection. This course reviews appropriate antibiotic use in dental settings, including indications, preferred treatment options, and safety concerns associated with specific agents. You will be better prepared to support evidence-based antibiotic use, identify opportunities for intervention, and collaborate with dental colleagues to promote antimicrobial stewardship.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Julie Goldberg, DDS
Senior Dental Risk Specialist, Pharmacists Mutual Insurance Group

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe appropriate indications for antibiotic use in common dental conditions.
2. Compare antibiotic options used in dental care, including safety considerations and risks associated with specific agents.

Rachel Maynard and Julie Goldberg have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-224-H01-P
Initial release date: 6/8/2026
Expiration date: 6/8/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Chronic pain is a prevalent and complex condition where evidence continues to evolve around commonly prescribed therapies. This course discusses the latest systematic review comparing tramadol with placebo in adults with chronic pain, highlighting limited analgesic benefits and the balance of potential harms versus benefits that pharmacists should understand. You will gain evidence-based insights to guide medication review, patient counseling, and clinical decision-making in chronic pain management.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Emma Murter, PharmD, MPHClinical Pharmacist, Intermountain Health

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize the current evidence on tramadol’s efficacy and safety profile in chronic pain based on placebo-controlled randomized trials.
2. Describe the clinical implications of recent tramadol evidence for pharmacist-led medication management in chronic pain care.

Rachel Maynard and Emma Murter have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-223-H01-P
Initial release date: 6/1/2026
Expiration date: 6/1/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Melatonin—widely available over the counter and often perceived as
“natural and safe”—has become increasingly used by caregivers to
address sleep disturbances in children and adolescents, yet its proper
role and safety profile in pediatrics remain nuanced and evolving. This
course examines current evidence on indications such as insomnia and
circadian rhythm sleep disorders, highlights concerns about
unregulated supplement use and adverse effects, and reviews practical
considerations for safe and informed use in pediatric patients. You will
gain insight into how to support caregivers with balanced counseling,
emphasize behavioral and environmental strategies, and apply clinical
judgment when melatonin is being considered for sleep management
in pediatric patients.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Monica Bogenschutz, PharmD, BCPS, BCPPS, DPLA, FPPA
Pediatric Clinical Pharmacist and PGY2 Pediatric Pharmacy Residency Program Director at UW Health

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe common pediatric indications and available evidence for
melatonin use in children and adolescents

Identify pharmacist considerations related to safety, dosing,
behavioral counseling, and monitoring when melatonin is
recommended or used in pediatric patients.

Rachel Maynard and Monica Bogenschutz have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-222-H01-P
Initial release date: 5/25/2026
Expiration date: 5/25/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Acute rescue medications are critical in time-sensitive emergencies, and pharmacists play an essential role in ensuring patients and caregivers are prepared to use them correctly. This course discusses the roles of glucagon, naloxone, and epinephrine, including recent updates on novel formulations and device innovations that are reshaping emergency response in community settings. You will gain practical insights to strengthen counseling, improve readiness, and support optimal outcomes when seconds matter most.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT
Professor of Pharmacy Practice
Drake University CPHS

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the mechanisms of action and primary indications for glucagon, naloxone, and epinephrine as acute rescue medications.
2. Summarize recent updates for glucagon, naloxone, and epinephrine that impact pharmacist counseling and patient access.

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Wendy Mobley-Bukstein is a Diabetes Care Speaker for Abbott. All relevant financial relationships have been mitigated.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-131-H01-P
Initial release date: 5/18/2026
Expiration date: 5/18/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate training. This course reviews the regulatory changes, outlines clinical and operational considerations for pharmacist-led MOUD prescribing, and discusses the opportunities and responsibilities that accompany expanded prescriptive authority. You will gain practical insight into how integrating MOUD prescribing into pharmacy practice can improve treatment access while maintaining safe, evidence-based care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Korey Kreider, PharmD
Pharmacist Owner
Medicine Man

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent federal policy changes authorizing pharmacists to independently prescribe buprenorphine for opioid use disorder.
2. Identify clinical, regulatory, and workflow considerations associated with integrating MOUD prescribing into pharmacy practice.

Rachel Maynard and Korey Kreider have no relevant financial relationships with ineligible companies to disclose.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-150-H01-P
Initial release date: 5/11/2026
Expiration date: 5/11/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Updated cholesterol guidelines introduce important changes in cardiovascular risk assessment and lipid management that directly impact pharmacist practice. This course reviews key updates from the new ACC/AHA dyslipidemia guideline, including risk assessment tools, LDL-C targets, and evolving roles for statin and nonstatin therapies. You will be better prepared to identify practice-relevant recommendations and support evidence-based lipid management in patient care.

HOST
Rachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Janelle Ruisinger, PharmD, FAPhAAssociate Dean for Academic Affairs and Clinical Professor
The University of Kansas School of Pharmacy

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION

Learning Objectives

Upon successful completion of this knowledge-based activity, participants should be able to:

Describe key pharmacist-relevant updates in the new ACC/AHA Guideline for the Management of Dyslipidemia.
Differentiate risk assessment and lipid-lowering treatment considerations that may influence pharmacist recommendations under the updated guideline.

Rachel Maynard and Janelle Ruisinger have no relevant financial relationships to disclose.

0.75 CEU/0.75 Hr
UAN: 0107-0000-26-156-H01-P
Initial release date: 5/4/2026
Expiration date: 5/4/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Seasonal allergies affect millions of patients each year and are a common reason individuals seek guidance from pharmacists for symptom relief and product selection. This course reviews the pathophysiology, common symptoms, and current management strategies for seasonal allergies, with a focus on over-the-counter treatment options and patient counseling considerations. You will strengthen your ability to recommend evidence-based therapies, differentiate treatment options, and support patients in managing seasonal allergy symptoms effectively.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Tyler Kiles, PharmD, MPH, BC-ADMClinical Associate Professor
The University of Texas at Austin College of Pharmacy

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

Compare pharmacologic and nonpharmacologic treatment options for seasonal allergies, including considerations for safe and effective use in patient care.

Rachel Maynard and Tyler Kiles have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-155-H01-P
Initial release date: 4/27/2026
Expiration date: 4/27/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Federal guidelines now recognize self‑collected HPV testing as an option for cervical cancer screening for average‑risk individuals, offering a more accessible and patient‑preferred alternative to clinician‑collected samples. This course explains current guideline updates supporting self‑collection, highlights screening intervals and follow‑up recommendations, and explores how pharmacists can support patients in choosing appropriate screening options and navigating coverage and reimbursement. You will learn practical strategies to educate patients, help them understand test options and results, and integrate HPV self‑screening into preventive health services in your practice.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Sarah Westberg, PharmD, FCCP, BCPSProfessor & Associate Dean for Professional Affairs
University of Minnesota College of Pharmacy

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent guideline updates supporting self‑collected HPV testing as part of cervical cancer screening.

Identify pharmacist‑led strategies to counsel patients on self‑screening options, appropriate follow‑up steps, and considerations related to insurance coverage and reimbursement.

Rachel Maynard and Sarah Westberg have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-075-H01-P
Initial release date: 4/20/2026
Expiration date: 4/20/2027
Additional CPE details can be found

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Treatment for atopic dermatitis has changed dramatically, with new therapies offering more targeted relief across the severity spectrum. This course highlights recent drug approvals, updated guideline recommendations, and the clinical implications of managing atopic dermatitis as a chronic inflammatory condition. You will learn how pharmacists can guide therapy decisions, enhance adherence, and improve patient outcomes in personalized atopic dermatitis care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Melanie Plotke, PharmD
Manager, Clinical Research
American Academy of Dermatology

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the updated treatment landscape for atopic dermatitis, including new topical and systemic options.
2. Identify opportunities for pharmacists to collaborate and support atopic dermatitis management through therapy recommendations, patient education, and adherence strategies.

Rachel Maynard and Melanie Plotke have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-074-H01-P
Initial release date: 4/16/2026
Expiration date: 4/16/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores key highlights from the AHA's recent scientific statements, including single-pill combination therapy and the clinical limitations of some blood pressure devices, alongside updates to the 2025 hypertension guidelines. You will gain a clear understanding of how these changes affect patient care, medication strategies, and pharmacist-driven interventions.

Recent ACC/AHA Cholesterol Guidelines further emphasize comprehensive cardiovascular risk assessment and evidence-based management of dyslipidemia alongside other major risk factors such as hypertension. These updates complement the hypertension topics discussed in this episode by reinforcing the importance of coordinated, risk-based approaches to reducing cardiovascular disease.

This resourceprovides a concise, guideline-based overview of hypertension management, summarizing the 2025 ACC/AHA recommendations for blood pressure classification, treatment goals, and stepwise pharmacotherapy. It highlights first- and second-line antihypertensive options, emphasizes individualized, risk-based treatment decisions, and outlines practical considerations for therapy initiation, intensification, and monitoring to optimize cardiovascular outcomes.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, HF-Cert, CDCES, AACC
Clinical Pharmacist Practitioner
LTC Charles S. Kettles VA Medical Center

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Alpha-gal syndrome (AGS), a growing allergy linked to tick bites and mammalian meat exposure, is a condition pharmacists can’t afford to overlook. This course discusses the pathophysiology of the syndrome, common triggers, and emerging case trends—while highlighting how pharmacists can play a critical role in helping patients navigate safe OTC and prescription therapies by screening for allergenic excipients. You will gain practical knowledge to support patient education, ensure safe medication use, and guide appropriate referrals.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Geoff Wall, PharmD, BCPS
Professor of Pharmacy Practice
Drake University

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the pathophysiology, triggers, and clinical presentation of alpha‑gal syndrome.
2. Identify pharmacist‑led strategies for patient counseling, medication review, and referral when AGS is suspected or confirmed.

Rachel Maynard and Geoff Wall have no relevant financial relationships with ineligible companies to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-058-H01-P
Initial release date: 3/30/2026
Expiration date: 3/30/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Artificial intelligence (AI) is rapidly transforming the healthcare landscape—and pharmacy is no exception. This course explores emerging and potential uses of AI in pharmacy practice, including workflow automation, drug information access, and tools that support patient care and clinical decision-making. You will gain insight into practical considerations, limitations, and ethical responsibilities pharmacists must navigate as AI becomes more integrated into practice.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Timothy Aungst, PharmDProfessor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify current and potential uses of AI that support pharmacist-led patient care services.
2. Describe considerations, limitations, and ethical concerns related to implementing AI tools in pharmacy practice.

Rachel Maynard and Timothy Aungst have no relevant financial relationships with ineligible companies to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-060-H04-P
Initial release date: 3/23/2026
Expiration date: 3/23/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Second-generation (also known as atypical) antipsychotics are increasingly used as adjunctive therapy for patients with major depressive disorder who have an inadequate or partial response to antidepressants. This course reviews the clinical rationale for their use, highlights newly approved options, and examines key safety, efficacy, and monitoring considerations. You will gain practical guidance to support patient selection, counseling, and shared decision-making when these agents are incorporated into depression management.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Sarah Grady, PharmD, BCPS, BCPPProfessor of Pharmacy Practice, Clinical Pharmacist
Drake University/Broadlawns Medical Center

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the role of second-generation (atypical) antipsychotics as adjunctive therapy in the management of major depressive disorder.
2. Identify pharmacist-relevant considerations for counseling, monitoring, and risk benefit assessment when second-generation antipsychotics are used for depression.

Rachel Maynard and Sarah Grady have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-059-H01-P
Initial release date: 3/16/2026
Expiration date: 3/16/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research. This course explores key updates, including the FDA approval of the first oral GLP‑1 for chronic weight management and ongoing investigations into GLP‑1 therapies for conditions beyond diabetes and obesity. You will gain a timely overview of recent developments in GLP‑1s and how pharmacists can anticipate and support their evolving role in patient care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Christine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP
Professor, Pharmacy Practice and Clinical Pharmacist
Midwestern University

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATIONLearning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize recent regulatory and clinical updates related to GLP‑1 receptor agonists, including new formulations.
2. Describe emerging areas of research into the use of GLP‑1 therapies beyond diabetes and obesity treatment.

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Christie Schumacher is a speaker for and is on the advisory board for Abbott. All relevant financial relationships have been mitigated.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-081-H01-P
Initial release date: 3/9/2026
Expiration date: 3/9/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating confusion among patients and providers alike. This course explains what shared clinical decision‑making means in the context of immunizations, examines how it affects pediatric vaccine discussions, and highlights opportunities for pharmacists to support informed, individualized conversations with patients and caregivers. You will gain clarity on how to apply shared clinical decision‑making principles—alongside proven health coaching strategies—to strengthen patient trust and foster more meaningful dialogue in pharmacy practice.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Elizabeth Skoy, PharmD, RPh
Professor
North Dakota State University

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe shared clinical decision-making and how it applies to recent pediatric vaccine recommendations.
2. Identify the pharmacist's roles in counseling, education, and facilitating shared clinical decision-making conversations with patients and caregivers.

Rachel Maynard and Elizabeth Skoy have no relevant financial relationships with ineligible companies to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-077-H01-P
Initial release date: 3/2/2026
Expiration date: 3/2/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety and scope of use are also rising. This episode explores recent trends in gabapentin use, highlights key patient safety concerns, and examines pharmacist-led opportunities to reduce risks through education and medication review. You will walk away with timely insights to help navigate the growing complexities and responsibilities associated with gabapentin use.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Nakia Duncan, PharmD BCGP, BCPS
Associate Professor/ Pain& Palliative Care Clinical Pharmacist
Texas Tech Health Science Center - School of Pharmacy

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize recent national prescribing trends and safety concerns associated with gabapentin use.
2. Identify pharmacist-led strategies to support safe use, patient education, and medication review involving
gabapentin.

Rachel Maynard and Nakia Duncan have no relevant financial relationships with ineligible companies to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-053-H01-P
Initial release date: 2/23/2026
Expiration date: 2/23/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures — reflecting advances in antiretroviral therapy and evolving evidence. This course summarizes key changes, including preferred regimens, testing/follow‑up modifications, and special‑population considerations, and explores how these updates influence clinical practice. You will gain the practical knowledge needed to inform prompt PEP decision‑making, patient counseling, and care coordination.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Kenric Ware, Pharm DClinical Associate Professor of Pharmacy Practice
Mercer University

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify current guideline recommendations for initiating HIV PEP after occupational and non-occupational exposure.
2. Describe key considerations for selecting and managing HIV PEP regimens.

Rachel Maynard and Kenric Ware have no relevant financial relationships with ineligible companies to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-052-H01-P
Initial release date: 2/16/2026
Expiration date: 2/16/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance — are changing the landscape of Pre-Exposure Prophylaxis (PrEP) therapy. This course reviews the latest developments, compares prevention strategies, and examines how these changes affect PrEP delivery, counseling, and monitoring. You will gain timely insights to better counsel patients, support adherence, and contribute to prevention strategies in your practice.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
David Hachey, PharmD, AAHIVP
Professor
Idaho State University

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe key new HIV PrEP therapy options recently approved or recommended, including their dosing schedules and clinical indications.
2. Identify pharmacist responsibilities when counseling patients about PrEP, including initiation, adherence, monitoring, and risk-benefit discussions.

Rachel Maynard and David Hachey have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-049-H01-P
Initial release date: 2/9/2026
Expiration date: 2/9/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory conditions. This episode highlights approval pathways, interchangeability, and real-world challenges pharmacists may face when integrating biosimilars into care plans. You will walk away better prepared to support prescribers, counsel patients, and contribute to cost-effective, evidence-informed therapy decisions.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Reemal Zaheer, PharmD, CSPPharmacist
Johns Hopkins Medicine

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the role of biosimilars in the treatment of inflammatory conditions.
2. Describe considerations for the pharmacist when evaluating or counseling on biosimilar therapies.

Rachel Maynard and Reemal Zaheer have no relevant financial relationships with ineligible companies to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-045-H01-P
Initial release date: 2/2/2026
Expiration date: 2/2/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Menopausal hormone therapy has long carried a boxed warning (formerly a "black box warning") that may not accurately reflect the therapy's risk-benefit profile for all patients. This course discusses the FDA's recent removal of boxed warnings for select hormone therapy (HT) products, the rationale for this change, and how evolving guidance may impact patient care. You will explore strategies to support evidence-based counseling and individualized decision-making for patients considering HT.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Erin Raney, PharmD
Professor
Midwestern University College of Pharmacy

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize the FDA's updated position on boxed warnings for menopausal hormone therapy.
2. Identify key considerations for pharmacists when counseling patients about the benefits and risks of hormone therapy.

Rachel Maynard and Erin Raney have no relevant financial relationships with ineligible companies to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-044-H01-P
Initial release date: 1/26/2026
Expiration date: 1/26/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Ranitidine — once withdrawn from the market over safety concerns — was recently re‑approved by the FDA in a reformulated version, raising important questions for pharmacists and patients alike. This course outlines the FDA’s recent approval, reviews the reformulated product's changes (including manufacturing and labeling), and examines practical considerations for dispensing, counseling, and patient safety. You will gain clarity on when ranitidine may be appropriate for use (again) and how to guide patients confidently in its safe use.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
K. Ashley Garling-Nanez, PharmDAssistant Director of Program
UT Center of Health Communications

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: All your CE in one convenient subscription.

All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

What the Subscription Includes:

The Pharmacist CE Subscription includes:

· Compliance and licensure CE

· GameChangers Clinical Updates

· Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize the major safety and regulatory issues that prompted ranitidine's withdrawal, and the changes made in the reformulated product approved in 2025.
2. Describe pharmacist‑relevant considerations for dispensing, patient counseling, and transition from alternative acid‑reducing therapies.

Rachel Maynard and K. Ashley Garling-Nanez have no relevant financial relationships with ineligible companies to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-043-H01-P
Initial release date: 1/19/2026
Expiration date: 1/19/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Recent years have seen a troubling resurgence of whooping cough and measles — diseases many thought were largely controlled — highlighting the continuing importance of vaccination, surveillance, and community education. This course reviews the latest evidence on global and local trends, explores the factors driving renewed outbreaks, and discusses the key roles of pharmacists in prevention and early detection. You will gain insights to be better prepared to support immunization efforts, patient counseling, and public health awareness in response to this resurgence.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Christina O'Connor, PharmD, BCPS, BCIDPClinical Pharmacy Manager
Mayo Clinic

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: All your CE in one convenient subscription.

All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

What the Subscription Includes:

The Pharmacist CE Subscription includes:

· Compliance and licensure CE

· GameChangers Clinical Updates

· Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent epidemiologic trends in pertussis and measles resurgence and factors contributing to increased incidence.
2. Identify the pharmacist's responsibilities for promoting vaccination, encouraging timely immunization, supporting outbreak prevention, and providing patient education.

Rachel Maynard and Christina O'Connor have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-038-H01-P
Initial release date: 1/12/2026
Expiration date: 1/12/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Corticosteroids in the treatment of community-acquired pneumonia (CAP) remain a topic of clinical curiosity and mixed opinions. In this unique episode, two expert guests share opposing perspectives—one advocating for corticosteroid use in CAP and the other urging caution—offering pharmacists a balanced view of the current evidence and practice considerations. Tune in to explore both sides of the debate and walk away with insights to inform your role in collaborative patient care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUESTS
Sam Markle, PharmDCritical Care Pharmacist
Sanford Health

Tristan Houle, PharmDPGY2 Critical Care Pharmacy Resident
Sanford Health

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: All your CE in one convenient subscription.

All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

What the Subscription Includes:

The Pharmacist CE Subscription includes:

· Compliance and licensure CE

· GameChangers Clinical Updates

· Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current evidence supporting and challenging the use of corticosteroids in the treatment of community-acquired pneumonia (CAP).
2. Identify key considerations for pharmacists when evaluating corticosteroid use as adjunctive therapy in CAP.

Rachel Maynard, Sam Markle, and Tristan Houle have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-032-H01-P
Initial release date: 1/5/2026
Expiration date: 1/5/2027
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

As cannabis becomes more widely available and socially accepted, so does the misconception that it's safe to use during pregnancy and lactation. This course reviews updated guidance from the American College of Obstetricians and Gynecologists (ACOG), highlighting the evidence behind the risks and outlining how pharmacists can address misinformation and counsel patients effectively. You will learn how to support safe, informed decision-making that promotes the health of both parent and child.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Kevin Shea, PharmDPharmacist
Vytal Options

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: All your CE in one convenient subscription.

All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

What the Subscription Includes:

The Pharmacist CE Subscription includes:

· Compliance and licensure CE

· GameChangers Clinical Updates

· Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

If you are already enrolled in this course, click here to redeem your credit.
To purchase this episode and claim your CPE credit, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify current ACOG recommendations regarding cannabis use during pregnancy and lactation.
2. Describe pharmacist strategies for screening, counseling, and reducing risks associated with cannabis use during the perinatal period.

Rachel Maynard and Kevin Shea have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-377-H

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Recent preclinical studies highlight the potential of micro‑dosed lithium to modulate Alzheimer’s disease pathology and support neuronal health. This episode examines the molecular mechanisms, current evidence in Alzheimer’s models, and emerging considerations for safe use and monitoring. You will gain insights to navigate this evolving topic and support informed discussions around lithium micro‑dosing in Alzheimer’s care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Dawn Gerber, PharmD, BCGP, FASCP, FAzPA, CPAFHProfessor of Pharmacy Practice
Midwestern University

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: All your CE in one convenient subscription.

All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

What the Subscription Includes:

The Pharmacist CE Subscription includes:

· Compliance and licensure CE

· GameChangers Clinical Updates

· Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current evidence on the use of microdose lithium in Alzheimer's disease.
2. Identify pharmacist considerations for monitoring, patient selection, and safety in the context of lithium micro-dosing for Alzheimer's.

Rachel Maynard and Dawn Gerber have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-375-H01-P
Initial release date: 12/22/2025
Expiration date: 12/22/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Patients with fibromyalgia have waited more than a decade for a new therapeutic option, and a recent regulatory approval signals a shift for these patients. This episode reviews the clinical trial data, mechanism of action, dosing considerations, and pharmacist‑relevant monitoring for the newly approved sublingual formulation of cyclobenzaprine HCl. You will gain practical insights to inform patient education, therapy optimization, and interdisciplinary collaboration in fibromyalgia care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Amanda (Mandy) Mullins, PharmD, BCPS
Clinical Pharmacist Practitioner
Veterans Affairs

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: All your CE in one convenient subscription.

All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

What the Subscription Includes:

The Pharmacist CE Subscription includes:

· Compliance and licensure CE

· GameChangers Clinical Updates

· Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the mechanism of action and key clinical trial outcomes associated with the newly approved prescription medication for fibromyalgia.
2. Identify pharmacist responsibilities for dosing, monitoring adverse effects, and patient counseling when supporting the use of this new fibromyalgia therapy.

Rachel Maynard and Amanda (Mandy) Mullins have no relevant financial relationships with ineligible companies to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-371-H01-P
Initial release date: 12/15/2025
Expiration date: 12/15/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Pain relief medications like acetaminophen and ibuprofen are staples in everyday care—but emerging research suggests they may play a role in antibiotic resistance. This episode reviews recent findings, explores how these common drugs may influence bacterial response to antibiotics, and highlights pharmacist‑specific considerations. You will walk away with practical insights to support informed medication use and strengthen antibiotic stewardship.

HOST
Rachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Hunter O. Rondeau, PharmD, BCIDP, AAHIVPAntimicrobial Stewardship Coordinator, SSM Health
Adjunct Clinical Assistant Professor, University of Kansas School of Pharmacy

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: All your CE in one convenient subscription.

All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

What the Subscription Includes:

The Pharmacist CE Subscription includes:

· Compliance and licensure CE

· GameChangers Clinical Updates

· Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe emerging evidence on how common OTC pain medications may influence antibiotic resistance.
2. Identify pharmacist strategies to optimize analgesic and antibiotic use while supporting antimicrobial stewardship.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-372-H01-P
Initial release date: 12/8/2025
Expiration date: 12/8/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Recent FDA actions have brought renewed attention to leucovorin as a potential treatment for managing symptoms associated with autism spectrum disorder. This course explores the clinical distinctions between autism and cerebral folate deficiency, reviews key evidence behind leucovorin use, and outlines counseling considerations relevant to pharmacy practice. You will gain clarity on this complex and evolving topic to better support informed, evidence-based care.

HOST
Rachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

GUEST
Geoff Wall, PharmD, FCCP, BCPSProfessor of Pharmacy Practice
Iowa Methodist Medical Center

Rachel Maynard and Geoff Wall have no relevant financial relationships to disclose.

GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.

Pharmacist CE Subscription: All your CE in one convenient subscription.

All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!

What the Subscription Includes:

The Pharmacist CE Subscription includes:

· Compliance and licensure CE

· GameChangers Clinical Updates

· Practical continuing education across patient care topics

*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.

Purchase Now!

PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:

If you are already enrolled in this course, click here to redeem your credit.
To purchase thePharmacist CE Subscription and claim your CPE credit,click hereor to purchase this course individually, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current clinical evidence related to the use of leucovorin in autism and cerebral folate deficiency.
2. Identify key counseling considerations for pharmacists discussing leucovorin therapy with patients and caregivers.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-363-H01-P
Initial release date: 12/1/2025
Expiration date: 12/1/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Pharmacists play a critical role in infectious disease care, and staying up to date on antibiotic therapies is key to ensuring optimal patient outcomes. This episode reviews recently FDA-approved antibiotics, offers a practical refresher on commonly used antibiotic classes, and highlights frequent side effects—along with strategies for managing them in practice. Tune in to strengthen your clinical knowledge and support safe, effective antibiotic use across care settings.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Hunter Rondeau, PharmD, BCIDP, AAHIVPAntimicrobial Stewardship Coordinator
SSM Health

Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.

Hunter Rondeau is a consultant for Pyrls, a speaker for ASHP, and was a speaker for ACCP (ended October 2025) and Vituity (ended May 2025). All relevant financial relationships have been mitigated.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

If you are already enrolled in this course, click here to redeem your credit.
To purchase this episode and claim your CPE credit, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify newly FDA-approved antibiotics and their clinical indications.
2. Describe commonly used antibiotic classes, their typical side effects, and strategies to manage or mitigate those effects.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-362-H01-P
Initial release date: 11/24/2025
Expiration date: 11/24/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Discover the benefits of implementing a long-acting injectable (LAI) service at your pharmacy practice site and the impact this service can have on patient care and outcomes. Listen to this week’s episode and learn how to elevate your pharmacy services!

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Lindsay McCoy, PharmD, BCPP
Pharmacy Manager
Village Drug Shop at Advantage

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

If you are already enrolled in this course, click here to redeem your credit.
To purchase this episode and claim your CPE credit, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Analyze the benefits and challenges of implementing a long-acting injectable (LAI) service in a pharmacy practice site.
2. Discuss how an LAI service can improve patient care, increase financial sustainability, and optimize patient outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-354-H01-P
Initial release date: 11/17/2025
Expiration date: 11/17/2026
Additional CPE details can be found here.

Take your pharmacy practice to the next level with our comprehensive course on the administration of long-acting injectables:
Pharmacy-Based Administration of Long-Acting Injectables: A Sharp Idea4 hours | On DemandExplore a cutting edge clinical service opportunity with this collection of courses specifically designed to equip pharmacists with the knowledge and skills necessary for the effective management and administration of long-acting injectable medications (LAIs). Course content explores diverse drug profiles, advanced administration techniques, and the strategic implementation of LAI-related services to support the needs of your patients and communities.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Opioids remain a cornerstone of palliative care for patients with serious illnesses like cancer, yet their use is often misunderstood, undertreated, or approached with unnecessary hesitation. This episode explores what pharmacists need to know about assessing opioid appropriateness, questioning therapy when warranted, and supporting comfort-focused care within established clinical and ethical standards. Tune in to build confidence in your role and contribute meaningfully to the care of patients facing serious illness.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Lorin Fisher, PharmD, BCACPClinical Assistant Professor
University of Iowa College of Pharmacy

Joshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose.

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

If you are already enrolled in this course, click here to redeem your credit.
To purchase this episode and claim your CPE credit, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify the role of opioids in managing pain and other symptoms for patients receiving palliative care.
2. Describe key considerations for evaluating opioid prescriptions in the context of serious illness, including appropriate use and safety concerns.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-330-H01-P
Initial release date: 11/10/2025
Expiration date: 11/10/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Kalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPA
Professor
University of Florida College of Pharmacy

Joshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

If you are already enrolled in this course, click here to redeem your credit.
To purchase this episode and claim your CPE credit, click here.

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.
2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-312-H01-P
Initial release date: 11/3/2025
Expiration date: 11/3/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a higher risk of various ocular disorders, especially with long-term use. This episode reviews the findings of these studies, places them in context with the overall benefits of GLP-1s, and covers what pharmacists should know when counseling patients. Listen in to enhance your ability to guide safe, informed medication choices and stay updated on emerging safety information.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Jamie Pitlick, PharmD, BCPS, BC-ADM
Professor and Chair of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences

Joshua Davis Kinsey and Jamie Pitlick have no relevant financial relationships with ineligible companies to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the potential relationship between GLP-1 receptor agonist use and the development of ocular disorders.
2. Identify key considerations for pharmacist counseling related to GLP-1 therapy and ocular health.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-311-H01-P
Initial release date: 10/27/2025
Expiration date: 10/27/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Heart failure remains a leading cause of hospitalization, prompting ongoing research into treatment strategies that improve outcomes for patients. A recent study explores the potential of combining an MRA agent and SGLT2 inhibitor, showing meaningful clinical benefit while also reinforcing the need for thoughtful patient selection and safety monitoring. Tune in to explore how this evidence may shape pharmacist-driven care and contribute to more confident, individualized treatment decisions.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Zachary Cox, PharmD
Professor
Lipscomb University College of Pharmacy

Joshua Davis Kinsey has no relevant financial relationships to disclose.

Zachary Cox is a consultant for Roche, Reprieve Cardiovascular, Abiomed, Vectorious, Kestra Medical Technologies, and WhiteSwell. He was also a consultant for Lexicon Pharmaceuticals (ended 2025) and conducted research for AstraZeneca (ended 2024). All relevant financial relationships have been mitigated.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the clinical evidence supporting the use of multiple drug classes in combination therapy for heart failure.
2. Identify pharmacist considerations for evaluating patient-specific factors related to efficacy and safety of combination treatment approaches.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-299-H01-P
Initial release date: 10/20/2025
Expiration date: 10/20/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Diagnosis and prescribing are no longer on the margins for pharmacy practice, but explicitly called out in the ACPE Standards that guide pharmacy education. Once considered out of bounds for pharmacists, diagnostic reasoning is now central to preparing practice-ready graduates. This episode explores how preceptors can support learners in applying clinical decision-making frameworks, integrating shared decision-making, and navigating prescriptive authority across diverse practice settings—equipping the next generation of pharmacists for expanded patient care.

HOST
Kathy Schott, PhDVice President, Education & Operations
CEimpact

GUESTS
Jennifer Adams, PharmD, EdDAssociate Professor, Associate Dean for Academic Affairs
Idaho State University L.S. Skaggs College of Pharmacy

Rachel AllenAssociate Teaching Professor
University of Washington School of Pharmacy

Cherith Smith, PharmDClinical Assistant Professor and Director, Experiential Education
University of Montana – College of Health Skaggs School of Pharmacy

Kathy Schott, Jennifer Adams, Rachel Allen, and Cherith Smith have no relevant financial relationships with ineligible companies to disclose.

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE INFORMATION
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Describe key principles of diagnostic reasoning and prescribing within the context of pharmacy practice.
2. Identify evidence-based frameworks such as the One-Minute Preceptor and shared decision-making to support learner development in clinical settings.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-319-H99-P
Initial release date: 10/15/2025
Expiration date: 10/15/2028
Additional CPE details can be found here.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

As questions continue to surface about the potential link between prenatal acetaminophen use and autism spectrum disorder, pharmacists must be prepared to address patient concerns with confidence and clarity. This episode explores the current body of evidence, public health messaging, and practical strategies for counseling during pregnancy. Tune in to strengthen your knowledge and support safe, evidence-informed guidance for your patients.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
John Swegle, PharmDClinical Associate Professor
University of Iowa College of Pharmacy

Joshua Davis Kinsey and John Swegle have no relevant financial relationships with ineligible companies to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize current evidence regarding the association between prenatal acetaminophen exposure and autism spectrum disorder.
2. Identify patient counseling considerations for the safe use of acetaminophen during pregnancy.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-310-H01-P
Initial release date: 10/13/2025
Expiration date: 10/13/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Allergic reactions can range from a bothersome nuisance to a life-threatening emergency, making it crucial for pharmacists to stay informed about current treatment options and best practices. This episode discusses common triggers, effective therapies—from antihistamines and injections to the newly approved epinephrine nasal spray—and key counseling strategies to ensure patients receive safe, prompt relief. Tune in to improve your preparedness and support confident, patient-centered care.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

Rachel Maynard, PharmD
Lead Editor
Pyrls

Joshua Davis Kinsey and Rachel Maynard have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common triggers and clinical features associated with allergic reactions.
2. Describe available treatment options for allergic reactions, including newly approved therapies and their appropriate use.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-300-H01-P
Initial release date: 10/6/2025
Expiration date: 10/6/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

With numerous new medications launching each year, pharmacists play a vital role in translating complex drug information into practical, patient-centered care. This episode offers a brief overview of select FDA-approved drugs from the past year, highlighting their therapeutic importance, key considerations, and clinical uses. Whether counseling patients or working with healthcare providers, pharmacists need to stay informed about what’s new—and understand its impact on practice.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Joe Strain, PharmD
Professor of Pharmacy Practice
South Dakota State University/Monument Health Rapid City Hospital

Joshua Davis Kinsey and Joe Strain have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. List unique pharmacological properties for select newly approved medications.
2. Recognize important safety considerations, including adverse effects, interactions, and monitoring parameters, for each featured drug.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-295-H01-P
Initial release date: 9/29/2025
Expiration date: 9/29/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The FDA remains a powerful driver of change in pharmacy practice through its approvals, policies, and public health actions. This episode highlights timely FDA developments and emerging areas of focus that pharmacists need to be aware of—from regulatory shifts to new communication initiatives. Tune in to stay informed on FDA activity that could influence the way you practice and care for patients.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Mary Ross Southworth, PharmD
Principal
S&S Consulting Partners

Joshua Davis Kinsey has no relevant financial relationships to disclose.
Mary Ross Southworth is a consultant for Travere, Unicycive, Liquidia, and Mineralys. All relevant financial relationships have been mitigated.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize current FDA topics and areas of focus relevant to pharmacy practice.
2. Describe how current FDA priorities may impact medication use, pharmacist responsibilities, or patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-296-H03-P
Initial release date: 9/22/2025
Expiration date: 9/22/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

As more patients live beyond cancer treatment, survivorship care is becoming an essential—but often overlooked—part of the healthcare journey. This episode explores how pharmacists can support survivors through medication management, mental health awareness, lifestyle counseling, and connection to broader care resources. Tune in to learn how you can play a meaningful role in helping patients navigate life after cancer.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Erica Marchese, PharmD, BCPS, BCOP, BCSCP, MHAClinical Pharmacy Program Director
City of Hope

Joshua Davis Kinsey and Erica Marchese have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common physical, emotional, and medication-related challenges faced by patients in the survivorship phase of cancer care.
2. Describe the pharmacist's role in supporting survivorship through medication review, lifestyle counseling, and care coordination.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-292-H01-P
Initial release date: 9/15/2025
Expiration date: 9/15/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Falls are a leading cause of injury and death in older adults, and pharmacists are in a key position to help prevent them. This episode highlights how to identify medication risks, share practical prevention strategies, and connect patients with trusted tools and resources. Tune in to learn how you can make a meaningful impact in reducing falls in your community.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Kristin Meyer PharmD, BCGP, FASCP
Professor of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences

Joshua Davis Kinsey and Kristin Meyer have no relevant financial relationships to disclose.

RESOURCES

National Council on Aging (NCOA) Falls Prevention
NCOA Falls Prevention Awareness Week
NCOA Falls Free CheckUp®
CDC STEADI

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common medication classes and household hazards associated with increased fall risk in older adults.
2. Describe the pharmacist's role in fall prevention through medication review, patient education, and community engagement.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-269-H05-P
Initial release date: 9/8/2025
Expiration date: 9/8/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

With shifting policies, payment models, and an unpredictable respiratory virus landscape, pharmacy teams need more than clinical updates to prepare for the upcoming immunization season. This episode explores key issues shaping immunization practice today — including policy changes, billing and documentation trends, and how teams can proactively adapt and advocate for their role. Tune in for timely insights that go beyond the clinical headlines and complement our in-depth, on-demand course, Annual Immunization Update 2025.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Elizabeth Skoy, PharmDProfessor
North Dakota State University

Joshua Davis Kinsey and Elizabeth Skoy have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize recent policy and reimbursement updates that influence pharmacy-based immunization services and their potential to improve patient access to care.
2. Identify strategies pharmacy teams can use to prepare for the 2025-26 respiratory virus season in ways that support timely, equitable, and effective patient immunization.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-286-H01-P
Initial release date: 9/1/2025
Expiration date: 9/1/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Low-dose naltrexone (LDN) is generating growing interest as a potential therapy for conditions such as chronic pain and immune-related disorders. This episode offers a foundational overview of what LDN is, how it’s thought to work, where current evidence stands, and how pharmacists may encounter it in practice. Learn what pharmacists need to know to confidently approach patient questions about LDN and how it fits into current conversations in pharmacy and patient care.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Michelle Moser, RPhRetired Compounding Pharmacist

Joshua Davis Kinsey has no relevant financial relationships to disclose.

Michelle Moser was a volunteer board member for LDN Research Trust (ended June 2025), a board member for Alliance for Pharmacy Compounding (ended September 2024), and an employee of Revelation Pharma (ended June 2024). All relevant financial relationships have been mitigated.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Define low-dose naltrexone (LDN) and describe how it differs from traditional naltrexone dosing.
2. Identify proposed mechanisms of action and areas of emerging interest related to LDN use in practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-275-H01-P
Initial release date: 8/25/2025
Expiration date: 8/25/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Compounded medications serve a critical role in meeting patient-specific needs, but compliance is essential to ensure safety and quality. This episode covers what pharmacists need to know about documentation, prescription validity, beyond-use dating, and common missteps that can put compliance at risk. Tune in to strengthen your compounding practices and stay aligned with current regulatory expectations.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

Jessica Gustin, PharmD
CMO & PIC/COO
Gwinnett Drugs/SynerGrx

Joshua Davis Kinsey and Jessica Gustin have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify key compliance requirements related to patient-specific prescriptions and compounded medication preparation.
2. Describe common compliance challenges in pharmacy compounding and strategies to avoid regulatory missteps.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-273-H07-P
Initial release date: August 18, 2025
Expiration date: August 18, 2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Uncontrolled hypertension continues to drive cardiovascular risk and remains a major gap in chronic disease management. This episode discusses what pharmacists need to know to support treatment adherence, identify therapeutic gaps, and address barriers to blood pressure control. Listen to strengthen your role in helping patients achieve meaningful, sustained outcomes.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Ryan Jacobsen, PharmD, BCPS
Clinical Pharmacy Specialist
U of Iowa HealthCare

Joshua Davis Kinsey and Ryan Jacobsen have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common causes and consequences of uncontrolled hypertension in various patient populations.
2. Describe the pharmacist's role in recognizing gaps in therapy, addressing adherence, and supporting blood pressure control.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-271-H01-P
Initial release date: 8/11/2025
Expiration date: 8/11/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

With sexually transmitted infection (STI) rates continuing to rise, over-the-counter testing kits are expanding access to care, and pharmacists are well-positioned to support their safe and effective use. This episode explores key facts about available OTC kits, regulatory updates, counseling responsibilities, and the potential for test-and-treat models in pharmacy practice. Join us to learn how pharmacists can contribute meaningfully to STI prevention and care.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Elizabeth Skoy, PharmD
Professor
North Dakota State University

Joshua Davis Kinsey and Elizabeth Skoy have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify the types and regulatory status of over-the-counter STI testing kits available to patients.
2. Describe the pharmacist's role in educating patients on the use of OTC STI kits and recognizing potential opportunities to support follow-up care or treatment.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-270-H01-P
Initial release date: 8/4/2025
Expiration date: 8/4/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Pharmacists are key partners in helping patients navigate the challenges of managing pain safely and effectively. This episode covers practical strategies for counseling, identifying potential concerns in therapy, and supporting appropriate treatment, plus a quick review of the newly approved non-opioid option. Tune in to strengthen your clinical confidence and improve outcomes in pain care.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Lorin Fisher PharmD, BCACP
Residency Program Director
University of Iowa

Joshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize essential counseling points and patterns in medication use that pharmacists should address when managing patients with pain.
2. Describe the role of pharmacists in supporting safe and effective pain management, including awareness of newly approved medications.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-258-H08-P
Initial release date: 7/28/2025
Expiration date: 7/28/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

HIV treatment has evolved significantly, offering streamlined regimens and improved patient outcomes. This episode will discuss the latest antiretroviral therapy (ART) guidelines, highlighting preferred regimens, key pharmacologic considerations, and practical counseling strategies for pharmacists. Tune in to enhance your clinical knowledge and play a pivotal role in optimizing care for individuals living with HIV.

Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

Rachel Maynard, PharmD
Lead Editor
Pyrls

Joshua Davis Kinsey and Rachel Maynard have no relevant financial relationships to disclose.

BONUS: With this episode, you also get exclusive, FREE access to beautifully designed clinical charts and practice resources from our friends at Pyrls, that you can use in your everyday practice. Click the links below to access these practical tools:

HIV Pharmacotherapy
HIV Medications
And more!

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify current guideline-recommended antiretroviral therapy (ART) regimens and their key components.
2. Describe important counseling points for pharmacists supporting patients on HIV treatment, including adherence, side effects, and drug interactions.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-245-H02-P
Initial release date: 7/21/2025
Expiration date: 7/21/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Integrative oncology blends conventional cancer treatments with supportive therapies like nutrition, acupuncture, and mind-body practices to improve patient outcomes and quality of life. This episode outlines what pharmacists need to know about the principles of integrative medicine, how to evaluate evidence-based resources, and counseling tips for guiding patients through safe, effective complementary options. Tune in to strengthen your ability to support cancer patients with credible, compassionate, and comprehensive care.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Ginger Blackmon, PharmD
Associate Director of Clinical Initiatives
NCODA

Joshua Davis Kinsey and Ginger Blackmon have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Define integrative oncology and identify its role in supporting patients undergoing conventional cancer treatment.
2. Describe how pharmacists can evaluate and counsel on evidence-based complementary therapies used in integrative oncology.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-257-H01-P
Initial release date: 7/14/2025
Expiration date: 7/14/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Ginger Blackmon,PharmDAssociate Director of Clinical Initiatives
NCODA

Joshua Davis Kinsey and Ginger Blackmon have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-256-H01-P
Initial release date: 7/7/2025
Expiration date: 7/7/2028
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Dyslipidemia remains a major contributor to cardiovascular disease, and pharmacists play a key role in optimizing therapy and improving outcomes. This episode reviews recent updates in guidelines, pharmacologic options, and practical counseling tips for supporting patients with lipid disorders. Tune in to strengthen your clinical impact and support long-term health for the patients you serve.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Janelle Ruisinger, PharmD, FAPhAClinical Professor
The University of Kansas School of Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current guidelines and evidence-based pharmacologic options for managing dyslipidemia.
2. Identify key counseling strategies pharmacists can use to support adherence and improve lipid-related outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-226-H01-P
Initial release date: 6/30/2025
Expiration date: 6/30/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Fatty liver disease affects a growing number of patients, often progressing silently until advanced stages. This episode highlights what pharmacists need to know about recent terminology changes, risk factors, pharmacotherapy updates, and key counseling strategies to support patients. Tune in to sharpen your clinical knowledge and help identify, manage, and educate patients at risk for this increasingly common condition.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Sarah Wheeler, PharmD, BCACP, CDCES
Assistant Professor
VCU School of Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current terminology, risk factors, and stages associated with fatty liver disease.
2. Identify evidence-based pharmacologic and non-pharmacologic strategies that pharmacists can use to support patients with or at risk for fatty liver disease.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-219-H01-P
Initial release date: 6/23/2025
Expiration date: 6/23/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this episode, Kathy Schott sits down with Dr. Kate Smith, clinical faculty and pharmacy education expert, to explore one of the most critical and challenging aspects of training student pharmacists and residents: developing clinical reasoning skills. Drawing from over a decade of experience in both clinical practice and education, Dr. Smith discusses nuanced differences between clinical reasoning, critical thinking, and problem-solving and offers preceptors practical, classroom-tested strategies to support learners. From using patient cases and SOAP notes to applying the "One Minute Preceptor" model, this episode is a must-listen for any pharmacy educator or preceptor aiming to foster confident, capable, and patient-centered practitioners.

Host
Kathy Schott, PhDVice President, Education & Operations
CEimpact

Guest
Kathryn (Kate) Smith, PharmD, BCACP
Associate Professor of Instruction
University of Iowa College of Pharmacy

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Differentiate clinical reasoning from critical thinking and problem-solving
2. Identify practical strategies to teach and assess clinical reasoning skills in student pharmacists and residents in experiential settings.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-215-H99-P
Initial release date: 6/18/2025
Expiration date: 6/18/2028
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Asthma management continues to evolve, with updated guidelines emphasizing personalized care, smart inhaler use, and early intervention. This episode reviews key pharmacotherapy updates, stepwise treatment strategies, and practical counseling tips to support adherence and inhaler technique. Tune in to strengthen your role in improving outcomes for patients living with asthma.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Rachel Maynard, PharmD
Lead Editor
Pyrls

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current guideline-recommended pharmacologic treatments for asthma, including stepwise therapy approaches.
2. Identify key counseling points for improving inhaler technique, adherence, and asthma control in patients.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-214-H01-P
Initial release date: 6/16/2025
Expiration date: 6/16/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Creatine is often associated with athletic performance, but growing evidence points to its broader benefits for brain health, aging, and overall muscle preservation. This episode breaks down what pharmacists need to know about creatine’s evidence-based uses, safety considerations, and counseling opportunities. Tune in to strengthen your knowledge and help ensure patients receive accurate, evidence-based information about this widely used supplement.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Mark Smith, PharmD, CDCES, AFAA-CGFI
Pharmacist
UAB Medicine

Ian Haywood, PharmD, BCPS, CDCES
Clinical Pharmacist
Baptist Memorial Hospital

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the evidence-based uses of creatine beyond athletic performance, including its potential benefits for brain health and aging.
2. Identify key counseling points for pharmacists when discussing creatine supplementation with patients.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-200-H01-P
Initial release date: 6/9/2025
Expiration date: 6/9/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Long COVID continues to affect millions, leaving patients with persistent symptoms that impact daily life and overall health. Pharmacists are uniquely positioned to recognize these patients, recommend supportive treatments, and provide guidance on symptom management. Tune in to learn how you can help improve the quality of life for those struggling with this complex condition.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Dan Majerczyk, Pharm.D., Ed.M., FCCP, BCPS, BCADM, CACP
Associate Professor of Clinical Sciences/Chair of Teaching and Academic Excellence
Roosevelt University College of Science, Health and Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common symptoms of Long COVID and the pharmacist's role in recognizing patients who may need further evaluation or support.
2. Describe strategies for managing Long COVID symptoms, including pharmacologic and non-pharmacologic approaches.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-198-H01-P
Initial release date: 6/2/2025
Expiration date: 6/2/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

With over-the-counter birth control expanding access to contraception, pharmacists have a growing role in guiding patients through their options, ensuring safe use, and providing essential counseling. This episode explores the pharmacist’s role in OTC birth control recommendations, patient education, and broader hormonal contraception services within community pharmacy practice. Tune in to learn how you can confidently support patients in making informed decisions about their reproductive health.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Kate Riddell, PharmD, MS
Pharmacist
Consultant/CPESN IN

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

Looking for more information on Over-the-Counter Contraception? Check out our course, Pharmacist Prescribing of Hormonal Contraceptives: An Advanced Training!

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the pharmacist's role in recommending and counseling patients on over-the-counter birth control and other hormonal contraception options.
2. Identify key safety considerations, eligibility criteria, and best practices for providing contraception services in a community pharmacy setting.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-191-H01-P
Initial release date: 5/26/2025
Expiration date: 5/26/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Pharmacists are stepping into a critical role in addiction treatment, expanding access to life-saving medications like buprenorphine through pharmacy-based MOUD clinics. This episode examines how this innovative model is transforming care for patients with opioid use disorder and what pharmacists need to understand before considering an expansion of services in this space. Tune in to learn how pharmacist-led addiction treatment can improve patient outcomes, strengthen communities, and help combat the opioid crisis.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Korey Kreider, PharmD
Pharmacist, Owner
Medicine Man

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the role of pharmacists in providing medication for opioid use disorder (MOUD) and the impact of pharmacy-based addiction treatment services.
2. Identify key regulatory and scope of practice considerations pharmacists must evaluate before expanding services to include addiction treatment.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-190-H01-P
Initial release date: 5/19/2025
Expiration date: 5/19/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Travel health is more than just vaccines—pharmacists play a crucial role in protecting patients from preventable illnesses with essential immunizations, OTC medications, and prescription therapies. This episode explores the key components of a successful travel clinic, from vaccine recommendations to counseling on travel-related health risks. Tune in to learn how you can expand your impact and help travelers stay safe and healthy on their journeys.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Regina Richardson, PharmD
Pharmacist
Bremo Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify key vaccines, OTC medications, and prescription therapies recommended for travelers based on destination-specific health risks.
2. Explain the pharmacist's role in providing travel health services, including patient counseling, risk assessment, and preventive care strategies.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-160-H01-P
Initial release date: 5/12/2025
Expiration date: 5/12/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Building on the science of the gut-brain axis, this episode focuses on actionable strategies pharmacists can use to counsel patients on mental health, gut-related medication effects, and evidence-based lifestyle interventions. From tailored counseling tips to supplement and nutrition guidance, pharmacists will learn how to support patients managing both GI and mental health symptoms. Tune in to discover how small conversations can lead to big health improvements in both gut and brain function.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Lara Zakaria, PharmD, MS, CNS, CDN, IFMCP
Owner, Founder
Foodie Farmacist LLC

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify evidence-based strategies pharmacists can use to support patients with gastrointestinal issues linked to mental health conditions.
2. Explain how lifestyle, diet, and complementary supplements influence the gut-brain connection to support patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-154-H01-P
Initial release date: 5/5/2025
Expiration date: 5/5/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The gut and brain are in constant conversation, influencing everything from mood and motivation to digestion and hormonal health. In this episode, we unpack the fundamentals of the gut-brain axis, including the role of the microbiome, common medications that impact gut health, and how those changes can ripple into mental well-being. Tune in to build your foundational knowledge and start recognizing how pharmacy practice intersects with the gut-brain connection.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Lara Zakaria, PharmD, MS, CNS, CDN, IFMCP
Owner, Founder
Foodie Farmacist LLC

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the physiological connection between the gut and brain, including the role of the microbiome in mental and neurological health.
2. Describe how some drugs can influence the composition and function of the gut microbiome.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-153-H01-P
Initial release date: 4/28/2025
Expiration date: 4/28/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Headaches are a common yet complex condition, requiring pharmacists to differentiate between primary and secondary causes while providing effective treatment options. This episode explores evidence-based strategies for the management of headaches, emphasizing the pharmacist’s role in improving outcomes for patients with headaches. Stay informed and enhance your clinical expertise to better support patients dealing with this challenging condition.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Alison Martin, PharmD
Clinical Pharmacist
VA Healthcare System

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Classify a headache as either primary or secondary.
2. Explain evidence-based strategies for the management of migraines, including pharmacologic and non-pharmacologic approaches.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-119-H01-P
Initial release date: 4/21/2025
Expiration date: 4/21/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Dry eye syndrome is a common yet often overlooked condition that can significantly impact a patient’s quality of life. This episode explores the causes, symptoms, and latest treatment options, equipping pharmacists with the knowledge to provide effective counseling and recommend appropriate therapies. Tune in to enhance your expertise and help patients find relief from this chronic and frustrating condition.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Jennifer Salvon, BSPharm, RPh
Clinical Pharmacist, Medical Writer
Salvon Scientific

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the causes, symptoms, and risk factors associated with dry eye syndrome.
2. Identify evidence-based treatment options and counseling strategies pharmacists can use to help patients manage dry eye symptoms effectively.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-115-H01-P
Initial release date: 4/14/2025
Expiration date: 4/14/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Osteoporosis remains a significant health concern, with new screening and treatment guidelines aiming to improve prevention and care. This episode explores updated recommendations, the latest therapeutic options, and how medications for other conditions can impact bone health. Stay informed and ready to support your patients—tune in to learn how pharmacists can make a difference.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Erin Raney, PharmD, BCPS, BC-ADM
Professor
Midwestern University College of Pharmacy, Glendale Campus

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the updated screening and treatment guidelines for osteoporosis and their implications for patient care.
2. Identify medications that affect bone health strategies for pharmacists to mitigate their impact on osteoporosis risk.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-088-H01-P
Initial release date: 4/7/2025
Expiration date: 4/7/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Hormone replacement therapy (HRT) remains a cornerstone of managing menopausal symptoms, but understanding the latest evidence is crucial for safe and effective use. This episode dives into evidence-based therapies, weighing benefits and risks and highlighting the pharmacist’s role in guiding personalized care. Tune in to stay updated on the science behind HRT and its evolving role in patient care.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Ashley Meredith, PharmD, MPH, BCACP, BCPS, CDCES, FCCP
Clinical Professor
Purdue University

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the latest evidence-based approaches to hormone replacement therapy (HRT) for managing menopausal symptoms.
2. Identify key considerations for pharmacists when counseling patients on the benefits, risks, and appropriate use of HRT.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-087-H01-P
Initial release date: 3/31/2025
Expiration date: 3/31/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this episode, we dive into the evolving use of Entrustable Professional Activities (EPAs) as a tool for assessing and supporting learner development in pharmacy experiential education. Dr. Abigail Elmes, Research Assistant Professor at the University of Illinois Chicago College of Pharmacy, shares her insights on implementing EPA-based assessments in Advanced Pharmacy Practice Experiences (APPEs). Whether you're new to EPAs or navigating their integration into your practice site, this episode offers practical strategies to promote student growth, improve feedback conversations, and overcome common barriers in EPA-based assessment.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Abigail Elmes, PharmD, MHPE, BCPS
Research Assistant Professor
University of Illinois Chicago College of Pharmacy

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Explain the purpose and structure of Entrustable Professional Activities (EPAs) in pharmacy education
2. Identify strategies to provide effective learner feedback using entrustment-supervision scales

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-147-H99-P
Initial release date: 3/26/2025
Expiration date: 3/26/2028
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Want more education on this or other topics?Check out this article authored by our guest, Dr. Abigail Elmes, and colleagues – Preceptor Perspectives Using Entrustable Professional Activity-Based Assessments During Advanced Pharmacy Practice Experiences.

And here are links to a few great resources:

ten Cate O. Nuts and bolts of entrustable professional activities. J Grad Med Educ. 2013;5(1):157-158. doi:10.4300/JGME-D-12-00380.1
ten Cate O, Jarrett JB. Would I trust or will I trust? The gap between entrustment determinations and entrustment decisions for trainees in pharmacy and other health professions. Pharmacy. 2023;11(3):107. doi:10.3390/pharmacy11030107
ten Cate O, Schwartz A, Chen HC. Assessing trainees and making entrustment decisions: on the nature and use of entrustment-supervision scales. Academic Medicine. 2020;Publish Ahead of Print. doi:10.1097/ACM.0000000000003427
Persky AM, Fuller KA, Cate O ten. True entrustment decisions regarding entrustable professional activities happen in the workplace, not in the classroom setting. Am J Pharm Educ. 2021;85(5):8536. doi:10.5688/ajpe8536

Check out the full library of Preceptor By DesignTM courses available for preceptors on the CEimpact website. Ask your experiential program director or residency program director if you are a member so tha

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Tapering antidepressants requires careful planning to minimize withdrawal symptoms and ensure patient safety. This episode provides pharmacists with a brief update on antidepressant therapies and essential education on tapering, including recognizing withdrawal risks, adjusting schedules, and counseling patients effectively. Don’t miss this opportunity to stay informed and enhance your skills in supporting patients through their mental health treatment journey.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Sara Grady, PharmD, BCPS, BCPP
Professor, Clinical Pharmacist
Drake University
Broadlawns Medical Center

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the mechanisms of action of antidepressant therapies and their implications for patient care.
2. Explain best practices for tapering antidepressants, including recognizing withdrawal risks and providing effective patient counseling.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-075-H01-P
Initial release date: 3/24/2025
Expiration date: 3/24/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

GLP-1 receptor agonists are revolutionizing healthcare, offering benefits far beyond glucose management—from weight loss to potential improvements in sleep apnea and cardiovascular health. This episode explores the multifaceted roles of GLP-1s, the latest evidence behind their expanding uses, and what pharmacists need to know to maximize their impact. Don’t miss this chance to stay informed on one of the most versatile classes of medications shaping patient care today!

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
John Swegle, PharmD
Clinical Associate Professor
University of Iowa College of Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the diverse therapeutic applications of GLP-1 receptor agonists, including their roles in glucose management, weight loss, and other emerging uses.
2. Identify key considerations for pharmacists in optimizing GLP-1 therapy to improve patient outcomes across various conditions.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-074-H01-P
Initial release date: 3/17/2025
Expiration date: 3/17/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Hypertension remains a leading contributor to cardiovascular disease, but advancements in its management are reshaping treatment strategies. This episode highlights the latest updates in hypertension guidelines, emerging therapies, and practical approaches pharmacists can use to optimize care. Don’t miss this chance to stay informed and elevate your role in improving patient outcomes.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Joseph Saseen, PharmD, BCPS, BCACP, CLS, ASH-CHCProfessor and Associate Dean for Clinical Affairs
University of Colorado

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent updates in hypertension management guidelines and their implications for patient care.
2. Identify emerging therapies and evidence-based strategies pharmacists can use to optimize hypertension treatment and improve outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-058-H01-P
Initial release date: 3/10/2025
Expiration date: 3/10/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Antibiotic resistance is a growing global crisis, and pharmacists are on the frontlines of combating this threat through effective stewardship practices. This episode explores the latest updates in antimicrobial stewardship and shares actionable strategies to combat resistance and optimize antibiotic use. Tune in to strengthen your role as a steward of antibiotic efficacy and help preserve these life-saving medications for future generations.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Geoff Wall, PharmD, FCCP, BCPS
Professor of Pharmacy Practice
Iowa Methodist Medical Center

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the impact of antibiotic resistance on public health and the role of antimicrobial stewardship in addressing this crisis.
2. Identify evidence-based strategies pharmacists can implement to optimize antibiotic use and combat resistance in their practice settings.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-057-H01-P
Initial release date: 3/3/2025
Expiration date: 3/3/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Alzheimer’s Disease remains one of the most pressing challenges in healthcare, with new treatments and research breakthroughs reshaping the landscape of care. This episode dives into the latest advancements, including current medications, clinical trials, and emerging therapies that pharmacists need to know. Stay informed and ready to support patients and caregivers—tune in to expand your expertise and navigate this evolving field with confidence.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
James Hoehns, PharmD, BCPS
Clinical Professor
University of Iowa

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the current treatment options for Alzheimer's Disease.
2. Identify key considerations for pharmacists when counseling patients and caregivers on Alzheimer's Disease management and emerging therapies.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-042-H01-P
Initial release date: 2/24/2025
Expiration date: 2/24/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Stay up-to-date on the latest advancements in antipsychotic medications and how they’re shaping the management of mental health conditions. This episode highlights new formulations, expanded indications, and emerging treatment trends that every pharmacist should know. Don’t miss the chance to enhance your expertise and improve patient care!

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Katelynn Mayberry, PharmD
Clinical Assistant Professor of Pharmacy Practice
Mercer University College of Pharmacy

REFERENCEThe American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.177901

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Recall recent advancements in antipsychotic medications, including new formulations and expanded therapeutic indications.
2. Identify key considerations for pharmacists in optimizing the use of updated antipsychotic treatments to improve patient outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-031-H01-P
Initial release date: 2/17/2025
Expiration date: 2/17/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Explore the ADA 2025 Diabetes Guideline updates from a different lens – one focused on non-glycemic parameters like cardiovascular health, kidney protection, and weight management. This episode highlights evidence-based recommendations to equip pharmacists with the necessary knowledge to take a more holistic approach to patient care. Listen and discover how to integrate these key updates into your practice to improve outcomes beyond glycemic control.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Justinne Guyton, PharmD, BCACP
Associate Professor of Pharmacy Practice
University of Health Sciences and Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify three key non-glycemic updates in the ADA 2025 Diabetes Guidelines.
2. Explain the pharmacists role in addressing non-glycemic parameters in diabetes care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-030-H01-P
Initial release date: 2/10/2025
Expiration date: 2/10/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Learn the essentials of 340B pharmacy and how this program supports access to affordable medications for underserved communities. This episode simplifies key concepts, explains how 340B works, and offers practical guidance for pharmacists just getting started. Tune in to build your confidence and take the first step toward understanding the impact of 340B in your practice!

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Amanda Gaddy, R.Ph.
Co-Founder, COO
Secure340B

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the purpose and structure of the 340B Drug Pricing Program, including its role in expanding access to affordable medications.
2. Identify key responsibilities and considerations for pharmacists participating in 340B programs, including compliance and operational basics.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-020-H04-P
Initial release date: 2/3/2025
Expiration date: 2/3/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Are your student pharmacists or residents struggling with written communication? Join us for a candid conversation with experienced preceptor and former residency director Josh Kinsey, who shares creative, practical strategies to help pharmacy learners enhance their writing—from grammar and spelling to professional documentation and literature analysis. Discover tools, activities, and tips to foster these critical skills while balancing the demands of busy rotations. Tune in and gain insights that will empower you and your learners to succeed!

HOST
Kathy Schott, PhDVice President, Education & Operations
CEimpact

GUEST
Joshua David Kinsey, PharmD
Vice President, Education
CEimpact

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Identify common barriers that hinder student pharmacists writing development
2. Describe innovative and structured approaches to teach foundational and professional writing skills as part of experiential learning

0.075 CEU/0.75 Hr
UAN: 0107-0000-25-044-H99-P
Initial release date: 1/29/2025
Expiration date: 1/29/2028
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Stay ahead in stroke prevention with insights from the updated AHA/ASA guidelines, designed to optimize care for at-risk patients. This episode highlights key changes, actionable strategies, and the pharmacist’s role in reducing stroke incidence through evidence-based interventions. Tune in to stay informed and enhance patient outcomes in stroke prevention.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Justinne Guyton, PharmD, BCACP
Associate Professor of Pharmacy Practice
University of Health Sciences and Pharmacy

Reference2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association
https://www.ahajournals.org/doi/10.1161/STR.0000000000000475

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify three key updates in the AHA/ASA 2024 Stroke Prevention Guideline.
2. Explain the pharmacists role in applying evidence-based strategies for stroke prevention.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-022-H01-P
Initial release date: 1/27/2025
Expiration date: 1/27/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Discover how pharmacists can play a pivotal role in improving the quality of life for patients with cancer through supportive care interventions. This episode explores practical strategies for managing side effects, enhancing adherence, and addressing the unique needs of oncology patients. Don’t miss this chance to expand your impact—listen now and learn how to provide compassionate, evidence-based care to your patients.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Olivia Fahey, PharmD, BCOPCancer Care Education Pharmacist
The University of Kansas Cancer Center

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe common supportive care needs for patients with cancer, including management of side effects and comorbidities.
2. Identify evidence-based strategies pharmacists can use to enhance medication adherence and improve the overall quality of life for patients with cancer.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-021-H01-P
Initial release date: 1/20/2025
Expiration date: 1/20/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Explore the emerging role of psychedelics in pharmacy practice and their potential to transform mental health treatment. This episode dives into the science, safety, and regulatory considerations pharmacists need to know as these therapies move toward mainstream use. Don’t miss this opportunity to stay ahead of the curve—tune in and expand your understanding of this groundbreaking area of care!

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Colby Burns, PharmDClinical Pharmacist, CHAS Healthcare
President, Psychedelic Pharmacist Association
Owner/Host, Neural Pharm Online Platform and Podcast

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the current evidence and therapeutic potential of psychedelics in treating mental health conditions.
2. Identify key safety, regulatory, and clinical considerations for pharmacists as psychedelics become integrated into patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-023-H01-P
Initial release date: 1/13/2025
Expiration date: 1/13/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The rise of electronic tobacco use, especially among young adults, poses new challenges for public health and pharmacy practice. This episode highlights the pharmacist's role in addressing vaping trends through patient education, harm reduction strategies, and community outreach. Tune in to learn how you can make a meaningful impact in curbing this growing epidemic.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Francis M. Vitale, MANational Director
Pharmacy Partnership for Tobacco Cessation

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the current trends and health risks associated with electronic tobacco use.
2. Identify evidence-based strategies pharmacists can use to address vaping in their practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-015-H04-P
Initial release date: 1/6/2025
Expiration date: 2/6/2026
Additional CPE details can be found here.

LOOKING FOR MORE SMOKING CESSATION TRAINING? Click here to check out our advanced training course!

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Medications play a crucial role in managing symptoms and enhancing the quality of life for individuals with autism spectrum disorders, yet their use requires careful consideration and specialized knowledge. Pharmacists are essential in navigating the nuances of these therapies, from dosing adjustments to monitoring for side effects and interactions. Join us to expand your expertise in supporting this unique patient population through informed, compassionate care.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Jena Quinn, PharmD
CEO
Perfecting Peds

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify commonly used medications for managing symptoms in autism spectrum disorders and their primary therapeutic effects.
2. Describe key considerations for dosing, side effects, and drug interactions in medications prescribed for autism spectrum disorders.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-319-H01-P
Initial release date: 12/30/2024
Expiration date: 12/30/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Cough and cold season brings a surge of questions about over-the-counter treatments, making it vital for pharmacists to stay sharp on the latest recommendations and safety considerations. This episode offers a review of common OTC medication options, including their efficacy, appropriate use, and potential interactions. Enhance your confidence in guiding patients through the maze of choices—tune in to this episode for a refresher!

**THE GAMECHANGER: We are the medication experts. And really, even in this over-the-counter space, we have so much knowledge and there's so much we can do to help make sure our patients are walking away with a remedy that is safe for them, is hopefully effective for them. And that is the best fit for them.

HOST
Joshua Davis Kinsey, PharmD**VP, Education
CEimpact

GUEST
Kate Riddell, PharmD, MSPharmacist
Consultant

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify commonly used over-the-counter medications for cough and cold.
2. Describe key safety considerations, including contraindications and potential drug interactions, for OTC cough and cold medications.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-317-H01-P
Initial release date: 12/23/2024
Expiration date: 12/23/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this episode, host Kathy Schott and guest Andrea Sikora explore the transformative power of artificial intelligence in pharmacy education and clinical teaching. Join us as we discuss the latest trends in AI, practical strategies for integrating these tools into your teaching routine, and the challenges preceptors face in this rapidly evolving field. From selecting the right AI platforms to ensuring students critically evaluate AI-generated insights, we’ll provide actionable advice and real-world success stories to inspire innovation in your practice. Whether you’re a seasoned preceptor or just beginning your AI journey, this episode is your guide to leveraging technology for better learning and patient care. Tune in and transform the way you teach with AI!

Host
Kathy Schott, PhDVice President, Education & Operations
CEimpact

Guest
Andrea Sikora, PharmD, MSCR, BCCCP, FCCP, FCCMClinical Associate Professor
University of Georgia College of Pharmacy

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Describe how AI is transforming pharmacy practice and its implications for clinical education.
2. Discuss methods to balance AI recommendations with traditional clinical decision-making skills.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-322-H99-P
Initial release date: 12/18/2024
Expiration date: 12/18/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join us as we discuss the alarming rise of pediatric pneumonia and pertussis cases, unpacking the latest clinical insights and prevention strategies essential for today’s pharmacists. In this episode, we’ll explore the factors driving these trends, discuss how pharmacists can play a crucial role in patient education, and review updates to vaccine recommendations. Don’t miss this opportunity to stay at the forefront of patient care—tune in and be a proactive advocate in safeguarding children's health!

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Mona Ligvani, PharmD, APhClinical Pharmacist
Children’s Health Initiative for Medication Education (CHIME)

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the recent trends in pediatric pneumonia and pertussis incidence and their contributing factors.
2. Identify key vaccination recommendations and prevention strategies for pediatric pneumonia and pertussis.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-315-H06-P
Initial release date: 12/16/2024
Expiration date: 12/16/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Explore the latest GOLD guidelines for COPD management and discover how these updates can transform your patient care approach. In this episode, we break down key changes, practical applications, and evidence-based strategies to improve outcomes for your patients. Listen in and empower yourself to take a proactive role in optimizing COPD management in your practice.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Allison Hursman, PharmD, BCGP, CTTSPopulation Health Pharmacist
Essentia Health

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the rationale behind key evidence-based recommendations in the updated COPD guidelines.
2. Describe the intended impact of these updated COPD guidelines on disease management.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-309-H01-P
Initial release date: 12/9/2024
Expiration date: 12/9/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Hot flashes may be the most talked-about symptom of menopause, but how much do you know about managing them for your patients? In this episode, we uncover treatment options, debunk common myths, and explore how pharmacists can offer crucial support during this transition. Tune in to empower your patients with the knowledge and care they need—don’t miss an opportunity to get the latest on this “hot” topic!

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Anna Garrett, PharmD, BCPS, AFMCP
CEO
Dr. Anna Garrett

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the physiological mechanisms behind hot flashes during menopause and their impact on a patients quality of life.
2. Identify treatment options for managing hot flashes that pharmacists can recommend to patients experiencing menopause.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-308-H01-P
Initial release date: 12/2/2024
Expiration date: 12/2/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Did you know that ketamine, once known only as an anesthetic, is now being hailed as a game-changer in mental health and pain management? This episode dives into the surprising ways ketamine is revolutionizing treatments for depression, migraine headaches, and more. Get ready for a mind-blowing exploration of how this "wonder drug" could transform your pharmacy practice—don't miss out!

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Geoff Wall, PharmD, BCPS FCCP
Professor of Pharmacy Practice
Drake University

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Recall the pharmacological mechanisms of ketamine and its emerging therapeutic uses in mental health and pain management.
2. Discuss the potential clinical benefits and risks of incorporating ketamine into pharmacy practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-296-H01-P
Initial release date: 11/25/2024
Expiration date: 11/25/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this episode of Precept to Practice, host Kathy Schott speaks with Melissa McLean, Sue Cornell, and student pharmacists Nikesh Kumar and Justine Kaminski to explore a unique collaboration between Oswald’s Pharmacy and Midwestern University. Together, they established a diabetes-focused screening service led by pharmacy students, providing patients with critical access to blood pressure and A1C screenings. This partnership highlights the powerful role community pharmacies play in healthcare and the growth opportunities for students to lead and learn in real-world settings.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Melissa McLean
Pharmacy Manager
Oswald's Pharmacy
Naperville, IL

Sue Cornell
Director of Experiential Education
Professor of Pharmacy Practice
Midwestern University
Downers Grove, IL

Nikesh Kumar
PharmD Candidate 2025
Midwestern University
Downers Grove, IL

Justine Kaminski
PharmD Candidate 2025
Midwestern University

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Outline factors for consideration in developing a student-led screening service
2. Recognize the educational, professional, and community-related advantages, as well as the logistical challenges, of involving students in community health services

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-313-H99-P
Initial release date: 11/20/2024
Expiration date: 11/20/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Explore the complexities of legal liabilities and risks associated with pharmacy clinical services, such as point-of-care testing (POCT) and immunization administration. This episode will offer strategies for managing potential legal challenges, including handling adverse reactions and sensitive patient results while ensuring compliance with legal and regulatory standards. Listen to this episode and equip yourself with the knowledge to navigate these challenges and provide safe, effective care to your community.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
David Brushwood, RPh, JD
Senior Lecturer
U of Wyoming

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify potential legal risks and liabilities associated with various pharmacy clinical services.
2. Describe strategies to manage adverse events and patient outcomes in compliance with legal and regulatory requirements.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-295-H03-P
Initial release date: 11/18/2024
Expiration date: 11/18/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

This podcast explores the evolving role of pharmacists in the "food as medicine" movement, highlighting how nutrition can complement medication therapies in disease prevention and management. Learn practical strategies for counseling patients on nutrition and navigating medication-nutrient interactions to optimize therapeutic outcomes. Stay ahead of the curve—tune in and enhance your pharmacy practice by incorporating food-based interventions into patient care.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Marry Vuong, PharmD, BCPPS
Chief of Staff
Perfecting Peds

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify key nutritional strategies that complement medication therapies in the prevention and management of chronic diseases.
2. Explain common medication-nutrient interactions and their implications for patient care in pharmacy practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-271-H01-P
Initial release date: 11/11/2024
Expiration date: 11/11/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this episode, we explore the vital role pharmacists play in harm reduction strategies in pharmacy practice. Discover how pharmacy-led initiatives and interventions can save lives and transform pharmacy practice. Join us as we discuss opportunities, challenges, and actionable steps for integrating harm reduction into your pharmacy practice site.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Lindsay McCoy, PharmD, BCPPPharmacy Manager
Village Drug Shop at Advantage

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the importance of harm reduction in pharmacy practice.
2. Identify key harm reduction strategies and steps for their implementation into pharmacy practice sites.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-291-H04-P
Initial release date: 11/4/2024
Expiration date: 11/4/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

This episode discusses the relevancy of the Beers Criteria in clinical practice, examining how recent changes impact medication safety and prescribing practices for older adults. Learn strategies for effective deprescribing and discover best practices for applying these criteria to improve patient outcomes. This essential episode equips healthcare professionals with the knowledge needed to navigate complex medication regimens and advocate for safer prescribing practices.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Kristin Meyer, PharmD, BCGP, FASCPProfessor of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences

REFERENCE
American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss recent updates to the Beers Criteria and their impact on medication safety for older adults.
2. Describe evidence-based strategies to implement the Beers Criteria and manage complex medication regimens in clinical practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-282-H01-P
Initial release date: 10/28/2024
Expiration date: 10/28/2025
Additional CPE details can be found here.

Looking for more? Check out our course on deprescribing in older adults:
Less is More: A Patient-Centered Approach to Deprescribing for Older Adults1 hour | On DemandPolypharmacy in older adults leads to significant health risks and increased costs. Learn how to effectively engage in deprescribing, using patient-centered and evidence-based approaches to reduce unnecessary medications. Enroll in this course to enhance your skills in facilitating safer medication practices, become a leader in deprescribing, and improve patient outcomes!

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this episode of Precept2Practice, host Kathy Schott dives into the critical topic of psychological safety with guest Lisa Buss-Preszler, Pharmacy Education Supervisor at Mayo Clinic in Arizona. Together, they explore how fostering psychological safety in clinical learning environments empowers pharmacy students and professionals to thrive. Lisa provides practical strategies for preceptors to build trust, encourage open communication, and normalize failure, helping learners feel safe to ask questions and take risks. Tune in to learn how you can create a supportive environment that enhances both engagement and growth.

HOST
Kathy Schott, PhDVice President, Education & Operations
CEimpact

GUEST
Dr. Lisa Buss-Preszler, PharmD, BCACP
Pharmacy Education Supervisor and Program Director
PGY-1 Pharmacy Residency
Mayo Clinic Hospital - Arizona

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Define psychological safety and distinguish it from related concepts such as physical safety and emotional intelligence.
2. Identify strategies to foster psychological safety in a clinical education setting to improve learner engagement and performance.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-305-H99-P
Initial release date: 10/23/2024
Expiration date: 10/23/2025
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Want more information on this and related topics?Fostering an Inclusive Environment: Creating a Safe Space for Learners

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join us as we dive into the transformative power of functional medicine and its potential to revolutionize pharmacy practice. That’s right – we said revolutionize! Discover how addressing root causes, rather than just symptoms, is changing the way pharmacists approach patient care. Don’t you want to become a leader in this evolving field and elevate your practice site?!

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Josie Phillips-Ross, PharmD, ABAAHP, FAAMMPharmacist in Charge
Phillips Family Pharmacy and Functional PharmD Consulting

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the core principles of functional medicine and their application in pharmacy practice.
2. Identify key differences between conventional pharmaceutical care and functional medicine approaches.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-281-H01-P
Initial release date: 10/21/2024
Expiration date: 10/21/2025
Additional CPE details can be found here.

Take your pharmacy practice to the next level with our comprehensive course on functional medicine:
Beyond Prescriptions: A Pharmacists' Guide to Functional Medicine 6hr 30min | On Demand
Learn how functional medicine's patient-centered approach can impact the reduction of chronic diseases and how pharmacy teams can integrate functional medicine principles into daily pharmacy workflow. Course content will explain the influence of physiological processes on health and disease, and provide strategies for creating personalized treatment plans using functional medicine tools, resources, and patient case studies. Complete this course to excel in the essentials of functional medicine and lead the way in modern pharmacy care!

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

HOST
Jen Moulton, BSPharm
President
CEimpact

GUEST
Lindsay McCoy, PharmD, BCPP
Pharmacy Manager
Village Drug Shop at Advantage

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-261-H01-P
Initial release date: 10/14/2024
Expiration date: 10/14/2025
Additional CPE details can be found here.

Take your pharmacy practice to the next level with our comprehensive course on the administration of long-acting injectables:
Pharmacy-Based Administration of Long-Acting Injectables: A Sharp Idea3 hours | On DemandExplore a cutting edge clinical service opportunity with this collection of courses specifically designed to equip pharmacists with the knowledge and skills necessary for the effective management and administration of long-acting injectable medications (LAIs). Course content explores diverse drug profiles, advanced administration techniques, and the strategic implementation of LAI-related services to support the needs of your patients and communities.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Stay updated on ADHD care by reviewing new treatment options and navigating the dangers of medication shortages. With patients at risk from counterfeit drugs and overdose as a result of current shortages, now is the time to arm yourself with the knowledge to advocate for and protect your patients. Don't wait—this course is essential for ensuring the safe, effective management of your patients with ADHD.

HOST
Joshua Davis Kinsey, PharmDVP, Education
CEimpact

GUEST
Jena Quinn, PharmDCEO
Perfecting Peds

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize the impact of ADHD medication shortages on patient safety, including the risks associated with counterfeit medications.
2. Discuss emerging ADHD treatment options and their potential applications in clinical practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-269-H01-P
Initial release date: 10/7/2024
Expiration date: 10/7/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In today’s landscape of direct-to-consumer advertising, pharmacists are a vital source of guidance for both healthcare providers and patients seeking information on newly FDA-approved medications. Staying up-to-date on the latest drug approvals is crucial for pharmacists to ensure accurate dispensing and to offer thorough education to patients and other providers. This episode highlights several medications approved by the FDA in the last 12 to 18 months, providing essential insights into their clinical use.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Joe Strain, PharmDProfessor Pharmacy Practice
South Dakota State University

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. List unique pharmacological properties for each medication recently approved by the FDA.
2. Recall common side effects, contraindications, known drug interactions, and/or warnings associated with each new medication.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-267-H01-P
Initial release date: 9/30/2024
Expiration date: 9/30/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In an era where informed decisions are crucial to public health, understanding vaccine hesitancy has never been more critical.

Listen in to this week’s GC episode to learn actionable steps you can make today to break down vaccine hesitancy barriers and provide an accurate and data-driven approach to vaccine education in your community.

HOST
Jen Moulton, BSPharmPresident
CEimpact

GUEST
Lacy Epperson, PharmDDirector of Pharmacy Clinical Services
Mitchell's Drug Stores

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Analyze the underlying factors contributing to vaccine hesitancy and their effects on public health.
2. Discuss effective communication and outreach strategies to increase vaccination rates within a pharmacys community.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-262-H06-P
Initial release date: 9/23/2024
Expiration date: 9/23/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

According to the National Heart, Lung, and Blood Institute (NHLBI), 50–70 million Americans have sleep disorders, and one in three adults don't get enough uninterrupted sleep to maintain their health.

Listen in to this week’s GC episode to learn the physiology of sleep, why we need sleep, and what our role is in educating patients on sleep hygiene sleep disorders, and OTC vs. Non-OTC options.

HOST
Jen Moulton, BSPharm
President
CEimpact

GUEST
Ezequiel Medina, PharmD
Sleep Coach and Pharmacist
Live Love Sleep

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common sleep disorders and their impact on patient health and outcomes.
2. Explain strategies for managing sleep disorders through pharmacological and non-pharmacological interventions in pharmacy practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-263-H01-P
Initial release date: 9/16/2024
Expiration date: 9/16/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

A Community Health Worker (CHW) is a frontline public health worker who is a trusted member of the community they serve. CHWs act as a bridge between health and social services and the community, helping to improve health outcomes and access to care.

Our goal during this episode is to discuss why training pharmacy technicians to step into the role of a Community Health Worker has been imperative to meeting the health equity demands in local communities.

Jen Moulton, BSPharmPresident
CEimpact

Meredith Ayers, CPhT-Adv, CHWDevelopment Specialist
Bremo Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Evaluate the role and impact of pharmacy-placed Community Health Workers (CHWs) on patient outcomes and community health.
2. Describe a plan to integrate CHWs into pharmacy practice by cross-training pharmacy technicians.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-260-H04-P
Initial release date: 9/9/2024
Expiration date: 9/9/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.

The GameChanger
The new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.

Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Amanda Bushman, PharmD, BCPS-AQ ID, BCIDP, FIDSAInfectious Disease Pharmacist
UnityPoint Health

Tony Mannum, PharmDPGY2 Infectious Disease Resident
UnityPoint Health
ReferenceIDSA Guidelines for treating resistant gram negative organisms

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.
2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-251-H01-P
Initial release date: 09/02/2024
Expiration date: 09/02/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.

The GameChangerNew guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice.

Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Matthew Trump, DO, FACP, FCCPPulmonologist
The Iowa Clinic

ReferenceGuidelines
Paper

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.
2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-247-H01-P
Initial release date: 08/26/2024
Expiration date: 08/26/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Stigmatizing language may be part of our daily interactions with patients without even realizing it. It can appear in charts, regardless of race, gender, gender identity, ability, or socioeconomic status, but it has been found to occur more frequently for groups who are traditionally marginalized. How often do you reflect on the language you use with patients and how it might be interpreted by them, depending on their unique circumstances? And what are we doing as preceptors to help our residents and students understand the importance of language in their patient interactions? Listen in to learn more.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Kashelle Lockman, PharmD, MA
Clinical Associate Professor
University of Iowa

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. List examples of stigmatizing language and its impact on pharmacist-patient interactions
2. Describe strategies preceptors can use to foster the use of non-stigmatizing language by students and residents

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-250-H99-P
Initial release date: 8/21/2024
Expiration date: 8/21/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay it's onset.

The GameChangerSeveral studies suggest a delay in onset of dementia with the recombinant shingles vaccine.

Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceThe recombinant shingles vaccine is associated with lower risk of dementia

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe dementia's epidemiology and the significance of preventive interventions.
2. Discuss the strengths, weaknesses, and outcomes of the study.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-246-H01-P
Initial release date: 08/19/2024
Expiration date: 08/19/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings.

The GameChangerAdopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management.

Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGPCEO
Seguridad

ReferenceAtherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations

Previous GameChangers on PREVENT score

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.
2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-245-H01-P
Initial release date: 08/12/2024
Expiration date: 08/12/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The power of physical fitness in managing diabetes is transforming patient care. Join us this week as we discuss how pharmacists can significantly enhance patient outcomes by integrating exercise education into their practice, alongside traditional medication management.

The GameChangerIncorporating brief but impactful conversations about the importance of physical fitness into patient consultations can significantly enhance diabetes management.

Guests
Mark Smith, Jr., PharmD, CDCES, AFAA-CGFI
Pharmacist
UAB Medicine

Ian Haywood, PharmD, BCPS, CDCES
Clinical Pharmacist
Baptist Memorial Hospital

Reference MaterialsThe Role of Exercise in Diabetes
Physical Activity and Diabetes Position from the ADA

Supplemental Continuing Education Courses
Glucose Whisperers: The Role of CGMs in Pharmacy Practice - 1hr
Guardians of the Glucose Galaxy: The Rise of CGMs - 1hr
Pharmacy and Continuous Glucose Monitoring: The Sweetest Pairing - 6.5hrs

Additional GameChangers EpisodesContinuous Glucose Monitors

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the impact of physical fitness on diabetes management.
2. Identify strategies for educating patients on exercise and diabetes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-224-H01-P
Initial release date: 08/05/2024
Expiration date: 08/05/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.

The GameChangerSeveral new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss.

Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGPCEO
Seguridad

ReferencesTirzepatide for the Treatment of Obstructive Sleep Apnea and ObesitySemaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.
2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-238-H01-P
Initial release date: 07/29/2024
Expiration date: 07/29/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

1 out of 3 adult Americans take a daily multivitamin. On this episode of GameChangers, we discuss a recent study which examined whether daily multivitamin use extends life or prevents common causes of death.

The GameChangerThe study found no evidence that daily multivitamin use reduced death from common conditions such as heart disease or cancer.

Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO, Seguridad

ReferencesMulti-Vitamin StudyNIH Press Release

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the use of multivitamins.
2. Identify implications for healthy patients considering multivitamin use.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-226-H01-P
Initial release date: 07/22/2024
Expiration date: 07/22/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

While health inequity is considered by many to be the #1 issue in healthcare today, we’re still just learning to talk about it as part of pharmacy education. As preceptors, health equity and social determinants of health may not have been a language we learned as part of our education, and yet we rely on preceptors to help develop our learners in this area. What is our role in incorporating conversations and education around health equity and social determinants of health to better educate our learners in improving the lives of patients?

Host
Kathy Schott, PhDVice President, Education & Operations
CEimpact

Guest
Sally Arif, PharmD, BCCP
Professor of Pharmacy Practice/Clinical Cardiology Pharmacist
Midwestern University College of Pharmacy
Rush Medical Center
Chicago, IL

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss a preceptor's role in educating student pharmacists and pharmacy residents about social determinants of health
2. Describe strategies preceptors can use to incorporate social determinants of health into their teaching

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-210-H99-P
Initial release date: 7/17/2024
Expiration date: 7/17/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this week's episode, we dive into the fascinating world of gut health, including three actionable tips you can provide to patients. Explore the critical role of gut microbiome in health conditions ranging from autoimmune disorders to mental health to skin conditions.

The GameChangerHealth outcomes can be significantly impacted by addressing gut health issues through dietary modifications, understanding drug-nutrient depletions, and promoting the use of probiotics and prebiotics.

Guest
Anna Garrett, PharmD, BCPSPresident, AnnaGarrett.com

ReferenceHow Gut Health Affects Your Whole Body

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the relationship between gut health and systemic conditions.
2. Identify strategies for assessing and addressing gut health issues, including dietary modifications, the use of probiotics and prebiotics, and the identification of drug-nutrient depletions.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-221-H01-P
Initial release date: 07/15/2024
Expiration date: 07/15/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

On this week's GameChangers episode, we discuss prevention of recurrent UTIs, including whether use of d-mannose or antibiotics are effective.

The GameChangerRecurrent urinary tract infections plague some women throughout their lives. There are ways to prevent recurrent UTIs, however a recent study determined that d-mannose is not effective. We discuss what is effective.

Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Referenced-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women
A Randomized Clinical Trial

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe non-pharmacologic strategies proven to decrease recurrent UTIs.
2. Discuss selection of an antibiotic and a selected patient for continuous prophylaxis.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-220-H01-P
Initial release date: 07/08/2024
Expiration date: 07/08/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Did you know that 50% of antibiotics for pediatrics are dosed incorrectly?

In this episode of GameChangers, we are focusing on the role of the pharmacist and how we can prevent weight-based dosing errors.

By the end of this episode, you will learn:

Which body weights to use for which medication-based dosing?
Review of the four different scales of weight: Total Body Weight vs. Ideal Body Weight vs. Lean Body Weight vs. Adjusted Body Weight.
What are normal weights for kids and The Rule of 5 for dosing pediatric patients.
What the formula is for switching from pediatric dosing to adult dosing?
The definition of “Patient first language” is in medicine.

Make sure to tune in and share this episode with your friends!

The GameChangerToo often, health care providers don't dose medications based on weight. The pharmacist should be ensuring doses are correct based on patient weight.

Guests

Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Stephanie Weightman, PharmD, BCPS, BCPPS, BCEMP
Clinical Pharmacy Manager
Perfecting Peds

ReferencePediatric Weight is Crucial to Perfecting the Dose
Updated antimicrobial dosing recommendations for obese patients

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss strategies to verify weight-based dosing accuracy to improve patient safety and therapeutic outcomes.
2. Explain appropriate dosing adjustments for commonly prescribed antibiotics in pediatric patients and patients with obesity.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-208-H01-P
Initial release date: 06/24/2024
Expiration date: 06/24/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Today's episode is an absolute must-listen to. The FDA's decision to approve the drug, Mifepristone, has been escalated in a lawsuit to the U.S. Supreme Court. And, last week, in a unanimous 9-0 decision, the U.S. Supreme Court rejected the challenge to the drug's approval. Today on our podcast, we are answering what exactly is happening with the drug Mifepristone, the legal challenges associated with this medication, and how this U.S. Supreme Court ruling directly impacts pharmacists today.

Regardless of your position on this topic, knowing and understanding the history and why the mifepristone conversation is happening is critical.

By the time you finish listening, you'll be inspired to take immediate action to join your local and state-level pharmacy association.

For more resources, including links to the discussions, education, and training mentioned in the episode, click here to learn more.

The GameChangerPharmacists should understand legal boundaries and ethical considerations surrounding medications like mifepristone to provide safe, compliant, and patient-centered care.

Guest
David Brushwood, RPh, JDSenior Lecturer
University of Wyoming

ReferenceSupreme Court Document on Ruling
Supreme Court preserves access to abortion pill

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the historical context and legal evolution of mifepristone regulation by the FDA, including key changes and their implications for pharmacy practice.

Identify the ethical responsibilities and state and federal legal requirements when dispensing medications such as mifepristone.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-209-H03-P
Initial release date: 06/24/2024
Expiration date: 06/24/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Can compassion and empathy be learned? Can it be taught? The evidence suggests that the answer to both of these questions is yes, and yet as preceptors, we interact with student pharmacists and pharmacy residents who are wide-ranging in their abilities and comfort-level when it comes to fostering impactful patient care interactions.

In this episode, explore the value (and challenges) of incorporating strategies that model and teach empathy and compassion - for your patients, your learners, and for you.

Host
Kathy Schott, PhDVice President, Education & Operations
CEimpact

Guest
Kate Cozart, Med, PharmD, BCPS, BCGP, BCACPClinical Pharmacist Practitioner, Primary Care
Residency Program Coordinator
VA Tennessee Valley Healthcare System (TVHS)
Clarksville, TN

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Review evidence that compassionate and empathetic patient care positively impacts patients' healthcare experience.
2. Identify strategies preceptors can model to help pharmacy learners deliver more compassionate and empathetic care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-191-H99-P
Initial release date: 6/19/2024
Expiration date: 6/19/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this week's GameChangers we explore the emerging role of colchicine in the secondary prevention of cardiovascular disease. Drs. Wall and Boyd discuss colchicine's anti-inflammatory benefits, the challenges posed by side effects and drug interactions, and the latest research shaping its future in clinical practice.

The GameChanger
Colchicine shows potential for secondary prevention in cardiovascular disease due to its anti-inflammatory properties, but its clinical use is limited by gastrointestinal side effects and drug interactions.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Mathew Boyd, PharmD
Clinical Pharmacist, Unity Point

ReferenceMeta-AnalysisClear Synergy Study

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Identify the potential benefits of colchicine in secondary prevention of cardiovascular disease based on its anti-inflammatory properties.
2. Discuss the limitations of colchicine use in clinical practice, including gastrointestinal side effects and drug interactions.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-190-H01-P
Initial release date: 06/17/2024
Expiration date: 06/17/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

This week's GameChangers explores the transformative impact of continuous glucose monitors (CGMs) on diabetes care. Discover the latest advancements in CGM technology, current ADA recommendations, and practical tips for patient education.

The GameChanger
CGM technology is constantly changing. The devices are smaller, more user-friendly, and easier to integrate into daily life, thereby improving patient adherence and outcomes.

Guest
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
Clinical Professor and Director of Pharmacy Education
University of South Carolina College of Pharmacy

Reference
ADA Info on CGMs
AACE Guidelines Update on CGMs

Interested in additional Diabetes and CGM pharmacy education?
Save the date and join us – June 13 @ 7pmCT – registration details below!

During this 1-hour Live CGM CE, we will cover hot topics such as:

The evolution of Continuous Glucose Monitors (CGMs)
The impact of CGMs in improving health, clinical outcomes, and quality of life for persons with diabetes
The use of CGMs to manage diabetes across patient populations
The role of pharmacy teams in managing people with diabetes
The opportunity to integrate CGM devices into practice

Excited to see you next week!
Pharmacists Enroll Here
Technicians Enroll Here

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the principles and applications of continuous glucose monitors (CGMs) and summarize current recommendations for their use in diabetes management.
2. Discuss how to educate patients on CGM use, including device placement, data interpretation, and troubleshooting common issues.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-189-H01-P
Initial release date: 06/10/2024
Expiration date: 06/10/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

This week's GameChangers is a conversation about managing symptoms and age-related health effects through perimenopause, menopause, and post-menopause. Help patients through this time with evidence-based choices inlcuding medication, supplements, and lifestyle.

The GameChangerPerimenopause is not a diagnosis, but a natural part of reproductive life which should be managed with evidence-based strategies.

Guest
Anna Garrett, PharmD, BCPSPresident, AnnaGarrett.com

ReferenceGoing Mad in Perimenopause? Signs and SolutionsAARP (What Doctors Don’t Know About Menopause)EWG's Shopper's Guide to Pesticides in ProduceEWG's Skin Deep4 Reasons Why Menopausal Women Should Lift Heavy Weights

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Differentiate between perimenopause, menopause, and post-menopause by describing the potential physiological changes.
2. Identify common symptoms in perimenopause and evidence-based medication, supplement, and lifestyle recommendations

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-182-H01-P
Initial release date: 06/03/2024
Expiration date: 06/03/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this week's of GameChangers Podcast, we delve into the groundbreaking reclassification of marijuana to Schedule III. We discuss impacts on the legal landscape, medical research, pharmacogenomics for CBD, and the role of healthcare providers.

The GameChangerMarijuana's move to Schedule III will increase research opportunities, ease fear and stigma, and provide healthcare provider involvement in medical benefits and potential risks.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Marry Vuong, PharmD, BCPPS
Clinical Pharmacy Manager
Perfecting Peds

ReferenceUPDATE: DEA Moves to Reschedule Cannabis from Cannabis Business Times

NPR: Scientists welcome new rules on marijuana, but research will still face obstacles.

CEimpact Course for Reference:
Beyond the Haze: Pharmacist's Legal Insights on THC, CBD, and Medical Marijuana

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the reclassification of marijuana from Schedule I to Schedule III.
2. Explain the potential benefits of the marijuana schedule change including its impact on medical research and patient access.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-180-H01-P
Initial release date: 05/27/2024
Expiration date: 05/27/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join us as we discuss new guidelines from the American College of Gastroenterology for the management of acute pancreatitis.
The GameChangerNew guidelines from the ACG address changes in treatment and management of acute pancreatitis.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceThe American Journal of GastroenterologyDrug-Induced Acute Pancreatitis: An Evidence-Based Classification

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss changes Review the American College of Gastroenterology guidelines for the management of acute pancreatitis.
2. Discuss changes in treatment of acute pancreatitis.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-175-H01-P
Initial release date: 05/20/2024
Expiration date: 05/20/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Traumatic patient interactions may not occur very often, depending on where you practice, but they are important teaching opportunities on many levels. It’s not just how you navigate trauma with a pharmacy learner that matters, but how you support them in processing what has occurred.

In this episode, we bring together a preceptor and her former resident for an impactful conversation on how to best assess, navigate, and process traumatic patient interactions with pharmacy residents or student pharmacists, and how those learnings transfer to other areas of pharmacy practice after the fact.

Host
Kathy Schott, PhDVice President, Education & Operations
CEimpact

Guests
Samantha Katzman, PharmD, BCEMP
Clinical Pharmacy Specialist – Emergency Medicine
University of Louisville Health – Jewish Hospital
Louisville, KY

McKenzie Packard, PharmD, BCPPS
Pediatric Clinical Pharmacist
Atrium Health Wake Forest Baptist
Winston-Salem, NC

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss strategies to assess pharmacy resident or student pharmacist readiness for a potentially traumatic patient interaction
2. Describe strategies preceptors can use to support pharmacy learners after a traumatic patient interaction

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-177-H99-P
Initial release date: 5/15/2024
Expiration date: 5/15/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Want more information on this and related topics?

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join us as we explore new trial data examing Paxlovid's effectiveness in high-risk, vaccinated patients.

The GameChangerSignificantly high risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccincated patients.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceNew England Journal of Medicine Article

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss EPIC SR study findings.
2. Describe benefits of Paxlovid for specific patient groups based on trial data.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-172-H01-P
Initial release date: 05/13/2024
Expiration date: 05/13/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

New guidelines suggest that for most asthma patients a single inhaler strategy with both an ICS and a quick onset LABA can be used for maintenance and rescue therapy. This has been shown to improve symptoms and decrease need for health care visits. But what is the latest data on SMART therapy and what are the barriers to its use?

The GameChanger: SMART therapy should be the standard of care for most asthma patients.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

ReferenceMeta-analysis
https://pubmed.ncbi.nlm.nih.gov/35230437/

Asthma Action Plan
Do You Have an Asthma Action Plan?

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the latest information concerning SMART therapy in asthma.
2. Discuss how healthcare workers can decrease barriers and increase acces to SMART therapy.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-165-H01-P
Initial release date: 05/06/2024
Expiration date: 05/06/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this episode, we tackle a whole range of issues – how to assess and meet our pharmacy residents and student pharmacists where they are, the challenges of maintaining guardrails while providing flexibility, and the responsibility we have as preceptors to stay abreast of best practices not only clinically, but as teachers and mentors so that we can make changes to our precepting practice when they are needed.

Guest, Kelly Erdos is the Residency Program Director at Banner Baywood Medical Center in Mesa, AZ. She shares several great examples of how small adjustments in our precepting practice can have a big impact on our learners and ourselves. Tune in to hear more!

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Kelly Erdos, PharmD, BCACP, CACP
Pharmacy Clinical Coordinator Supervisor
Residency Program Director
Banner Baywood Medical Center, Mesa, AZ

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:

Describe the importance of adapting precepting strategies to meet pharmacy residents and student pharmacists where they are in their development
Identify strategies to assess pharmacy resident or student pharmacist readiness for a given rotation experience

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-171-H99-P
Initial release date: 05/01/2024
Expiration date: 05/01/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.
ChatGPT 3.5 (https://chat.openai.com) was utilized in the planning of this P2P episode.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

40% of people experience vertigo in their lifetime. These simple questions help us know what's causing it and how to provide relief to patients through medications or triaging to the appropriate provider.

The GameChangerMigraine headaches can present as vertigo. Simple questions and recommendations from pharmacists can be lifechanging for these patients.

Guest
Sarah Powell, MD
Physician, Surgeon
Ear, Nose, and Throat Consultants

Referencehttps://entad.org/resources/patient-information-dr-teixido/migraine-management-for-otolaryngologists/

Migraine Handout
Migraine, More Than A Headache

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. List three ways patients present with symptoms of vertigo.
2. Describe how to manage patient symptoms with medications or triage to another healthcare provider.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-158-H01-P
Initial release date: 04/29/2024
Expiration date: 04/29/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join us this episode as we discuss new recommendations from the American Dental Association on acute pain management.

The GameChangerDosing acetaminophen and ibuprofen where they peak at the same time due to their synergistic properties, resulting in treatment being often more effective than hydrocodone-apap and oxycodone-apap for pain relief.

Guest
Karen Baker, M.S.Pharm., R.Ph
Associate Professor
Colleges of Dentistry and Pharmacy, University of Iowa

Referencehttps://www.ada.org/about/press-releases/new-guideline-details-acute-pain-management-strategies-for-adolescent-adult-dental-patients

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss new guideline details on acute pain management for dental patients.
2. Identify how appropriate prescribing for acute dental pain can improve treatment and outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-157-H01-P
Initial release date: 04/22/2024
Expiration date: X/042/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Shortages, access, and cost have led to compounding GLP1s, which has created confusion and misinformation for patients and healthcare providers. Join us as we discuss this practice and delve into what you need to know as a healthcare provider.

THE GAMECHANGER: The advent of GLP1s is a true GameChanger in the health of patients with diabetes, cardiovascular diseases, and obesity, and has led to access issues for manufactured products.

Guests
Tenille Davis, PharmD, RPh
Chief Advocacy Officer
Alliance for Pharmacy Compounding

Scott Brunner, CAE
CEO
Alliance for Pharmacy Compounding

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Referencehttps://a4pc.org/advocacy/educating-prescribers/

https://a4pc.org/advocacy/statements-and-other-resources/

https://a4pc.org/files/APC-Compounded-GLP-1s-Media-Brief-REVISED-March-2024.pdf

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Review criteria for compounding drugs on the FDA drug shortage list.
2. Discuss the facts and misinformation surrounding compounded GLP1 medications.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-145-H01-P
Initial release date: 04/15/2024
Expiration date: 04/15/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

This episode discusses quality and value in healthcare and how the BPCI program, designed to lower costs and enhance care quality, particularly in the post-acute phase, did not demonstrate notable positive impacts on HF-related measures. What does this mean for the larger health quality landscape?

The GameChangerQuality in healthcare is rapidly evolving. There are pressures at the population level that evaluate how we do things; the quality always needs to be safety focused.

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
Article:
Bundled Payments for Care Improvement and Quality of Care and Outcomes in Heart Failurehttps://jamanetwork.com/journals/jamacardiology/article-abstract/2813066

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Define quality in healthcare.
2. Review outcomes of hospitals participating in the BPCI program.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-133-H04-P
Initial release date: 04/01/2024
Expiration date: 04/01/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

This episode discusses the 2023 Inflation Reduction Act and HHS's authority to negotiate prices for high-cost drugs in Medicare Part D. In addition to the initial list of 10 drugs, HHS is now focused on medications used in the hospital and covered under Medicare Part B.

The GameChangerHHS updates the Inflation Reduction Act that will impact over 750, 000 people.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Referencehttps://www.cms.gov/files/document/reduced-coinsurance-certain-part-b-rebatable-drugs-april-1-june-30-2024.pdf

https://www.hhs.gov/about/news/2024/03/26/hhs-announces-savings-41-prescription-drugs-thanks-inflation-rebates-from-biden-harris-administrations-lower-cost-prescription-drug-law.html?utm_source=MarketingCloud&utm_medium=email&utm_campaign=PT+Daily+March+27&utm_content=PT+Daily+March+27

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the monetary impact of the Inflation Reduction Act.
2. Discuss how the Medicare Part B drug addition will benefit patients.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-136-H04-P
Initial release date: 4/08/2024
Expiration date: 04/08/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The anti-rejection drug rapamycin has been shown in mice and other mammals to reverse cellular damage caused by aging to extend healthy life by up to 20%. This has caused massive off-label prescribing and use of rapamycin in humans as an anti-aging drug.

The GameChangerWhat do you tell patients about the evidence-based use of rapamycin for anti-aging?

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Referencehttps://www.washingtonpost.com/business/2024/03/15/rapamycin-longevity-drug/

https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00258-1/fulltext

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the mechanism of action of rapamycin and how it may reverse normal aging.
2. Discuss the current state of evidence of rapamycin for this indication and its safety concerns.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-129-H01-P
Initial release date: 03/25/2024
Expiration date: 03/25/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this episode, we delve into the crucial topic of understanding generational differences in the context of pharmacy education. Our guest expert, Melissa Medina from the University of Oklahoma, brings a wealth of knowledge and experience to the table, shedding light on why grasping these generational nuances is paramount for preceptors working with pharmacy students and residents.

Tune in to gain a fresh perspective on how everyone can win and learn by engaging across generations.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Melissa Medina, Ed.D
Interim Dean and Professor
The University of Oklahoma Health Sciences Center College of Pharmacy

Get CE: CLICK HERE TO GET CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:

Describe factors that have impacted how Generation Z p(Gen Z) pharmacy residents and student pharmacists see the world.
Identify strategies for engaging effectively with Gen Z learners.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-111-H99-P
Initial release date: 3/20/2024
Expiration date: 3/20/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.
ChatGPT 3.5 (https://chat.openai.com) was utilized in the planning of this P2P episode.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The GameChangerA new study looks at the utility of omalizumab in preventing food allergy reactions after accidental exposure.

ACEis and Beta-blockers should be avoided in patients with recurrent anaphylaxis if possible.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceStudy: https://www.nejm.org/doi/full/10.1056/NEJMoa2312382

Anaphylaxis guideline: https://www.annallergy.org/article/S1081-1206(23)01304-2/fulltext

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the OUtMATCH study results and their relevance to patients with food allergies.

Interpret the new AAAAI anaphylaxis guidelines in relation to patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-079-H01-P
Initial release date: 03/18/2024
Expiration date: 03/18/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Stay updated on recently FDA-approved medications crucial for pharmacists.
Gain essential insights on new drugs approved in the last 12 to 18 months, ensuring accurate dispensing and effective patient education.

The GameChangerSweatControl Patch approved for primary axillary hyperhidrosis.
Update in treatment for Alzheimer's with mild cognitive impairment.

Host
Joe Strain, PharmDClinical Faculty, Monument Health
South Dakota State College of Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the therapeutic indications of recent FDA-approved medications.
2. Describe unique pharmacological properties for each new medication.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-098-H01-P
Initial release date: 03/11/2024
Expiration date: 03/11/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The cardiometabolic syndrome is a concept recently developed by the American Heart Association to denote the totality of risk in a patient with risk factors that may lead to or worsen chronic kidney disease or cardiovascular events. A new validated scoring system has been endorsed by AHA to better assess the short and long-term risk for these in the general population. We will discuss this scoring system in this podcast.

The GameChangerA new validated scoring system has incorporated factors to better determine the 10 and 30 year risk of CVD and CKD in a general population.

Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Mathew Boyd, PharmDClinical Pharmacist
Unity Point

ReferenceGuidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001191

Calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the concept of the Cardiovascular-Kidney-Metabolic syndrome.
2. Discuss how the PREVENT scoring system is applied to patients.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-075-H01-P
Initial release date: 3/4/2024
Expiration date: 3/4/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Several outbreaks of a relatively new, resistant fungal infection - candida auris - have been reported in the Pacific Northwest. It is highly contagious and its mortality has approached 60%. Listen in as we discuss what to watch for and how to prepare if this reaches your geography.

THE GAMECHANGER:
Candida auris is resistant to most antifungals, has high plasticity, and its mortality approaches 60%.

Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceCristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, Boni S, Pontali E. An Overview on Candida auris in Healthcare Settings. J Fungi (Basel). 2023 Sep 8;9(9):913. doi: 10.3390/jof9090913. PMID: 37755021; PMCID: PMC10532978.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss characteristics of C. auris infections that make it difficult to avoid outbreaks 2. Describe issues surrounding treatment of serious infections with C. auris

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-058-H01-P
Initial release date: 2/26/2024
Expiration date: 2/26/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Do you feel like it is getting more difficult to engage your students or residents on your rotation and keep them engaged? Or maybe you personally feel a little bored with the same old activities and strategies. In this episode, preceptors Beth Cady and Carrie Vogler of Southern Illinois University Edwardsville on some creative strategies they use to engage their learners.

Kathy Schott, PhDVice President, Education & Operations
CEimpact

Kate Newman, PharmD
Director of Experiential Education
Southern Illinois University Edwardsville

Elizabeth Cady, PharmD
Clinical Associate Professor
Southern Illinois University Edwardsville

Carrie Vogler
Clinical Professor
Southern Illinois University Edwardsville

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss barriers to effectively engaging students and residents in their experiential learning
2. Identify creative strategies for engaging students and residents to optimize their learning

0.075 CEU/0.75 Hr
UAN: 0107-0000-24-059-H99-P
Initial release date: 2/21/2024
Expiration date: 2/21/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

ChatGPT 3.5 (https://chat.openai.com) was utilized in the planning of this Precept2Podcast episode.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

With pockets of measles outbreaks throughout the country, we discuss the reasons and strategize ways pharmacy can impact vaccination rates in their communities.

The GameChangerMeasles was essentially eliminated from the US in 2000. Now, we are seeing a resurgence of outbreaks that have prompted the CDC to issue warnings and reminders of the importance of proper vaccination.

Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Elizabeth Skoy, PharmD
Professor
North Dakota State University

Lacy Epperson, PharmDClinical Pharmacist
Mitchell’s Drug Store

Referencehttps://www.usatoday.com/story/news/health/2024/01/26/cdc-issues-alert-measles-global/72365871007/

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the CDC warning about the increased incidence of measles
2. Discuss ways pharmacy can have an impact on increasing vaccination rates and decreasing measles outbreaks

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-057-H01-P
Initial release date: 2/19/2024
Expiration date: 2/19/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

With record-cold temperatures in much of the United States this winter, a high number of cold injuries have been reported. This podcast discusses prevention and treatment for hypothermia and frostbite. Brrrrr!

The GameChangers:

Frostbite prevention using layers and heating measures
Hypothermia treatment using external and internal heating
Frostbite treatment with anticoagulants

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Referencehttps://www-nejm-org./doi/10.1056/NEJMra1800868?url_ver=Z39.88-2003𝔯_id=ori:rid:crossref.org𝔯_dat=cr_pub%20%200pubmed

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Differentiate between types of hypothermia
2. Discuss treatments for frostbite

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-051-H01-P
Initial release date: 2/12/2024
Expiration date: 2/12/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The American Diabetes Association has released the 2024 Standards of Care for people with Type 1 and Type 2 Diabetes. Join us as we talk with one of our favorite diabetes experts, Dr. Sue Cornell, about the major shifts in diabetes care that are omnipresent in this year's guideline updates.

The GameChangerDiabetes treatment is shifting to prevention and delay. After a long period of time without many advances, we are now on the brink of changing the game in diabetes care and prevention with new drugs and technologies.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Susan Cornell, PharmD, CDCES, FAPhA, FADCESDiabetes Care & Education Specialist
Midwestern University College of Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss highlights of the 2024 American Diabetes Association Standards of Care Update
2. Describe the landscape of diabetes care as it shifts to prevention and delay

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-050-H01-P
Initial release date: 2/5/2024
Expiration date: 2/5/2025
Additional CPE details can be found here.

Join us Tuesday, February 13th from 7-9pm for our next live course:From A1C to Z: A Sweet Update on Diabetes GuidelinesThis course will review the latest revisions to the American Diabetes Association (ADA) Standards of Care specifically highlighting the rising rates of obesity-related to diabetes, a pressing health concern affecting millions worldwide and often referred to as "diabesity". Learners will gain insights into nuances related to medication management and therapeutic decision-making for patients with diabetes. Content will provide guidance for reviewing and crafting patient-centered treatment strategies that holistically address glucose management while fostering improvements in cardio-metabolic, kidney, liver, and cognitive health for individuals grappling with diabetes and related comorbidities.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Insulin icodec is the first class of long-acting insulin to be administered only once a week. Join host, Jen Moulton, as she discusses the safety and efficacy of insulin icodec with guest, Geoff Wall.

The GameChangerInsulin icodec is the first of the ultra long-acting insulins with once weekly dosing. Multiple clinical studies have suggested these pharmacokinetics work. A new meta-analysis suggests that insulin icodec is more effective than other basal insulins and at least as safe concerning hypoglycemia.

Jen Moulton, RPh
President + Founder
CEimpact

Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceWang P, Zhang Y, Xu W, et al. Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Diabetol Metab Syndr. 2024 Jan 3;16(1):3. doi: 10.1186/s13098-023-01240-5. PMID: 38172995; PMCID: PMC10763463.

https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-023-01240-5#Sec19

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the chemical and structural changes that make icodec different from other basal insulins
2. Discuss the results of the meta-analysis about insulin icodec

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-043-H01-P
Initial release date: 1/29/2024
Expiration date: 1/29/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Alcohol Use Disorder (AUD) and cirrhosis are common medical conditions with significant morbidity and mortality. Join host, Geoff Wall, as he evaluates the new American College of Gastroenterology guidelines.

The GameChangerThe MELD score is now preferred over the Madrey score for assessing mortality. Baclofen is the primary treatment for reducing consumption and craving in alcohol use disorder.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceJophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, Shah VH. ACG Clinical Guideline: Alcohol-Associated Liver Disease. Am J Gastroenterol. 2024 Jan 1;119(1):30-54. doi: 10.14309/ajg.0000000000002572. Epub 2023 Sep 1. PMID: 38174913.

https://journals.lww.com/ajg/fulltext/2024/01000/acg_clinical_guideline__alcohol_associated_liver.13.aspx?context=featuredarticles&collectionid=5

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the initial treatment of a patient admitted with acute alcoholic hepatitis
2. Describe a pharmacotherapeutic plan for adjunctive treatment of alcohol use disorder

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-042-H01-P
Initial release date: 1/22/2024
Expiration date: 1/22/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Communication is ‘an essential duty’ of a pharmacist and the cornerstone of quality patient care. And yet, it continues to be one of the most common frustrations reported by preceptors when working with students and residents. Many factors may be at play, including a pandemic, as well as a digital society where so much communication happens in quick, abbreviated bytes.

On this episode, guest Christine Klein reminds us of the many facets of communication, the complex range of reasons some students and residents may struggle, and how we as mentors and teachers can support their development in this area effectively.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Dr. Christine Klein, PharmD
Vice-Chair for Experiential Education
Clinical Associate Professor
Mercer University College of Pharmacy

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss the importance of strong communication skills for students and residents
2. Describe the preceptor's role in fostering professional communication

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-041-H99-P
Initial release date: 1/17/2024
Expiration date: 1/17/2025
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Hyponatremia is a side effect of most diuretics but the incidence from thiazides is unknown. Join host, Geoff Wall, as he evaluates a new study from Denmark evaluating hyponatremia and thiazides.

The GameChangerThiazide diuretics are considered first-line therapy but electrolyte side effects are underevaluated. A new study suggests hyponatremia is significantly more common than previously reported, especially in the elderly.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceAndersson NW, Wohlfahrt J, Feenstra B, et al. Cumulative Incidence of Thiazide-Induced Hyponatremia: A Population-Based Cohort Study. Ann Intern Med. 2023 Dec 19. doi: 10.7326/M23-1989. Epub ahead of print. PMID: 38109740.

https://www.acpjournals.org/doi/abs/10.7326/M23-1989?journalCode=aim

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the use of thiazides in hypertension and their adverse effects
2. Assess the strengths and weaknesses of the Andersson et al study

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-032-H01-P
Initial release date: 1/15/2024
Expiration date: 1/15/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Sickle cell disease (SCD) is a devastating medical condition causing pain, fatigue, and early mortality. Join host, Geoff Wall, as he evaluates a new gene therapy via CRISPR that may cure SCD.

The GameChangerCRISPR is a new method to develop targeted gene editing treatments. Lovo-cel is the first FDA-approved therapy and may treat sickle cell disease (SCD) - for only $2 million.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceFDA Approval. https://www.fda.gov/vaccines-blood-biologics/lyfgenia.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss what CRISPR is and how it can be used to treat diseases
2. Describe the use of lovotibeglogene autotemcel (lovo-cel) for sickle cell disease and its safety and efficacy data

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-031-H01-P
Initial release date: 1/8/2024
Expiration date: 1/8/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, with guest Matt Boyd, as they evaluate the pharmacotherapy changes in the new guidelines in this two-part episode.

The GameChangerRate and rhythm control medications largely have the same clinical outcomes. Patients with heart failure with reduced ejection fraction should try rhythm control first. Monitoring is key for atrial fibrillation pharmacotherapy.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Mathew Boyd, PharmD
Clinical Pharmacist
Unity Point

ReferenceJoglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)06465-3. doi: 10.1016/j.jacc.2023.08.017. Epub ahead of print. PMID: 38043043.

https://www.jacc.org/doi/10.1016/j.jacc.2023.08.017

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss rate versus rhythm control in patients with atrial fibrillation
2. Develop a monitoring plan and selection of medications in rhythm control

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-030-H01-P
Initial release date: 1/5/2024
Expiration date: 1/5/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, as he evaluates the first half of the guidelines in this two-part episode.

The GameChangerDifferent stratifying types of atrial fibrillation no longer exist. Additionally, left atrial occlusive devices are now recommended as first-line therapy for the prevention of stroke, though anticoagulants are the treatment of choice.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

https://www.jacc.org/doi/10.1016/j.jacc.2023.08.017

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe new definitions of atrial fibrillation and risk factors for stroke
2. Discuss mechanical prevention of stroke in high risk patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-401-H01-P
Initial release date: 12/25/2023
Expiration date: 12/25/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Utter the words "Artificial Intelligence" to other preceptors and pharmacy faculty, and you might get a reaction that ranges anywhere from fear and anxiety to excitement. In this insightful discussion, we explore the fundamental question of what AI is and its diverse application in shaping the landscape of pharmacy education. Guest Tim Aungst delves into the challenges surrounding student and resident access to AI tools, shedding light on the challenges and opportunities that access brings.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Timothy Dy Aungst, PharmD, RPh
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. List a primary advantage of using artificial intelligence (AI)
2. Discuss ways in which access to AI should inform teaching strategies.

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-402-H99-P
Initial release date: 12/20/2023
Expiration date: 12/20/2024
Additional CPE details can be found here.

Dr. Schott has no relevant financial relationships with ineligible companies to disclose.

Dr. Aungst reports he is a consultant for Otsuka and an advisor for Digital Therapeutics Alliance. All relevant financial relationships have been mitigated.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join Ashlee as she talks with Ina, the Director of Clinical Operations at RxGenomix, about the fascinating world of pharmacogenomics. Throughout this episode, Ashlee and Ina get into the nitty-gritty of pharmacogenomic testing - a game-changer in ensuring the right medication is administered to the right patient at the right time and dose.

Listen to this episode to equip yourself with the knowledge to grasp the potential and significance of pharmacogenomics in patient care. Whether a healthcare professional or simply curious, it's time to step into the future of personalized medicine.

In this episode, the two discuss:
- Pharmacogenomics & their implications
- The role genetics play in influencing medication responses
- Integrating pharmacogenomics into routine patient care
- The future of pharmacogenomics

Dr. Ina Liko received her Doctor of Pharmacy degree at the University of Illinois at Chicago where she was initially exposed to pharmacogenomics. She then completed a clinical residency program at Monroe Clinic where her research project was focused on the implementation of pharmacogenomics. After this initial exposure to the clinical application of pharmacogenomics, she gained experience in implementing it in a larger scale by completing a fellowship in the Clinical Implementation of Pharmacogenomics at the University of Colorado where she was exposed to a systematic approach of implementing pharmacogenomics in various therapeutic classes. Dr. Liko now serves as the Director of Clinical Pharmacogenomics Operations at RxGenomix where she works collaboratively in a multidisciplinary team leading the clinical operations.

To learn more about CEimpact's By Design memberships, click here.
To learn more about the CEimpact Advanced PGx training, click here

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

One of the oldest medications in our pharmacopeia is digoxin. It may be used for atrial fibrillation and heart failure, although not as a first-line agent. Despite this, digoxin use is on the rise. Join host, Geoff Wall, as he evaluates why more prescribers are using digoxin.

The GameChangerNo new randomized controlled trials have been published to justify the increased use of digoxin. However, when used, providers should routinely monitor digoxin levels.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceGazzaniga G, Menichelli D, Scaglione F, et al. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses. Eur J Clin Pharmacol. 2023 Apr;79(4):473-483. doi: 10.1007/s00228-023-03470-y. Epub 2023 Mar 6. PMID: 36872367; PMCID: PMC10039090.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039090/

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Apply information on the potential uses and harms of digoxin
2. Apply a strategy for monitoring digoxin in heart failure patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-400-H01-P
Initial release date: 12/18/2023
Expiration date: 12/18/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join Ashlee as she talks with Jen Moulton, the president of CEimpact, about her top five takeaways from a transformative year in pharmacy education and patient care.

Listen to this episode to reflect on, learn, and apply the biggest lessons 2023 taught us, from the every-day practices that define us to the big picture within pharmacy education that leads us.

In this episode, the two discuss:
- The power of focus, prioritization, and efficient processes within CEimpact.
- Technology's ever-growing influence on pharmacy education.
- How building connections with clients, team members, and customers can prevent burnout and foster positivity.
- CEimpact's efforts to address pharmacy burnout.

To learn more about CEimpact's By Design memberships, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Alzheimer's Disease is a progressive terminal disease. Many treatments are focused on lifestyle modification to delay diagnosis and onset. Join host, Geoff Wall, with guest Jake Galdo, as they look at a new study evaluating the association between vaccines and the development of Alzheimer's Disease.

The GameChangerPostviral inflammation may play a role in the development of Alzheimer's Disease. A recent claims-based study found an association between immunization status and the development of Alzheimer's Disease.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGPCourse Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

ReferenceHarris K, Ling Y, Bukhbinder AS, et al. The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching. J Alzheimers Dis. 2023;95(2):703-718. doi: 10.3233/JAD-221231. PMID: 37574727; PMCID: PMC10578243.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the potential mechanisms of inflammation and viral infections with the development of Alzheimer's Disease.
2. Describe the study discussed and its application in guiding patients to receive vaccines.

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-367-H01-P
Initial release date: 12/11/2023
Expiration date: 12/11/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Exocrine enzyme dysfunction is far more common than many primary care practitioners realize. Using pancreatic enzymes can help with symptoms and vitamin absorption. Join host, Geoff Wall, as he reviews new guidelines on the appropriate use of pancreatic enzymes.

The GameChangerChronic pancreatitis is the most common cause of exocrine dysfunction in adults. All pancreatic enzymes are equally effective; however, the use of pancreatic enzymes to treat chronic pain is controversial.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceWhitcomb DC, Buchner AM, Forsmark CE. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. Gastroenterology. 2023 Nov;165(5):1292-1301. doi: 10.1053/j.gastro.2023.07.007. Epub 2023 Sep 20. PMID: 37737818.

https://www.gastrojournal.org/article/S0016-5085(23)04780-7/fulltext

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss common symptoms and diagnoses associated with exocrine dysfunction.
2. Describe challenges associated with the use of pancreatic enzymes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-366-H01-P
Initial release date: 12/4/2023
Expiration date: 12/4/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The world of healthcare is changing and so are our students and residents. If you are in a precepting role, you are experiencing some challenges in navigating these new waters.

In this episode, Logan Murry, CPD champion, makes professional development practical, effective, and intentional. Listen in to learn how taking time to practice intentional CPD can make you a more effective, and more fulfilled preceptor.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Logan T. Murry, PharmD, PhD
Assistant Director of the Continuing Pharmacy Education Accreditation Program
Accreditation Council for Pharmacy Education (ACPE)

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Describe the Continuing Professional Development (CPD) cycle and its key components.
2. Articulate the value of practicing intentional CPD as a preceptor.

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-390-H99-P
Initial release date: 11/29/2023
Expiration date: 11/29/2024
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Menopausal vasomotor symptoms occur in about 80% of women and have a significant impact on quality of life. Hormone replacement therapy works well; however, it is often underused. Join host, Geoff Wall, as he evaluates Fezolinetant, a new medication to treat 'hot flashes.'

The GameChangerHRT is vastly underused in menopausal women. Gabapentin and SNRIs may help with some vasomotor symptoms. Fezolinetant is effective for hot flashes and seems to be well tolerated.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceLederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023 Apr 1;401(10382):1091-1102. doi: 10.1016/S0140-6736(23)00085-5. Epub 2023 Mar 13. PMID: 36924778.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00085-5/fulltext

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the pros and cons of hormone replacement therapy in women with vasomotor symptoms.
2. Discuss the role of fezolinetant for treatment of vasomotor symptoms.

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-365-H01-P
Initial release date: 11/27/2023
Expiration date: 11/27/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Respiratory failure from COVID-19 should be treated as soon as possible. Join host, Geoff Wall, as he evaluates the the role of convalescent plasma in treating patients with COVID-19 and on mechanical ventilation.

The GameChangerCOVID-19 is still a significant concern acutely and for long-term complications. Convalescent plasma may benefit severely ill COVID-19 patients on mechanical ventilation and with acute respiratory distress syndrome (ARDS).

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceMisset B, Piagnerelli M, Hoste E, Dardenne N, Grimaldi D, Michaux I, De Waele E, Dumoulin A, Jorens PG, van der Hauwaert E, Vallot F, Lamote S, Swinnen W, De Schryver N, Fraipont V, de Mey N, Dauby N, Layios N, Mesland JB, Meyfroidt G, Moutschen M, Compernolle V, Gothot A, Desmecht D, Taveira da Silva Pereira MI, Garigliany M, Najdovski T, Bertrand A, Donneau AF, Laterre PF. Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients. N Engl J Med. 2023 Oct 26;389(17):1590-1600. doi: 10.1056/NEJMoa2209502. Epub 2023 Oct 25. PMID: 37889107.

https://www.nejm.org/doi/full/10.1056/NEJMoa2209502?query=featured_home

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the latest NIH treatment guidelines for COVID-19 patients who are hospitalized
2. Describe the use of convalescent plasma in the context of a COVID-19 treatment algorithm

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-354-H01-P
Initial release date: 11/20/2023
Expiration date: 11/20/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join Ashlee as she talks with Derek Borkowski, CEO and founder of Pyrls about the journey that led to the creation of Pyrls. Alongside this, Derek discusses Pyrls' partnership with CEimpact and the future of Pyrls as a company.

Pyrls is an online drug information provider that focuses on design and simplicity in their delivery of that information. Through an deeper dive into Pyrls, this episode offers up an exclusive behind-the-scenes glimpse into the future of digital health and the role of technology in the medical field.

In this episode, the two discuss:
- The creation of Pyrls
- Pyrls' impact on the healthcare world
- Pyrls' partnership with CEimpact
- The future of Pyrls

To learn more about CEimpact's By Design memberships, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Piperacillin/tazobactam and vancomycin have been reported in numerous clinical trials to be associated with acute kidney injury. Comparatively, cefepime with vancomycin may increase neurotoxic effects. Join host, Geoff Wall, as he evaluates a new randomized controlled trial evaluating the safety of these medications.

The GameChangerVancomycin, even at appropriate doses, can cause nephrotoxicity. Piperacillin/tazobactam does not seem to increase the risk of adverse kidney outcomes. However, cefepime is associated with an increased risk of neurologic toxicity.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceTong SYC, Venkatesh B, McCreary EK. Acute Kidney Injury With Empirical Antibiotics for Sepsis. JAMA. 2023;330(16):1531–1533. doi:10.1001/jama.2023.18591

https://jamanetwork.com/journals/jama/fullarticle/2810593

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the risk of nephrotoxicity with piperacillin/tazobactam
2. Discuss the factors that exacerbate neurologic adverse effects with cefepime

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-353-H01-P
Initial release date: 11/13/2023
Expiration date: 11/13/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join Ashlee as she talks with Bernadette Jakeman, an ID-HIV specialized prescribing pharmacist and associate professor at the University of New Mexico College of Pharmacy. Her expertise lies in infectious diseases and HIV, a field that she's deeply passionate about and has dedicated her career to.

Listen in as she takes us on a fascinating journey, recounting her unique trajectory in the field of pharmacy, her experiences with an HIV specialist in an outpatient setting, and the incredibly impactful work she is currently doing within the HIV community.

In this episode, the two discuss:
- Bernadette's unique pharmacy career path
- Bernadette's work within the HIV community
- How pharmacists play a role in HIV prevention
- The updated Pre-Exposure Prophylaxis guidelines

For those keen on learning more or who work in the field, Bernadette has prepared an insightful course titled "Preparing for Tomorrow: A Pharmacist Guide to HIV Prevention". So, gear up to learn, engage, and feel empowered to discuss PrEP with patients and advocate for those who need it.

To learn more about CEimpact's By Design memberships and to gain access to Bernadette's course, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Polymyalgia rheumatica is a common rheumatic disorder. Steroids are the mainstay of therapy despite significant adverse reactions. Join host, Geoff Wall, as he evaluates a new treatment for PMR.

The GameChangerSarilumab is now FDA-approved for relapsing polymyalgia rheumatica. Sarilumab can be an alternative to long-term steroid therapy or methotrexate.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceSpiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. PMID: 37792612.

https://www.nejm.org/doi/full/10.1056/NEJMoa2303452

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the diagnosis and treatment of polymyalgia rheumatica
2. Assess the SAPHYR study and the role of sarilumab for treatment of polymyalgia rheumatica

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-352-H01-P
Initial release date: 11/6/2023
Expiration date: 11/6/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Join Ashlee and Tim Ulbrich, pharmacist and founder of Your Financial Pharmacist, in this week's Level Up episode as they discuss Tim's career, advice, and resources that pharmacists can use in the journey toward attaining financial wellness.

Tim Ulbrich, pharmacist & CEO of Your Financial Pharmacist, set out to help pharmacists solve this issue by helping them develop financial planning and organization skills

In this episode, the two discuss:- How Tim's blog developed into the Your Financial Pharmacist company
- Tim's best tips for pharmacists hoping to work towards financial wellness
- The upcoming CEimpact By Design course 'Dollars and Sense: Guidance for Building a Strong Financial Foundation', a course that Tim helped create.

To learn more about CEimpact's By Design memberships and to gain access to Tim's course, click here.

To get in touch with Your Financial Pharmacist, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

There are numerous formulations of aspirin available over-the-counter often advertised to decrease gastric issues. Join host, Geoff Wall, as he evaluates a new study to see if enteric aspirin is worth the extra money and effort.

The GameChangerBuffered and coated aspirin are purported to cause fewer gastric adverse events. However, no efficacy or safety differences exist in the various formulations of aspirin.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceSleem A, Effron MB, Stebbins A, et al. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. Published online October 04, 2023. doi:10.1001/jamacardio.2023.3364

https://jamanetwork.com/journals/jamacardiology/fullarticle/2809795?resultClick=1

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the history of various formulations of aspirin on the US market
2. Discuss the results and limitations of the ADAPTABLE study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-331-H01-P
Initial release date: 10/30/2023
Expiration date: 10/30/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Ever imagine what it's like to evolve from a retail pharmacy worker to a celebrated pharmacy technician trainer?

Join Ashlee as she talks with Nicole Foster, the manager of pharmacy technician and client education at CEimpact about her inspiring journey.

During this episode, the two discuss- Nicole's career and mentors
- The essential shift in the perceptions surrounding pharmacy technicians
- Nicole's predictions about the future of pharmacy technicians

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Hypertensive urgency - asymptomatic patients with elevated blood pressure - is frequently treated in the hospital and outpatient setting. Join host, Geoff Wall, as he critically examines the evidence to assess risk over benefit.

The GameChangerTreatment of asymptomatic hypertension has not been shown to improve clinical outcomes. Recent data highlights the risk with increased mortality through aggressive management.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceAnderson TS, Herzig SJ, Jing B, et al. Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults. JAMA Intern Med. 2023;183(7):715–723. doi:10.1001/jamainternmed.2023.1667

https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2805021

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the difference between hypertensive urgency and emergency
2. Discuss recent data about the possible harms of treating asymptomatic hypertension in the hospital setting

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-330-H01-P
Initial release date: 10/23/2023
Expiration date: 10/23/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Think journal clubs are a heavy lift? That they can't be done in a small pharmacy environment? Worried that you don't have enough statistical savvy? Listen to this episode and you'll discover how journal clubs can be incorporated into just about any setting with some simple strategies. The value they bring is immense - NAPLEX preparation for graduating students, expanded clinical knowledge for the learner and staff, the development of confidence and communication skills in your students and residents, and much more.

In this episode, I talked with Dr. Valerie Coppenrath, a drug information guru and preceptor for both residents and students. She shares some background on the concept, and also provides us with some practical strategies for taking a more intentional approach to supporting our students and residents in their own professional identity journey. And who knows, maybe we’ll learn a little about ourselves along the way as well.

Kathy Schott, PhDVice President, Education & Operations
CEimpact

Valerie Coppenrath, PharmDAssociate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE InformationLearning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss the advantages and challenges with conducting a journal club in a range of pharmacy settings.
2. List strategies for effective journal club selection.
3. Describe strategies for overcoming barriers associated with setting up a successful journal club.

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-342-H99-P
Initial release date: 10/18/2023
Expiration date: 10/18/2026
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Want more information on this and related topics?Mastering Journal Club Facilitation: A Toolkit for Engaging LearnersThis comprehensive collection of resources, tools, and best practice tips has been designed to help you facilitate an organized, effective, and engaging journal club experience, regardless of where you practice.

Journal Club Toolkit for LearnersA companion to the toolkit for preceptors, this robust resource provides residents and students with checklists, templates, guidance on journal selection, and much more.

Biostatistics RefresherThis course provides a crash course review in statistics to help you evaluate the literature and communicate its implications to providers and patients.

As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask your experiential program director if you are a member so that you can access it all for free AND get CE credit!

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Ever wonder about the journeys behind the professionals working to advance in the pharmacy technician field?

Join Ashlee as she talks with Liza Chapman, the Chief Professional Officer at the PTCB (Pharmacy Technician Certification Board), and Zachary Hall, the Associate Director of Professional Affairs about professional evolution in the pharmacy technician world.

During this episode, the three discuss:
- Liza & Zachary's professional journeys
- The PTCB's work in progressing the pharmacy technician profession
- The relationship between PTCB and P-TEC (Pharmacy Technician Educators Council)
- The relationship between PTCB and CEimpact!

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Injectable, long-acting therapy is a new frontier for hypertension management. Join host, Geoff Wall, as he evaluates zilebesiran, a hepatic angiotensinogen blocker for blood pressure control for up to six months.

The GameChangerZilebesiran blocks the final production of angiotensinogen at the hepatic level making it safer from a renal perspective than the ACEis or ARBs. A single subcutaneous injection provides therapy for up to six months.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceDesai AS, Webb DJ, Taubel J, et al. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. N Engl J Med. 2023 Jul 20;389(3):228-238. doi: 10.1056/NEJMoa2208391. PMID: 37467498.
https://www.nejm.org/doi/full/10.1056/NEJMoa2208391

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the mechanism of action of Zilebesiran
2. Discuss possible advantages and disadvantages of this drug in the treatment of hypertension

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-323-H01-P
Initial release date: 10/16 /2023
Expiration date: 10/16/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In the competitive pharmacy world, defining and separating yourself in the profession are keys to success. Far too often we overlook the benefits that can come from establishing a personal brand in this profession - at first glance, it can be a daunting and unfamiliar task.

Join Jen Moulton, President of CEimpact, as she interviews Ashlee, VP of market strategy and the Founder and Executive Career Coach of RX Ashlee, about the process of defining oneself in their profession and how even the slightest changes in how we brand ourselves can have massive benefits on our careers.

During this episode, the two discuss:
- Ashlee's experience in personal branding & career coaching
- The keys to establishing an effective personal brand
- How these keys can translate into career advancement opportunities

To access Ashlee's course through our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Emergency contraception use has an effectiveness of about 70%. Join host, Geoff Wall, as he reviews new literature to see if COX-2 inhibition improves that rate.

The GameChangerEmergency contraception (EC) is safe and effective but overall efficacy rates could be better. COX-2 inhibitors may enhance the effectiveness of EC but require multiday dosing.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceLi RHW, Lo SST, Gemzell-Danielsson K, et al. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023 Sep 9;402(10405):851-858. doi: 10.1016/S0140-6736(23)01240-0. Epub 2023 Aug 16. Erratum in: Lancet. 2023 Sep 9;402(10405):850. PMID: 37597523.
https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(23)01240-0.pdf

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the selection of the particular COX-2 medication used in this study
2. Discuss the implications of the COX-2 augmentation with patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-322-H01-P
Initial release date: 10/9/2023
Expiration date: 10/9/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The opioid crisis is still among us. In fact, according to the CDC, Opioids were involved in more than 68,000 deaths in 2020, which was 8.5 times the number of opioid-involved overdose deaths in 1999. The rate of drug overdose deaths involving opioids remains high, and CDC continues to track opioid overdose deaths.

In this episode of the Level Up podcast, Ashlee is joined by Richard Logan, a deputy sheriff and pharmacy owner, as they dive into Dr. Logan's experience working within both sectors of the community.

Dr. Logan discusses the future in which pharmacists play a crucial role in tackling this crisis - alongside specific steps on how to reach that future.

Join us, as we explore the world of pharmacy through the eyes of a pharmacist and deputy sheriff.

To learn more about the CE’s below, enroll to be a By Design Member today!

GameChangers: Street Valium: Inadvertent Sulfonylurea Overdose

Opioids for Pain Management - Important Changes from New Guidelines

Dispensing Opioids for Pain Management

Naloxone: The Essentials of Pharmacist-initiated Dispensing

Regulatory Compliance Specialist: A Training for Pharmacy Technicians

By Design membership links:

https://www.ceimpact.com/training/rph-membership/

https://www.ceimpact.com/training/tech-by-design-membership-1yr-959/

Community Health Worker:

Check out more about Community Health Workers here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

The cost of medications is often attributed to a burden on healthcare - despite hospitalizations costing four times as much. Join host, Geoff Wall, as he discusses the new Inflation Reduction Act which allows the government to negotiate medication prices.

The GameChangerThe US Federal Government can now negotiate with drug companies for the cost of medications. Similar to other countries, this bulk buying power can help lower medication prices for patients.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceHHS Selects the First Drugs for Medicare Drug Price Negotiation
https://www.hhs.gov/about/news/2023/08/29/hhs-selects-the-first-drugs-for-medicare-drug-price-negotiation.html

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. List the 10 medications first targeted by the new legislation for negotiation
2. Describe the common arguments against this provision of the Inflation Reduction Act

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-321-H03-P
Initial release date: 10/2/2023
Expiration date: 10/2/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

OTC Phenylephrine is in the news!

Join Ashlee and David Brushwood as they navigate the convoluted world of OTC decongestants, and the pivotal roles pharmacists play in ensuring patient safety and medication efficacy.

During this episode, the two discuss:
1. The role of the FDA in managing GRASE, Generally Recognized as Safe and Effective, medications.
2. The FDA's original decision to include oral Phenylephrine products in the OTC monograph for decongestants.
3. The CARES Act of 2020 and its impact on this efficacy and safety issue.
4. The instrumental roles of pharmacists in managing these products and providing the best options to patients.

To access the FBA briefing document on the efficiency of Oral Phenylephrine as a nasal decongestant, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Multiple studies highlight the benefits of direct oral anticoagulants (DOACS) with lower incidence of side effects and non-inferiority to warfarin. Join host, Geoff Wall, and guest, Mathew Boyd, as they discuss the FRAILE AF study and whether warfarin may be the best bet in older adults.

The GameChanger:DOACs are recommended by nearly all relevant major medical guidelines as the anticoagulant of choice in atrial fibrillation. A new study has found that in frail elderly patients, warfarin may be associated with fewer bleeding episodes.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Mathew Boyd, PharmD
Clinical Pharmacist
Unity Point

ReferenceJoosten LPT, van Doorn S, van de Ven PM,et al. Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial. Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066485. Epub ahead of print. PMID: 37634130.

https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.066485

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the design and results of the FRAIL AF study
2. Apply the results of the Groningen Frailty Index to a specific patient

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-302-H01-P
Initial release date: 9/25/2023
Expiration date: 9/25/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

In this week's Level Up episode Ashlee speaks with CoraLynn Trewet who has the honor of being the first recipient of the Thomas R. Temple Mentorship Award from the Iowa Pharmacist Association. A testament to the transformative power of mentorship, CoraLynn’s journey is one of reciprocation, authenticity, and the profound impact of being truly seen. Join us as we traverse her inspiring journey and unlock insights into the essence of a meaningful mentorship.

CoraLynn emphasizes the importance of openness to receiving mentorship and the ripple effect of paying it forward. We also shed light on the undeniably joyous pride that blooms from a mentee's success, and the invaluable role of having varied mentors at different junctures of our careers. This episode promises a refreshing view on mentorship, highlighting the significance of forging connections with individuals who ignite our inspiration.

Later in the episode, CoraLynn shares her wisdom on the art of building authentic relationships. We dive into the subtleties of trust, authenticity, and vulnerability, and their pivotal role in fostering meaningful relationships. CoraLynn also gives valuable tips on being an exceptional mentor, from being an attentive listener to inspiring others to find answers within themselves. We wrap up with a discussion on the importance of making others feel seen and cherished, a sentiment that beautifully encapsulates CoraLynn's own mentorship journey.

Join us for this enriching conversation on the transformative power of meaningful mentorship.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Although uncommon, severe headaches, neck sitffness, and other symptoms may occur after epidural procedures (lumbar puncture). Join host, Geoff Wall, as he evaluates new guidelines for the management of these symptoms

The GameChangerPost procedural headache can be severe and last up to two weeks or longer. Management includes standard pain medications but may require caffeine or application of a blood patch to prevent dural leak.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceUppal V, Russell R, Sondekoppam R, et al. Consensus Practice Guidelines on Postdural Puncture Headache From a Multisociety, International Working Group: A Summary Report. JAMA Netw Open. 2023;6(8):e2325387. doi:10.1001/jamanetworkopen.2023.25387

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2808365

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss with patients the risk factors and symptoms of post-procedural headache
2. Discuss pain management strategies for post-procedural headache

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-301-H01-P
Initial release date: 9/18/2023
Expiration date: 9/18/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

View Details

Drawing upon personal experiences and professional acumen, our guest Dawn Grittman, a steadfast advocate for mental health awareness and suicide prevention, joins Ashlee to peel back the layers of her journey intertwined with the National Alliance on Mental Illness (NAMI). As a pharmacist, Dawn’s story is a compelling narrative of transition from volunteering with NAMI to becoming a full-time crusader, keen on enlightening both healthcare providers and the general public on mental health issues. Expect an introspective look into her pioneering programs and the consequential role of candid discussions about mental health and suicide.

Navigating the labyrinth of suicide prevention, especially from a pharmacist's perspective, often encompasses a series of complexities. With an empathetic and expert approach, Dawn guides us through the nuanced process of recognizing cues and initiating life-saving conversations. Highlighting the imperative need for evidence-based resources and situational awareness, she brings to light the often overlooked role of the American Foundation for Suicide Prevention and NAMI’s Provider Program in equipping health professionals with vital knowledge about mental health conditions.

With a persistent focus on the role of pharmacists in suicide prevention, Dawn underscores the indispensable power of building patient relationships. Her passion is infectious as she emphasizes the wealth of available resources and the potential of pharmacists to provide critical help. Covering the deeply affecting personal impacts of suicide and its alarming statistics, she inspires a shift from despair to action. Dawn's poignant journey and incisive insights underscore our shared responsibility in fostering mental health awareness and suicide prevention. Her story serves as a compelling call to action to each one of us.

References:
NIMH
SAMHSA SAFE-T
QPR

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

N-Acetyl Cystine (NAC) has been long used as the antidose for acetaminophen poisonings - although with variable implementation. Join host, Geoff Wall, and guest, Kayla Myers, discuss a new consensus guideline for appropriate treatment of acetaminophen overdose.

The GameChangerNAC should be used if any doubt of acetaminophen poisoning based on new consensus guidelines. NAC may be used continued beyond standard dosing for chronic or high amounts of acetaminophen.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Kayla Myers, PharmD
Clinical Pharmacist
Unity Point

ReferenceDart RC, Mullins ME, Matoushek T, et al. Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement. JAMA Netw Open. 2023;6(8):e2327739. doi:10.1001/jamanetworkopen.2023.27739

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2808062

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Apply the new modified Rumack-Matthew nomogram to a potential acetaminophen poisoning
2. Discuss the use of fomepizole in the use of acetaminophen overdose

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-300-H01-P
Initial release date: 9/11/2023
Expiration date: 9/11/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Curious about the pivotal role pharmacists play in mental health care? Tune into Level Up host Ashlee Klevens-Hayes' enlightening conversation with Amy Werremeyer, a board-certified psychiatric pharmacist, tenured professor & chair of pharmacy practice at North Dakota State University, and tireless advocate for people with mental health and substance use disorders. Hear about her inspiring leap from inpatient psychiatry to her current role in a community mental health center, where she is dedicated to not only prescribing but educating patients about their medications and providing realistic expectations and coping tools.

The second half of our chat dives into the rising demand for specialty pharmacists in the mental health sector and the opportunities that arise with this shift. Amy enlightens us about the potential of improved medication management and non-pharmacological therapies. Her extensive knowledge and passion make her insights on the future of pharmacy in mental health invaluable. From creating access to improving the quality of care, this episode promises to deliver resources, tips, and personal anecdotes that can educate and inspire. Don't miss out on this exploration of mental health in pharmacy with Amy.

To learn more about our Pharmacist by Design membership, click here.

For more info on our upcoming live course 'Illuminating the Darkness: Depression Guideline Update', visit ceimpact.com.

References:
2023 ASHP Forecast
Shatterproof
American Association of Psychiatric Pharmacists

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The American Heart Association updated the Coronary Artery Disease (CAD) guidelines for the first time in a decade. Join host, Geoff Wall, as he evaluates what's new in CAD pharmacotherapy.

The GameChangerCAD pharmacotherapy is dependent on aggressive lipid management whereas antiplatelet and beta-blocker therapy is now more nuanced.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceVirani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023 Jul 20. doi: 10.1161/CIR.0000000000001168. Epub ahead of print. PMID: 37471501.https://www.ahajournals.org/doi/epdf/10.1161/CIR.0000000000001168

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the new AHA coronary artery disease (CAD) guidelines
2. Apply AHA CAD guidelines for medical management of a patient with stable CAD

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-295-H01-P
Initial release date: 9/4/2023
Expiration date: 9/4/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Episode ten of the Level Up podcast features host Ashlee Klevens Hayes and guest Hashim Zaibak CEO at Hayat Pharmacy.

Zaibek started Hayat Pharmacy in 2011, a locally owned pharmacy that has since expanded to 20 locations across the greater Milwaukee area.

In this episode, we discuss pharmacy-based hearing aids and how they can play a role in expanding your services as a pharmacy. Zaibak joins to discuss the benefits Hayat Pharmacy has found as a result of providing OTC hearing aids, the keys to his company's expansion & success, and how pharmacists can swiftly incorporate OTC hearing aids into their own private pharmacy.

To contact Hashim Zaibek, email zaibak@hayatrx.com.

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Narcolepsy can exact a devastating toll on the (probably underdiagnosed) patient. Treatment can range from lifestyle to medications. Join host, Geoff Wall, as he explores a new oral orexin agonist for the treatment of narcolepsy.

The GameChangerNarcolepsy is more common than assumed. Current treatments include stimulant agents but a new class of orexin agonists may be effective, yet have safety concerns.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceDauvilliers Y, Mignot E, Del Río Villegas R, et al. Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1. N Engl J Med. 2023 Jul 27;389(4):309-321. doi: 10.1056/NEJMoa2301940. PMID: 37494485.

https://www.nejm.org/doi/full/10.1056/NEJMoa2301940?query=featured_home

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the manifestations, prevalence, and types of narcolepsy and associated symptoms.
2. Discuss the benefits and risks of orexin drugs in treatment of narcolepsy.

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-292-H01-P
Initial release date: 8/28/2023
Expiration date: 8/28/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Episode ten of the Level Up podcast features host Ashlee Klevens Hayes and guest Elizabeth Skoy.

In this episode, we discuss how your pharmacy can expand its services. Elizabeth joins to discuss her career, and the Center for Collaboration and Advancement in pharmacy.

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

A new biologic agent, Dupilimab, may be a possible treatment for chronic obstructive pulmonary disorder. Join host, Geoff Wall, as he evaluates the use of dupilimab in COPD with Type 2 inflammation

The GameChangerType 2 inflammation is driven by eosinophils and IL-4, 5, and 11. It occurs in 20% of patients with COPD. Dupilimab was able to decrease COPD exacerbations by 50% and improve symptoms

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceBhatt SP, Rabe KF, Hanania NA, et al. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. PMID: 37272521.

https://www.nejm.org/doi/full/10.1056/NEJMoa2303951

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the different phenotypes of COPD and treatment options
2. Describe the BOREAS trial and the applicability to patients with COPD

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-288-H01-P
Initial release date: 8/21/2023
Expiration date: 8/21/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The concept of Professional Identity Formation (PIF) is receiving LOTS of attention in pharmacy education recently. What is it and why should it matter to you as a preceptor? Listen to this episode to better understand your critical role in your learners' journey of professional self-discovery.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Jamie Kellar, BscHK, BScPhm, PharmD, PhDAssociate Dean Academic Organization
Leslie Dan Faculty of Pharmacy
University of Toronto

About Dr. Kellar
Jamie Kellar is an Associate Professor and Associate Dean, Academic at the Leslie Dan Faculty of Pharmacy, University of Toronto. She received an Honors Bachelor of Science degree in Human Kinetics from the University of Guelph, followed by a Bachelor of Science in Pharmacy and Doctor of Pharmacy degree, both from the University of Toronto. She obtained her PhD from the School of Health Professions Education, Maastricht University, Netherlands. In addition to her education, she is a licensed pharmacist in Ontario, Canada. Professor Kellar’s practice area is in the field of mental health. Her research explores professional identity in pharmacy education and practice. Dr. Kellar is an award-winning educator, having won the University of Toronto Early Career Teaching Award, the President’s Teaching Award, and the Association of Faculties of Pharmacy of Canada (AFPC) National Award for Excellence in Education. Her research on professional identity in pharmacy education also won the Rufus A. Lyman Award for the outstanding paper published in the American Journal of Pharmaceutical Education in 2020.

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss the importance of professional identity formation (PIF) in student pharmacists and pharmacy residents
2. Describe strategies to mentor and support pharmacy learners in PIF

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-254-H99-P
Initial release date: 8/16/2023
Expiration date: 8/16/2024
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Want more information on this and related topics?From Individual to Professional: Supporting Learners in Developing their Professional IdentityProfessional identity formation is a critical pillar of a pharmacy professional's career as it boosts confidence, reinforces professional behaviors, and fosters ethical practice. Discover why professional identity formation is essential and how pharmacists, preceptors, and mentors can support a student's journey of professional self-discovery.

It’s Time to be Thriving: Starting with the Whole YouMany pharmacists are facing professional burnout due to the increasing demands of pract

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Episode nine of the Level Up podcast features host Ashlee Klevens Hayes and guest pharmacist Rikki Horne.

In this episode, we discuss how veterinary medicine can play a role in your pharmacy. Rikki joins to discuss her professional experiences & expertise as a pharmacist specialized in veterinary medicine.

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The pharmacotherapy for tobacco cessation continues to evolve with new treatment options. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss the role of the pharmacy team in tobacco cessation.

The GameChangerPharmacotherapy alone may not be sufficient for tobacco cessation - counseling and support are often required. A new medication, cytisinicline, may provide additional options for treatment.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jake Galdo, PharmD, MBA, BCPS, BCGPCourse Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

ReferenceRigotti NA, Benowitz NL, Prochaska J, et al. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial. JAMA. 2023 Jul 11;330(2):152-160. doi: 10.1001/jama.2023.10042. PMID: 37432430; PMCID: PMC10336611.

https://jamanetwork.com/journals/jama/article-abstract/2807079

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss obstacles to effective tobacco cessation therapy
2. Compare and contrast cytisinicline with other pharmacotherapy agents for tobacco cessation

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-287-H01-P
Initial release date: 8/14/2023
Expiration date: 8/14/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Episode eight of the Level Up podcast features host Ashlee Klevens Hayes and guest Jake Galdo.

In this episode, we discuss Community Health Workers (CHW) and their role in the community. Jake joins to cover the benefits of becoming a CHW and the necessities to addressing health inequity within your community.

To read more about CHW's, read this article mentioned in the beginning of the episode.

To learn more about CEimpact's CHW training, click here.

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Numerous treatments exist for the management of acne - from over-the-counter products to prescriptions. Join host, Geoff Wall, as he evaluates a new treatment modality - lasers.

The GameChangerPrescription medications, like isotretinoin, are effective for acne but have significant adverse effects. Laser therapy may be just as efficacious with fewer adverse effects - and treat scarring
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceBrunk D. 1,726-nm Lasers Poised to Revolutionize Acne Treatment, Expert Predicts.

https://www.medscape.com/s/viewarticle/991731

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the adverse effects of laser treatment for acne
2. Describe the efficacy rates of laser therapy for the treatment of severe acne and acne scarring

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-X-H01-P
Initial release date: 8/7/2023
Expiration date: 8/7/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Episode six of the Level Up podcast features host Ashlee Klevens Hayes and guest Alex Cappano from Ananda Professional.

In this episode, we discuss how pharmacists, clinicians, and technicians can more effectively manage CBD products within their own practice. Alex joins the podcast to discuss how Ananda Professional's resources and tools can assist in this process.

Click here to join the CBD Academy today.

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Thrombolytics are the standard of care for acute stroke yet are not without risk. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss combination aspirin and clopidogrel versus thrombolytics in mild stroke.

The GameChangerThrombolytic use in mild stroke is common due to the time factor of administration, but data is mixed. New research has shown DAPT to be non-inferior to TPA.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGPCourse Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

ReferenceChen H, Cui Y, Zhou Z, et al. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial. JAMA. 2023;329(24):2135–2144. doi:10.1001/jama.2023.7827

https://jamanetwork.com/journals/jama/article-abstract/2806532

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss how the inclusion and exclusion criteria impact the interpretation of the ARIMIS study
2. Describe the potential benefits of DAPT therapy compared to thrombolytic therapy in mild stroke

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-249-H01-P
Initial release date: 7/31/2023
Expiration date: 7/31/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Episode six of the Level Up podcast features host Ashlee Klevens Hayes and guest Stephanie Zimmerman from Ananda Professional.

In this episode, we discuss how pharmacists, clinicians, and technicians can initiate more comfortable conversations about the benefits of CBD with their patients. Stephanie joins the podcast to discuss how Ananda Professional's resources and tools can assist in this process.

Click to here join the CBD Academy today.

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Depression is a major medical condition and severe refractory depression is a difficult condition to treat. Electroconvulsive therapy may treat refractory depression but has limitations in access and cost. Join host, Geoff Wall, as he evaluates ketamine as a treatment option for severe depression.

The GameChangerKetamine has been shown to treat depression and was recently compared to ECT in a non-inferiority trial. Relapse rates and adverse drug reaction rates between treatments were similar.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceAnand A, Mathew SJ, Sanacora G, et al. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. N Engl J Med. 2023 Jun 22;388(25):2315-2325. doi: 10.1056/NEJMoa2302399. Epub 2023 May 24. PMID: 37224232.

https://www.nejm.org/doi/full/10.1056/NEJMoa2302399

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the history and barriers of ECT for severe depression
2. Describe the results of ketamine vs ECT in depression

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-248-H01-P
Initial release date: 7/24/2023
Expiration date: 7/24/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Everyone has a voice, but rarely do we pay attention to how it is perceived by those around us. As a result, we don’t know how to use our voice to develop effective relationships with our students and residents. In this episode, guests Brandon Jennings and Nicole Caffiero - will help listeners identify their dominant voices as well as the dominant voices of their learners in order to lay the foundation for more productive interactions with students and residents.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guests
Brandon Jennings, PharmD, BCACP
President/CEO
Abilyn Consulting, LLC

Nicole Caffiero, PharmD, BCACP
Senior Guide
Abilyn Consulting, LLC

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
Learning ObjectivesAt the end of this course, preceptors will be able to:1. Discuss various 'voices' and how they manifest in both preceptors and pharmacy learners
2. Identify strategies for effectively leveraging one's 'voice' for effective and impactful communication

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-241-H99-P
Initial release date: 7/19/2023
Expiration date: 7/19/2026
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:*Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.*

Want more information on this and related topics?Pitch Perfect Precepting: Using Your Voice to Engage More EffectivelyEveryone has a voice, but rarely do we pay attention to how it is perceived by those around us. As a result, we don’t know how to use our voice to develop relationships or precept and mentor others. In this session, you'll learn your dominant voices and the dominant voices of those around you, laying the foundation to effectively engage and interact with your trainees and peers.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Episode five of the Level Up podcast features host Ashlee Klevens Hayes and guest Ed Cohen.

In this episode, we discuss a series of key talking points and questions surrounding pharmacists and their careers;

1. Define how pharmacists transition their mindset from feeling stuck to transitioning into empowerment.

2. Review the different outpatient roles in the community for pharmacists.

3. Review what the hyper-disperser role means and how to make the most of your experience working in this environment.

4. How can pharmacists take back control of their career?

5. What are your biggest learning lessons from your career?

6. 5 tips to practicing pharmacists re: empowerment.

To learn more about our Pharmacist by Design membership, click here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The hygiene hypothesis postulates early allergen exposure mitigates allergy development in children. Join host, Geoff Wall, and guest, Jake Galdo, as they evaluate what pet parents should adopt.

The GameChangerPrenatal and early childhood exposure to pets may decrease the incidence of severe allergy. Cats and Dogs seem to have the strongest inverse relationship to childhood allergies.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

ReferenceOkabe H, Hashimoto K, Yamada M, et al; Japan Environment and Children’s Study (JECS). Associations between fetal or infancy pet exposure and food allergies: The Japan Environment and Children's Study. PLoS One. 2023 Mar 29;18(3):e0282725. doi: 10.1371/journal.pone.0282725. PMID: 36989214; PMCID: PMC10057762.

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0282725

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the potential mechanism(s) of the hygiene hypothesis
2. Describe the results of JECS and types of allergies affected by type of pet ownerships

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-247-H04-P
Initial release date: 7/17/2023
Expiration date: 7/17/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

This podcast is a deep dive into the important responsibilities undertaken by any pharmacist who accepts the position of pharmacist-in-charge (PIC).

Listen to this episode to learn more about the roles and responsibilies of the PIC. Pharmacist-in-Charge (PIC) is the person regulators turn to when there is a complaint of unlawful activity in the pharmacy. Prepare yourself for this role - whether you are in it now or plan to be - by knowing how to mitigate your risk through systems, policies and procedures, and other proactive strategies.

To access this CEimpact course, visit our course catalogue here.

To support CEimpact, visit our Instagram, Facebook, and LinkedIn pages. Consider giving us a follow while you're there to stay up to date on the latest CEimpact products and podcasts.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Vasomotor symptoms associated with menopause - often called hot flashes - are associated with significant decreases in quality of life. Join host, Geoff Wall, as he evaluates a novel approach for non-hormonal treatment of hot flashes.

The GameChangerNitric oxide plays a key role in regulating body temperature in patients with hot flashes. Treatment of hot flashes should continue to be evaluated for novel treatment.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceHuang AJ, Cummings SR, Ganz P, et al. Efficacy of Continuous Transdermal Nitroglycerin for Treating Hot Flashes by Inducing Nitrate Cross-tolerance in Perimenopausal and Postmenopausal Women: A Randomized Clinical Trial. JAMA Intern Med. Published online June 05, 2023. doi:10.1001/jamainternmed.2023.1977
https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2805584

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the findings of a topical nitroglycerin study
2. Apply a treatment algorithm to individuals with menopausal hot flashes

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-242-H01-P
Initial release date: 7/10/2023
Expiration date: 7/10/2024
Additional CPE details can be found here.

This podcast episode was financially supported through grant funding from Ananda Professional.

Want to learn more about CBD as an expanded pharmacy service? Join the CBD Academy in the CEimpact App by CLICKING HERE.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The Drug Supply Chain Security Act (DSCSA) is intended to identify counterfeit drugs and keep patients safe. Many believe it is the wholesaler's responsibility. But the success of DSCSA ultimately depends on the frontline pharmacist.In November 2023, pharmacists will have operational responsibility to ensure DSCSA is being followed.

Learn more by listening to this podcast that features:
Jake Galdo, CEimpact Podcast Host
Mark Tate, President, InfiniTrak
Sam Pizzo, Senior Vice President, Strategic Alliances, InfiniTrak

InfiniTrak is a dispenser-friendly tool to ensure compliance for DSCSA.

To learn more about CEimpact and our memberships, visit http://ceimpact.com today.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Long COVID, or PostAcute Sequelae of SARS-CoV-2 Infection (PASC), was identified early in the pandemic. With over 200 symptoms attributed to PASC, join host, Geoff Wall, as he evaluates a seminal paper describing the diagnostic criteria, symptoms, and incidence of Long COVID.

The GameChangerThe PASC score can be used to detect Long COVID and help establish patients into care.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceThaweethai T, Jolley SE, Karlson EW, et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. Published online May 25, 2023. doi:10.1001/jama.2023.8823

https://recovercovid.org/

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CPE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Apply the PASC score to a patient with Long COVID.
2. Describe the limitations of the RECOVER study.

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-236-H01-P
Initial release date: 7/3/2023
Expiration date: 7/3/2024
Additional CPE details can be found here.

This podcast episode was financially supported through grant funding from Ananda Professional.

Want to learn more about CBD as an expanded pharmacy service? Join the CBD Academy in the CEimpact App by CLICKING HERE.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Visit http://ceimpact.com to learn more about what we do.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Non-alcoholic fatty liver disease (NAFLD) is a primary cause of chronic liver disease and cirrhosis. Join host, Geoff Wall, as he evaluates new data on the diagnosis and treatment of NAFLD.

The GameChangerHistorical treatment of NAFLD includes beta-blockers, diuretics, and lactulose for hepatic encephalopathy. Newer agents include statins, pioglitazone, and even vitamin E.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and ResourcesTapper EB, Parikh ND. Diagnosis and Management of Cirrhosis and Its Complications: A Review. JAMA. 2023 May 9;329(18):1589-1602. doi: 10.1001/jama.2023.5997. PMID: 37159031.

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the treatment of cirrhosis and subsequent complications
2. Develop treatment recommendations for persons with NAFLD

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-235-H01-P
Initial release date: 6/26/2023
Expiration date: 6/26/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Visit http://ceimpact.com to learn more about what we do.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Many of us avoid giving feedback because it can feel negative and uncomfortable. We’re afraid of a poor reaction from the student and we really don’t want to hurt their feelings – after all – they already have so much pressure on them. And let’s be honest - sometimes, we just want to be liked.

And yet as preceptors, giving good feedback is probably one of the most important jobs we have. If our learners – whether students or residents - are going to be successful, deliver excellent patient care, and even keep patients safe, they’ve got to hear some tough feedback every now and again. If we’re being truthful – so do we.

Dr. Shannon James from Husson University joined me for a discussion about giving good feedback to learners. Her thoughtful and fearless approach to this really resonated with me and I hope it does for you, too.

HostKathy Schott, PhD
CEimpact

GuestShannon James, PharmD, BCPP
Assistant Professor of Pharmacy Practice
Husson University School of Pharmacy

About Dr. James:Dr. Shannon James is a Board Certified Psychiatric Pharmacist and an Assistant Professor of Pharmacy Practice at the Husson University School of Pharmacy. Shannon earned B.S. Pharmaceutical Studies and Doctor of Pharmacy degrees at the University of Kansas. After graduation, she completed a PGY1 Pharmacy Practice residency at the New Mexico VA Health Care System in Albuquerque, NM followed by a PGY2 Psychiatric Pharmacy residency at Community Health Network and Butler University in Indianapolis, IN. She is a certified Mental Health First Aid instructor and is involved in grant-funded efforts to improve access to harm reduction resources for opioid use disorder in Maine. Her clinical interests include severe mental illness, substance use disorders, and patient advocacy.

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CE InformationAt the end of this course, preceptors will be able to:
1. Describe strategies for effective feedback.
2. Discuss how establishing a set of core assumptions about learners can assist in delivering effective feedback.

UAN: 0107-0000-23-231-H99-P
Release Date: 06/21/2023
Expiration Date: 06/21/2026

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:· Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
· Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics?Providing Effective FeedbackMany of us avoid giving feedback because it can feel negative, however, it is essential for growth and quality communication. The evidence-based methods discussed in this course give you skills to provide effective feedback that facilitates learning and empowers students and residents.

Using Feedback to Improve Your Teaching
Feedback is essential to developing a trusting and safe environment where learners can grow in their confidence. This course will give you some proven strategies for accepting and implementing critical feedback on your teaching.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Half of patients with heart failure have Heart Failure with Preserved Ejection Fraction (HFpEF). Join host, Geoff Wall, as he talks about the new guidelines from the American College of Cardiology for diagnosis, treatment, and challenges in therapy for persons with HFpEF.

The GameChangerHFpEF is the fastest growing cause of heart failure and is often difficult to diagnose. New therapies are shown to improve symptoms and decrease hospitalizations. Management of comorbid conditions, like obesity and diabetes, is critical to optimizing care.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

ReferenceKittleson MM, Panjrath GS, Amancherla K, et al. 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 May 9;81(18):1835-1878. doi: 10.1016/j.jacc.2023.03.393. Epub 2023 Apr 19. PMID: 37137593.

Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the H2FPEF scoring system for HFpEF diagnosis
2. Apply the new practice guidelines to HFpEF patient pharmacotherapy

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-228-H01-P
Initial release date: 6/19/2023
Expiration date: 6/19/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Adulteration of medications of abuse is a rampant issue in the US. Most attention is on opioids; however, benzodiazepine adulteration is occurring – with sulfonylureas. Join host, Geoff Wall, as he talks about managing emergent hypogylcemia episodes.

The GameChanger
Several case reports have detailed patients unresponsive due to severe hypoglycemia caused by mistaken sulfonylurea ingestion. Treatment of acute sulfonylurea overdose includes dextrose and octreotide.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Tucker, M. Sulfonylureas as Street Drugs: Hidden Hypoglycemia Cause. Medscape. May 2023. https://www.medscape.com/viewarticle/991680

Redeem your CPE here
CPE (Pharmacist) https://learn.ceimpact.com/library/course/5768

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership https://www.ceimpact.com/

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the phenomenon of ‘street valium’ overdoses
2. Discuss the treatment of severe sulfonylurea overdose

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-XXX-H01-P
Initial release date: XX/XX/2023
Expiration date: XX/XX/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Septic shock has a 40% mortality rate in many patients. Methylene blue has been shown in small non-controlled case series to have a benefit. Join host, Geoff Wall, as he reviews a randomized controlled study from Mexico on this novel strategy.

The GameChanger
Methylene blue is a specific inhibitor of the inducible nitric oxide synthase for indirect pressor effects. Despite confounders, this small study may be a good start for a larger randomized controlled study for methylene blue as early adjunct care in patients with septic shock.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Ibarra-Estrada M, Kattan E, Aguilera-González P, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023 Mar 13;27(1):110. doi: 10.1186/s13054-023-04397-7. PMID: 36915146; PMCID: PMC10010212.

Redeem your CPE here
CPE (Pharmacist) https://learn.ceimpact.com/library/course/5768

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership https://www.ceimpact.com/

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the potential physiologic mechanism of benefit for methylene blue in septic shock
2. Discuss the Ibarra-Estrada et al study limitations

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-XXX-H01-P
Initial release date: XX/XX/2023
Expiration date: XX/XX/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The proverbial ‘pill’ or hormonal contraception may be available over-the-counter (or at least a progestin-only version) by year’s end. Join guest host, Jake Galdo, as he discusses improved access to care with Erin Raney as the FDA debates over-the-counter status for hormonal contraceptives.

The GameChanger
Women’s health is a priority area from a public health perspective – the US has lots of room for improvement. One initiative is to allow a progestin-only hormonal contraceptive have over-the-counter status; in other words, be available without prescription. Progestin-only therapy has unique counseling considerations, so pharmacy intervention can help to optimize care.

Show Segments
[insert here]

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

Guest
Erin C. Raney, Pharm.D., BCPS, BC-ADM
Professor of Pharmacy Practice
Midwestern University College of Pharmacy-Glendale

References and Resources

Opill Rx-to-OTC Switch Program. www.fda.gov/media/167893/download

Redeem your CPE here
CPE (Pharmacist) https://learn.ceimpact.com/library/course/5768

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership https://www.ceimpact.com/

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the efficacy of OTC hormonal contraceptive
2. Identify contraindications for OTC hormonal contraceptives

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-XXX-H01-P
Initial release date: XX/XX/2023
Expiration date: XX/XX/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Sexually transmitted infection (STI) risk in high risk patients is a common problem compounded by antimicrobial resistance. Join host, Geoff Wall, with guest Amanda Bushman, as they discuss a new post-exposure prophylaxis (PEP) therapy for STI prevention

The GameChanger
Sexually transmitted infection incidence is higher than most clinicians suspect. Doxycycline may offer effective post-exposure prophylaxis for some HIV positive patients.

Show Segments
[insert here]

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Amanda Bushman, PharmD, BCIDP
Clinical Pharmacist, UnityPoint Health

References and Resources

Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N Engl J Med. 2023 Apr 6;388(14):1296-1306. doi: 10.1056/NEJMoa2211934. PMID: 37018493; PMCID: PMC10140182.

Redeem your CPE here
CPE (Pharmacist) https://learn.ceimpact.com/library/course/5768

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership https://www.ceimpact.com/

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the DOXY-PEP study
2. Apply results of DOXY-PEP to patient care

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-XXX-H01-P
Initial release date: XX/XX/2023
Expiration date: XX/XX/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

While we all know students who may exhibit more confidence that they have the right to based on their actual knowledge and experience, more often as preceptors we have students who demonstrate a lack of confidence that gets in the way of their learning. It is easy to make assumptions about why a student demonstrates a lack of confidence, but often we have missed the mark. By understanding the root cause of waning confidence in a pharmacy learner, we can develop strategies to increase confidence and allow them to optimize their learning.

Dr. Kate Newman, Director of Experiential Education, and Dr. Stephanie Hunziker, Director of Skills and Simulation and a Clinical Assistant Professor are both from Southern Illinois University Edwardsville School of Pharmacy. They have recognized the negative impact that low confidence can have on learner outcomes and have lots to share about challenges and strategies for identifying the root cause of low confidence, as well as teaching tactics and methods to overcome them.

Host
Kathy Schott, PhD
CEimpact

Guests
Kate Newman, PharmD

Director of Experiential Education

Clinical Associate Professor, Pharmacy Practice

Southern Illinois University Edwardsville, School of Pharmacy

Stephanie Hunziker, PharmD

Director of Skills and Simulation

Clinical Assistant Professor

Southern Illinois University Edwardsville School of Pharmacy

Get CE
Click here to access the course:

https://learn.ceimpact.com/library/course/5678

CE Information

At the end of this course, preceptors will be able to:

Recognize potential reasons as learner may appear to lack confidence in a clinical setting.
Discuss strategies to help students overcome barriers and increase confidence.

UAN: 0107-0000-23-208-H99-P
Release Date: 05/17/2023
Expiration Date: 05/17/2026
The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics?

True Grit: Developing a Philosophy of Failure

https://learn.ceimpact.com/library/course/3911

Pharmacy learners are innately afraid to look silly, say the wrong thing, or make mistakes that could result in negative feedback. This fear can manifest in a perceived lack of confidence. This course provides pearls for creating an safe and supportive environment where failure isn’t something to be ashamed of, but rather a path to greater learning.

We’ve also got a great podcast on this topic. Check out Season 2, Episode 1.

https://ceimpactpodcast.buzzsprout.com/1788250/9915405-developing-a-philosophy-of-failure

Using Feedback to Improve Your Teaching https://learn.ceimpact.com/library/group/36/course/5102

Feedback is essential to developing a trusting a

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

About 50% of Americans have hypertension, yet WHICH is a preferred anti-hypertensive strategy is a random process. And pharmacogenomics may not be needed. Join host, Geoff Wall, as he evaluates a recent study evaluating the role of personalized medication selection for persons with hypertension.

The GameChanger
Although no genetic markers exist to determine optimal hypertensive pharmacotherapy, initial and secondary hypertensive therapy does impact outcomes. A personalized approach does produce a greater reduction in blood pressure.

Show Segments
[insert here]

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Sundström J, Lind L, Nowrouzi S, et al. Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial. JAMA. 2023;329(14):1160–1169. doi:10.1001/jama.2023.3322

Redeem your CPE here
CPE (Pharmacist) https://learn.ceimpact.com/library/course/5768

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership https://www.ceimpact.com/

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the results of the PHYSIC study
2. Discuss the limitations of the PHYSIC study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-XXX-H01-P
Initial release date: XX/XX/2023
Expiration date: XX/XX/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Respiratory syncytial virus (RSV) is a leading cause of pneumonia and hospitalizations in children and older adults. A search for a vaccine may finally be over. Join host, Geoff Wall, and guest, Jake Galdo, as they dive into part 2 of a two-part series examining new research on the proposed RSV vaccine.

The GameChanger
RSV, COVID-19, and influenza are major disease burdens on children and older adults. Fortunately, COVID-19 and influenza have widely available vaccines – and maybe soon for RSV. A recent study of the mRNA vaccine in pregnant patients may help newborns.

Show Segments
[insert here]

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jake Galdo, PharmD, MBA, BCPS, BCGP
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources

Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5. PMID: 37018474.

Redeem your CPE here
CPE (Pharmacist) https://learn.ceimpact.com/library/course/5769

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the MATISSE study in relation to RSV vaccines
2. Describe barriers to applying the information in this study to general populations

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-193-H06-P
Initial release date: 05/08/2023
Expiration date: 05/08/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Respiratory syncytial virus (RSV) is a leading cause of pneumonia and hospitalizations in children and older adults. A search for a vaccine may finally be over. Join host, Geoff Wall, and guest, Jake Galdo, as they dive into part 1 of a two-part series examining new research on the proposed RSV vaccine.

The GameChanger
RSV, COVID-19, and influenza are major disease burdens on children and older adults. Fortunately, COVID-19 and influenza have widely available vaccines – and maybe soon for RSV. A recent study of the mRNA vaccine in older adults improves antibody titers.

Show Segments
00:00 - Introductions
03:06 - Barriers to Development of the RSV Vaccine
06:46 - Looking at the RSV Vaccine Study
13:01 - The GameChanger: The Vaccine Outcomes
20:57 - Connecting to Practice: The Potential Future of This Vaccine
28:19 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jake Galdo, PharmD, MBA, BCPS, BCGP
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources
Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005 Apr 28;352(17):1749-59. doi: 10.1056/NEJMoa043951. PMID: 15858184.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe barriers to development of an RSV vaccine
2. Discuss outcomes of an RSV vaccines in older adults

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-192-H06-P
Initial release date: 05/01/2023
Expiration date: 05/01/2024

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Community Acquired Pneumonia (CAP) has a high mortality rate. A new study evaluates the use of hydrocortisone for severe CAP in the ICU setting. Join host, Geoff Wall, as he evaluates if the evidence stacks up.

The GameChanger
The use of steroids to treat severe pneumonia has waxed and waned for many years with insufficient evidence. A recent study found steroids improved a number of outcomes, including mortality.

Show Segments
00:00 - Introductions
01:19 - Past Studies on CAP Treatment
03:32 - The CAPE Code Study
17:05 - The GameChanger: The Study Findings
24:31 - Connecting to Practice: Study Limitations
26:01 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Hydrocortisone in Severe Community-Acquired Pneumonia

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the past history of major mortality studies for CAP pharmacotherapy
2. Discuss the CAPE Code study and its possible implications in the ICU

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-147-H01-P
Initial release date: 04/24/2023
Expiration date: 04/24/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Several studies have found the improved outcomes and quality of life through deprescribing. However, it rarely happens. Join host, Geoff Wall, with guest, Kristin Meyer, as they evaluate a new studying looking at pharmacist-provided describing services during transition of care.

The GameChanger
Older patients are on numerous medications often with limited therapeutic benefit and high risk of adverse events. Many of these medications can be discontinued with no change in outcomes. Pharmacists are uniquely positioned to support deprescribing protocols.

Show Segments
00:00 - Introductions
01:46 - Arguments for Deprescribing
05:44 - Looking at the Study
16:32 - The GameChanger: Deprescribing Results
22:42 - Connecting to Practice: Dr. Meyer’s Thoughts on Results
31:08 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Kristin Meyer, PharmD, BCGP
Professor of Pharmacy Practice, Drake University

References and Resources

Vasilevskis EE, Shah AS, Hollingsworth EK, et al. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial. JAMA Intern Med. 2023;183(3):223–231. doi:10.1001/jamainternmed.2022.6545

O'Mahony D. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020 Jan;13(1):15-22. doi: 10.1080/17512433.2020.1697676. Epub 2019 Nov 30. PMID: 31790317.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the importance and benefits of deprescribing medications in elderly patients
2. Discuss the assessment scoring systems used to assess deprescribing activities

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-146-H01-P
Initial release date: 04/17/2023
Expiration date: 04/17/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

ICU patients are at high risk for venous thromboembolism, and the majority of patients require prophylaxis. The challenging therapy is thrombocytopenia. Join host Geoff Wall, as he evaluates the results of a new study evaluating the clinical thresholds for chemical prophylaxis.

The GameChanger
The majority of ICU patients eligible for VTE prophylaxis do not receive it. Different clinicians use different thresholds to initiate or stop prophylaxis. The database study discussed provides a potential evidence-based threshold.

Show Segments
00:00 - Introductions
00:47 - VTE Prophylaxis Background
09:34 - Looking at the Study
18:42 - The GameChanger: A Potential Threshold for Chemical Prophylaxis
22:15 - Connecting to Practice: Applicability
26:13 - Closing Remarks
Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the history and use of VTE prophylaxis in the ICU
2. Describe the results of the Pang et al study discussed and its applicability to ICU patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-134-H01-P
Initial release date: 04/10/2023
Expiration date: 04/10/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The Updated AAAAI Guidelines on Drug Allergies

Drug allergies are a common challenge for all prescribers, patients, and pharmacies. They are associated with increased costs, adverse effects, and extended hospitalizations. Join host Geoff Wall as he reviews the newly released AAAI guidelines on drug allergies.

The GameChanger
Over 90% of patients claiming a penicillin allergy are not allergic. Sulfamethoxazole desensitization is largely not needed. A thorough evaluation of patient allergies with testing may help establish true allergies in patients and help optimize pharmacotherapy.

Show Segments
00:00 - Introductions
01:55 - Changes in Classifications
07:35 - The GameChanger: Beta-Lactam Allergy Approach
21:05 - Sulfonamide Allergy Approach
27:04 - Non-Steroidal Allergy Approach
30:05 - Connecting to Practice: Applying these Changes
30:58 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
A 2022 practice parameter update.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss approaches to a patient with a claimed penicillin allergy who requires a beta lactam
2. Discuss the protocol for desensitization for a sulfonamide allergic patient when a sulfonamide is required

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-133-H01-P
Initial release date: 04/03/2023
Expiration date: 04/03/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Although the numbers may be low, COVID-19 and other illnesses remain a significant threat to patients. The role of masks in preventing SARS-CoV-2 spread has been politicized since the beginning. A new meta-analysis purports to answer the question of mask effectiveness. Join host Geoff Wall, with guest Jake Galdo, as they deep dive into the article and evaluate the science.

The GameChanger
A new meta-analysis suggests that mask mandates do not affect the prevention and spread of COVID-19. However, the study has numerous limitations and errors, making its interpretation difficult.

Show Segments
[insert here]

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources
Jefferson T, Dooley L, Ferroni E, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses (Review). Cochrane Library.

Novella S. Masks Revisited. Science Based Medicine.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the pros and cons of a meta-analysis
2. Describe the limitations of the Jefferson et al meta-analysis

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-119-H01-P
Initial release date: 03/22/2023
Expiration date: 03/22/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Pharmacogenomics have long held the promise of using personalized information for drug selection to maximize efficacy and minimize adverse reactions. A new study evaluates the routine use of pharmacogenomic testing to improve safety in a wide range of medications. Join host, Geoff Wall, as he evaluates personalized medicine.

The GameChanger
Most studies using routine pharmacogenomic testing in clinical practice have not been significant. However, a new study found a 12 panel pharmacogenomic test did decrease the incidence of patient reported adverse effects compared to usual care. Several limitations still exist preventing widespread implementation.

Show Segments
00:00 - Introductions
01:38 - Genomic Guided Therapy to Date
05:05 - Importance of Genomic Variations
08:37 - Looking at the Study
21:20 - The GameChanger: Swen et al Results
27:50 - Connecting to Practice: Current Barriers to Pharmacogenomic Testing
30:38- Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.

Clinical Pharmacogenomics Implementation Consortium.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current barriers to routine use of pharmacogenomic testing
2. Discuss issues and results of the Swen et al study on pharmacogenomics

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-118-H01-P
Initial release date: 03/19/2023
Expiration date: 03/19/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Pharmacy learners - IPPE, APPE, Residents - may not always be forthcoming with honest feedback. But they know what they appreciate (or don't) in a learning experience. As a preceptor, your approach to teaching has a huge impact on student learning.

We asked two 4th year pharmacy learners to share what matters most to them in a preceptor. Their answers may surprise you! Listen in to learn what students most value in their learning experiences and gather some strategies you can use to enhance your teaching and mentor in an impactful way for your learners.

HostKathy Schott, PhD
CEimpact

GuestsLily Gardner, PharmD Candidate 2023
Drake University

Keaton Higgins, PharmD Candidate 2023
University of Iowa

Get CEClick here to access the course

CE Information

At the end of this course, preceptors will be able to:

Identify practices that pharmacy learners most value in their preceptors and why
Describe effective strategies to enhance learning in the pharmacy education experience you provide

UAN: 0107-0000-23-116-H99-P
Release Date: 03/15/2023
Expiration Date: 03/15/2026
The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics?

Check out the full course created by Dr. Cox on this topic:Using Feedback to Improve Your Precepting, and learn what you can do to help facilitate better feedback from your learners.

This book is a great resource for building feedback skills – Thanks for the Feedback: The Science and Art of Receiving Feedback Well. I’ve read this book and there’s something in it for everyone – from a teacher, mentor, preceptor, parent, partner, or spouse. Check out the LINK!

As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask you experiential program director if you are a member so that you can access it all for free!

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

Thanks for the Feedback: The Science and Art of Receiving Feedback Well

View Details

For the past two decades, large amounts of isotonic fluids have been the first step in treating septic shock despite adverse events of fluid overload, coagulopathy, and pulmonary edema. A new NIH study evaluates this strategy. Join host, Geoff Wall, with guest, Matt Trump, DO, as they evaluate initial septic shock management.

The GameChanger
Liberal fluid management (30 mL/Kg) in the early phase of septic shock may not result in lower mortality than a more restrictive strategy. However, vasopressor predominant strategy may be used in its place.

Show Segments
00:00 - Introductions
01:08 - Background on Fluid Administration in Septic Shock
05:44 - Looking at the Study
15:55 - The GameChanger: Shapiro et al Results
21:21 - Connecting to Practice: What Should We Takeaway
34:31 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Matt Trump, DO
Iowa Clinics

References and Resources
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the background of fluid administration in septic shock
2. Describe the results of the Shapiro et al study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-103-H01-P
Initial release date: 03/13/2023
Expiration date: 03/13/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Every January, the American Diabetes Association publishes the Standards of Care in Diabetes. The guidelines are a living document and change throughout the year; however, the January update is the seminal changes for the entire document. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss what’s new and great in the guidelines.

The GameChanger
In addition to medication recommendations, the guidelines now emphasize the role of Community Health Workers in the management of health-related disparities affecting patients with diabetes. Pharmacotherapy continues to be driven by comorbid conditions and the impact of clinical outcomes, like a cardiovascular or renal disease.

Show Segments
00:00 - Introductions
01:59 - Prevention and Delay of Type 2 Diabetes
08:12 - Vaccines and Diabetes
10:49 - Continuous Glucose Monitoring Goals
17:21 - Glycemic Treatment Updates
19:25 - Lipid Goals and Treatment
20:39 - The GameChanger: Treatment Recommendations with Comorbid Conditions
23:49 - Connecting to Practice: Comorbid Driven Therapy
27:31 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources
American Diabetes Association. Standards of Care in Diabetes-2023 Abridged for Primary Care Providers.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the goal for continuous glucose monitoring in diabetes patients
2. Describe the lipid goals in patients with diabetes and treatment recommendations
3. Describe treatment recommendations for patients with diabetes and chronic kidney disease

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-102-H01-P
Initial release date: 03/06/2023
Expiration date: 03/06/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Furosemide is the most prescribed loop diuretic for heart failure; however, furosemide’s pharmacokinetic parameters are less than ideal compared to other loop diuretics. Join host, Geoff Wall, as he evaluates the first randomized controlled trial comparing loop diuretics in heart failure.

The GameChanger
Torsemide has potential pharmacokinetic advantages compared to furosemide in the treatment of heart failure. However, a recent study did not find meaningful differences in clinical outcomes when comparing loop diuretics for the treatment of heart failure.

Show Segments
00:00 - Introduction
01:00 - Current Loop Diuretic Use
02:21 - Furosemide vs Torsemide Pharmacokinetics
04:58 - Looking at the TRANSFORM-HF Study
14:54 - The GameChanger: TRANSFORM-HF Outcomes
19:16 - Connecting to Practice: Picking Between the Two
21:52 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. List the pharmacokinetic differences between furosemide and torsemide
2. Discuss the findings of the Mentz et al study evaluating loop diuretics

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-101-H01-P
Initial release date: 02/27/2023
Expiration date: 02/27/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Routine pediatric vaccines are declining and 97% of pediatric influenza deaths are in unvaccinated children. Join host Geoff Wall, with guest Jake Galdo, as they discuss what the heck is happening with pediatric vaccines and how the healthcare community can step up.

The GameChanger
The Advisory Committee on Immunization Practices provides recommendations for routine vaccines for all persons. Pharmacists are an integral part of ensuring adherence to vaccine schedules. Differences in state scope of practice may influence what vaccines may be administered, but not what vaccines can be recommended.

Show Segments
00:00 - Introductions
00:53 - Pediatric Vaccine Coverage
02:51 - Connecting to Practice: How Pharmacists Can Help
14:21 - The GameChanger: Pediatric COVID Vaccines
26:22 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources
Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2021-22 School Year.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the current state of pediatric vaccinations in the US
2. Describe clinical information to be collected during pediatric vaccinations

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-100-H01-P
Initial release date: 02/20/2023
Expiration date: 02/20/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

As preceptors, sometimes one of the hardest things we do is give feedback. What about when we receive it? Listen to learn how to engage students in ways that result in meaningful feedback you can use to improve your teaching. You're putting in the work. Why not make it as impactful as possible for your learners?

This week I’m speaking with Nick Cox – a faculty member and preceptor in an ambulatory care setting – on the topic of feedback – how to invite it, how to prepare to receive it, and what to do with it when you like it – or not.

As part of our discussion, Nick refers to this book – Thanks for the Feedback: The Science and Art of Receiving Feedback Well. I’ve read this book, and there’s something in it for everyone – from a teacher, mentor, preceptor, parent, partner, or spouse. Check out the Here!

HostKathy Schott, PhD
CEimpact

GuestNicholas Cox, PharmD BCACP
Assistant Professor (Clinical)
University of Utah

Get CEClick here to access the course

CE Information

At the end of this course, preceptors will be able to:

List common barriers that prevent learners from providing meaningful feedback to preceptors.
Describe ways to create a learning environment where students feel they can safely offer feedback.

UAN: 0107-0000-23-092-H99-P
Release Date: 02/15/2023
Expiration Date: 02/15/2026
The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics?

Check out the full course created by Dr. Cox on this topic:Using Feedback to Improve Your Precepting, and learn what you can do to help facilitate better feedback from your learners.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Patient use of any anticoagulation during an acute stroke is a contraindication for the use of thrombolytics or clot busters. Recent meta-analyses and animal studies raise the question of this contraindication. Join guest, Geoff Wall, as he examines the data on Direct Oral Anticoagulants (DOACs) and thrombolytics.

The GameChanger
DOACs have a significantly smaller intracranial hemorrhage (ICH) risk compared to warfarin and this benefit may translate to risk of bleed with thrombolytics. A new study found a numerically decreased risk of ICH in patients with DOACs compared to controls.

Show Segments
00:00 - Introductions
01:07 - Current Practices with Thrombolytics
05:05 - Looking at the Study
19:45 - The GameChanger: Decreased ICH Risk?
23:30 - Study Limitations
26:11 - Connecting to Practice
27:01 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:

Discuss the theory about why DOACs may not increase risk of intracranial bleed in stroke patients receiving thrombolytics
Describe the limitations of the Meinel et al study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-064-H01-P
Initial release date: 02/13/2023
Expiration date: 02/13/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Osteoporosis may be a forgotten disease – common but rarely treated. The 2023 guidelines are not here. Join host, Geoff Wall, as he reviews the new treatment recommendations and how we can optimize pharmacotherapy for all persons with osteoporosis.

The GameChanger
Osteoporosis is common and routine screenings should be implemented. Bisphosphonates are still the drug of choice, but treatment for persons over 65 should be made on a case-by-case basis.

Show Segments
00:00 - Introduction
00:25 - Background on Osteoporosis
04:17 - How Guidelines Are Formed
08:45 - Bisphosphonate Recommendation
14:14 - Denosumab Recommendation
16:40 - Anabolic Drugs
20:40 - SERMs
22:24 - The GameChanger: Recommendations Summary
27:20 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians.

FRAX Calculator

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the epidemiology and diagnosis of osteoporosis
2. Apply the treatment guidelines for osteoporosis to a specific patient

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-063-H01-P
Initial release date: 01/06/2023
Expiration date: 01/06/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Hydrochlorothiazide is the go-to thiazide for hypertension control despite better data for chlorthalidone. Join host Geoff Wall as he evaluates the new randomized controlled study to determine what is the best thiazide.

The GameChanger
Several pharmacologic differences exist between hydrochlorothiazide and chlorthalidone. The new DCP Study did not find any differences in cardiovascular outcomes.

Show Segments
00:00 - Introductions
02:20 - History of HCTZ vs Chlorthalidone
05:26 - The Diuretic Comparison Project: HCTZ vs Chlorthalidone
12:27 - The GameChanger: DCP Results
19:48 - Connecting to Practice: Choosing Between the Two
21:47 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
Redeem your CPE or CME here
CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the pharmacologic differences of hydrochlorothiazide and chlorthalidone
2. Apply the results of the DCP Study to clinical practice

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-025-H01-P
Initial release date: 01/30/2023
Expiration date: 01/30/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Results from early COVID-19 studies are still emerging. Some micronutrients, such as zinc, have been shown to decrease the severity of viral infections yet human data is sparse. Join host, Geoff Wall, as he evaluates a new study looking at the proposed benefit of zinc in COVID-19 infections.

The GameChanger
Zinc has several antiviral properties. A recent trial showed a decreased risk of ICU admission – however, has numerous exclusion criteria impacting the external validity.

Show Segments
00:00 - Introductions
01:45 - Zinc Role In COVID-19
04:20 - Looking at the Study
10:33 - The GameChanger: Study Results
19:03 - Connecting to Practice: Applicability of Exclusions
21:48 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial, Clinical Infectious Diseases
A Potential Role for Zinc to Enhance Treatment for Coronavirus Disease 2019 (COVID-19)

Redeem your CPE or CME here
CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the putative role of zinc in treating COVID-19
2. Describe the application of the results of the Zinc COVID-19 study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-025-H01-P
Initial release date: 01/23/2023
Expiration date: 01/23/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Sometimes teaching isn't "telling" but "asking" - asking questions that encourage students and residents to problem-solve in a stepwise manner. Listen in as we discuss a teaching strategy that builds confidence and encourages curiosity in your learners.

We’ve all heard students and residents complain about ‘pimping’ from preceptors during rotations or during their residency experience. Pimping has given a bad name to what can truly be a very effective teaching strategy when done right – Socratic Questioning.

In this month's episode, I’m speaking with Lindsay Davis of Midwestern University – Glendale, and Kevin Carrasco, a preceptor who has jumped on the Socratic Questioning bandwagon after experiencing what a difference it has made in his effectiveness as a preceptor. During our conversation – they debunked many of the assumptions often made about Socratic questioning as a teaching method and also gave some great advice on how to approach this method in a trusting and safe way for learners.

Download this pocket guide, then listen in to get started!

HostKathy Schott, PhD
CEimpact

GuestsLindsay Davis
Lindsay E. Davis, PharmD, BCPS, BCCP, FCCP
Director, Cardiology & Metabolism Team
Pfizer, Internal Medicine Field Medical Group
Adjunt Professor, Pharmacy Practice
Midwestern University - Glendale

Kevin Carrasco, Pharm.D., MPH
Emergency Medicine Pharmacist
Banner Univeristy Phoenix Pharmacy

Dr. Davis reports that she is employed by Pfizer. All relevant financial relationships have been mitigated.

Get CEClick here to access the course

CE Information

At the end of this course, preceptors will be able to:

Define the concept of 'microaggression'
Identify strategies to support students who may experience microaggressions during experiential learning

UAN: 0107-0000-23-058-H99-P
Release Date: 01/18/2022
Expiration Date: 01/18/2025
The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics?

Check out this free resource to guide the implementation of Socratic Questioning in your teaching.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Celiac disease is of the most common auto-immune diseases in the world. The only current treatment is maintaining a strict gluten-free diet. Join host, Geoff Wall, as he discusses the results of a phase 2 study investigating a novel pharmacologic treatment of Celiac disease.

The GameChanger
Celiac disease is common and has a myriad of symptoms. A new drug may offer a way for patients with Celiac disease to eat gluten without issue.

Show Segments
00:00 - Introductions
00:50 - The Effects of Celiac Disease
03:45 - Why Celiac Causes Problems
09:08 - Latiglutenase Study Background
14:48 - The GameChanger: Latiglutenase Study Results
19:11 - Connecting to Practice
21:31 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Murray JA, Syage JA, Wu TT, et al. Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge. Gastroenterology. 2022 Dec;163(6):1510-1521.e6. doi: 10.1053/j.gastro.2022.07.071. Epub 2022 Aug 2. PMID: 35931103; PMCID: PMC9707643.

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the extraintestinal manifestations of Celiac disease
2. Discuss the Murray et al study and its implications in patients with Celiac disease

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-024-H01-P
Initial release date: 01/16/2023
Expiration date: 01/16/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The American Diabetes Association Standards of Care in Diabetes are a “living” guideline – the recommendations are updated throughout the year and major revisions occur in January. In this episode, guest host, Jake Galdo, is joined by Susan Cornell as they evaluate new pharmacotherapy recommendations in the ADA Standards of Care.

The GameChanger
Treatment recommendations for diabetes are no longer metformin plus. Now initial, and augmented therapy, is driven by comorbid conditions.

Show Segments
00:00 - Introductions
02:09 - Reason for ADA Standards of Care Update
05:09 - The GameChanger: Comorbid Condition-Driven Therapy
08:32 - Connecting to Practice: Clinical Decision Points
11:13 - Diabetes Therapies Use for Weight Loss and Drawbacks
13:29 - Lifestyle Modification Suggestions
19:48 - Insulin Use According to New Guidelines
25:03 - Pharmacy Intervention Opportunity: Glucagon
26:37 - Closing Remarks

Host
John A Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Director, Education Projects, CEimpact
CEO, Seguridad

Guest
Susan Cornell, BS, PharmD, CDCES, FAPhA, FADCES
Associate Director, Experiential Education
Professor, Pharmacy Practice
Midwestern University College of Pharmacy

References and Resources
Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023. Diabetes Care

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify the first line therapy for treatment of diabetes
2. Discuss key clinical decision points for the treatment of diabetes

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-023-H01-P
Initial release date: 01/09/2023
Expiration date: 01/09/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Stimulant medications, like methylphenidate and amphetamines, have adverse cardiovascular effects, like elevated blood pressure, increasing the risk of cardiovascular events. Join host Geoff Wall as he reviews a new meta-analysis trying to quantify the risk of ADHD medications on cardiovascular outcomes.

The GameChanger
A large meta-analysis did not find an association between medications for ADHD and cardiovascular disease. Several limitations may interfere with the applicability of these results.

Show Segments
00:00 - Introductions
01:38 - Background on ADHD and Stimulant Medications
02:58 - Rationale for Analysis
06:42 - Looking at the Meta-Analysis
11:44 - The GameChanger: Meta-Analysis Findings
17:43 - Connecting to Practice: Addressing Patient Concerns
20:00 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis
Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the purported mechanism of the potential risk of cardiovascular disease in patients taking stimulant medications
2. Discuss the findings of a recent meta-analysis by Zhang et al on cardiovascular disease and stimulant medications

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-016-H01-P
Initial release date: 01/03/2023
Expiration date: 01/03/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

COPD is a common and complex disease for both inpatient and outpatient providers. GOLD guidelines provide diagnosis and treatment recommendations for COPD and were recently updated. Join host Geoff Wall as he breaks down the salient recommendations in the 2023 GOLD guidelines.

The GameChanger
A new severity scoring system for COPD exists – category E. Additionally, inhaled corticosteroids may play a larger role in the pharmacotherapy of COPD.

Show Segments
00:00 - Introductions
01:40 - Background on COPD
04:09 - The GameChanger: Severity Scoring Changes
08:23 - Connecting to Practice: Impact of Inhaler Technique
16:08 - Use of Inhaled Corticosteroids
23:23 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

2023 GOLD Report

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the new severity scoring system for COPD in the 2023 GOLD guidelines
2. Discuss appropriate use of inhaled corticosteroids in COPD patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-422-H04-P
Initial release date: 12/20/2022
Expiration date: 12/20/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

We’ve heard a lot about microaggressions in the past couple of years. A microaggression can include verbal, behavioral, or environmental aggressions that negatively communicate about race, culture, or gender. They can be intentional or unintentional but can negatively impact healthcare interactions – whether those involve students, residents, patients, or all of the above.

In this episode, speaking with Anisa Hansen, a clinical pharmacist who leads diversity, equity, and inclusion initiatives for the College of Pharmacy and Health Sciences at Drake. Her passion is educating learners on topics in the areas of mental health, LGBTQ health and wellness, and equity and inclusion. Anisa has first-hand experience supporting students who have experienced microaggressions as part of their pharmacy practice experiences. Listen to learn more about how she has navigated those situations to support students.

Download this social identity mapping exercise. Don’t worry – it will make sense after you listen to the episode!

HostKathy Schott, PhD
CEimpact

GuestsAnisa Hansen, PharmD
Professor of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences

Anisa Hansen, PharmD, is a Professor of Pharmacy Practice at Drake University in Des Moines, Iowa. She has a passion for educating students on mental health, wellness, LGBTQ health, and equity and inclusion. Anisa teaches a 3-credit J-Term course focused on LGBTQ Health Issues and a first-year course exploring the portrayal of mental illness and disabilities in the media. Anisa is the mental health clinical pharmacist for Iowa Lutheran Hospital. She provides clinical service, educates sixth-year pharmacy students, and provides medication education groups in outpatient and inpatient settings.

Get CEClick here to access the course.

CE Information

At the end of this course, preceptors will be able to:

Define the concept of 'microaggression'
Identify strategies to support students who may experience microaggressions during experiential learning

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Gabapentin is often used in a multi-model pain management strategy in both peri- and post-operative setting. Little data exists looking at the adverse effects of this practice. Join host Geoff Wall, as he reviews data from a new study looking at this question.

The GameChanger
Gabapentin’s data is sparse for use in postoperative pain; however, new data suggest use after orthopedic surgery is associated with poor outcomes.

Show Segments
00:00 - Introductions
00:58 - The Current Use of Gabapentin
03:19 - Perioperative Gabapentin Study
09:34 - GameChanger: Study Findings
15:30 - Connecting to Practice: Gabapentin on Order Sets
16:52 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Perioperative Gabapentin Use and In-Hospital Adverse Clinical Events Among Older Adults After Major Surgery

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Apply the results of the gabapentin study to the perioperative patient population
2. Discuss the evidence of the effectiveness of gabapentin in multi-modal pain management

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-441-H04-P
Initial release date: 12/16/2022
Expiration date: 12/16/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The standard of care for pancreatitis has been aggressive (liters) of intravenous fluids. New data suggests that this level of fluid resuscitation may not be needed – and possibly harmful. Join host Geoff Wall as he evaluates the role of fluids in pancreatitis treatment.

The GameChanger
In patients with mild disease, moderate fluid resuscitation is safer than aggressive fluid use.

Show Segments
00:00 - Introduction
01:17 - Current Standard of Care
04:37 - The WATERFALL Study
10:20 - GameChanger: Study Findings
16:00 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the current standard of care for treating pancreatitis
2. Describe the findings of the WATERFALL study and how it applies to patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-440-H04-P
Initial release date: 12/09/2022
Expiration date: 12/09/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

A recent study showed that ethanol abuse is a leading cause of death in young adults in the US and that rates of alcoholism have increased. Join host Geoff Wall as he reviews the treatment of ethanol withdrawal.

The GameChanger
Ethanol abuse is a leading cause of death in young adults. Fortunately, multiple therapies exist to treat hospitalized patients with acute ethanol withdrawal.

Show Segments
00:00 - Introductions
01:44 - Alcohol Abuse and Mortality in the United States
03:38 - GameChanger: Study Results
06:15 - Connecting to Practice: Alcohol Withdrawl Syndrome Treatment
24:11 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Estimated Deaths Attributable to Excessive Alcohol Use Among US Adults Aged 20 to 64 Years, 2015 to 2019
Management of Alcohol Withdrawal in the Emergency Department: Current Perspectives

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the epidemiology of alcohol abuse and mortality in the United States
2. Describe treatment of the hospitalized patient with acute ethanol abuse

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-435-H04-P
Initial release date: 12/06/2022
Expiration date: 12/06/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Obesity is still at epidemic levels in the United States. More and more medications are coming to market to help with weight loss. The American Gastroenterological Association (AGA) just released guidelines for evidence-based care for persons with obesity.

The GameChanger
Guidelines are now available for the treatment of obesity. The evidence-based recommendations will help providers determine appropriate therapy for persons with obesity.

Show Segments
00:00 - Introduction
01:16 - The Obesity Epidemic in the United States
05:57 - Looking at the AGA Obesity Guidelines
16:30 - AGA Obesity Guidelines: Combination Products
26:25 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology
Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the framework of the 2022 AGA obesity guidelines
2. Apply the guideline recommendations to persons with obesity

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-428-H01-P
Initial release date: 11/28/2022
Expiration date: 11/28/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Health Equity is achieved when every person has the opportunity to attain their full health potential and no one is disadvantaged. Oftentimes, this is evaluated and addressed through resolving social determinants of health. A recent study evaluated the impact of food insecurity on cardiovascular outcomes. Join host, Geoff Wall, as he discusses how healthcare teams can address food insecurity with guest Jake Galdo.

The GameChanger
Increased screening, identification, and referrals are needed to address the negative consequences of food insecurity on cardiovascular outcomes.

Show Segments
00:00 - Introductions
00:55 - Background on the Issue
05:45 - Looking at the Study
13:00 - The GameChanger: Results of the Study
15:40 - Connecting to Practice
26:54 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Director, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc
References and Resources

Food Insecurity Among Individuals With Cardiovascular Disease and Cardiometabolic Risk Factors Across Race and Ethnicity

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the prevalence of food insecurity in patients with cardiovascular disease
2. Discuss the role of the healthcare team in addressing food insecurity

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-425-H04-P
Initial release date: 11/16/2022
Expiration date: 11/16/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Whose job is it to teach risk management principles to pharmacy learners? Sure – they have to take a law course as part of their curricular requirements, but how much does that mean to them until they are in real life situations as part of their IPPEs, APPEs, or residency? As preceptors, it’s important that we not only recognize and manage the legal risks of welcoming pharmacy learners within our pharmacy practice but also that we are prepared to teach practical concepts such as risk management in addition to developing their clinical skills. Listen to this episode where we talk with David Brushwood, a well-known expert, and educator in the practical and professional aspects of risk management and pharmacy law.

HostKathy Schott, PhD
CEimpact

GuestsDavid Brushwood, RPh, JD
Senior Lecturer, University of Wyoming School of Pharmacy
Professor Emeritus, University of Florida
Content Development, CEimpact

David Brushwood graduated with degrees in pharmacy and law from the University of Kansas. He practiced both professions prior to entering academia. David retired from the University of Florida, College of Pharmacy, in 2014 where he is currently Professor Emeritus of Pharmaceutical Outcomes and Policy. In 2015, David joined the faculty at the University of Wyoming, School of Pharmacy, and he serves there as a Senior Lecturer teaching online courses in the Master of Science in Health Services Administration program. David is a pharmacy law content developer with CEimpact, where he produces educational programs for pharmacists, pharmacy technicians, and pharmacy students. David’s primary research interests are pain management policy, patient safety regulation, and pharmacist professional responsibility.

Get CEClick here to access the course

CE Information

At the end of this course, preceptors will be able to:

Describe situations where exposure to malpractice liability may occur for preceptors during experiential learning
Discuss techniques for teaching risk management to pharmacy learners in the experiential learning setting

UAN: 0107-0000-22-422-H99-P
Release Date: 11/16/2022
Expiration Date: 11/16/2025
The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics?

Avoiding Malpractice Liability with Effective Teaching Strategies
FERPA: A Guide for Preceptors
Advanced Certificates in Risk Management:
- For IPPE Students
- For APPE Students
- For Pharmacy Residents
Pharmacist-In-Charge Bootcamp

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Various SGLT-2s have been shown to improve cardiovascular outcomes in the presence and absence of diabetes. A recent study evaluated the effect of dapagliflozin in mildly reduced or preserved ejection fraction. Join host, Geoff Wall, as he discusses how SGLT-2s may be a real GameChanger in heart failure with expert, Troy Lynn Lewis.

The GameChanger
The data showcasing the benefits of SGLT-2s in patients with heart failure with or without diabetes continues to grow. Dapagliflozin may be another treatment option for persons with heart failure.

Are you a CEimpact Member? Members get exclusive access to new courses and CE for this podcast. Over 62 hours of new CE each year + access to hundreds more on demand. Go to www.CEimpact.com to become a member today!

Show Segments
00:00 - Introductions
01:55 - The DELIVER Study
14:10 - GameChanger: DELIVER Discussion
20:44 - Connecting to Practice: Patient Considerations
26:11 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Troy Lynn Lewis, PharmD, BC-ADM
Assistant Professor, Pharmacy Practice
Wilkes University

References and Resources
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the role of SGLT-2s in heart failure management
2. Discuss the results of the DELIVER trial

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-414-H01-P
Initial release date: 11/14/2022
Expiration date: 11/14/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Less than ten percent of people filled a glucagon prescription after a hospitalization due to hypoglycemia. In the past few years, a slew of new glucagon products have come to market. Join host, Geoff Wall, as he discusses how to optimize glucagon therapy with diabetes expert, Jamie Pitlick.

The GameChanger
Despite glucagon products being proven safe and effective, they are severely under-prescribed and underutilized. Patients that are at risk for level 2 or 3 hypoglycemia should be prescribed glucagon.

Did you know poisons have been used as murder weapons throughout human history? Join us on November 10th at 7 PM CT for a free, live CE on Murder with Medications exclusively on the CEimpact App. It's free to join! You'll learn about medical professionals who used their access to medications to commit murder. It's fascinating and unimaginable. Sign up here!

Show Segments
00:00 - Introductions

01:54 - The Risk of Hypoglycemia

10:45 - GameChanger: New Glucagon Products

20:40 - Connecting to Practice: What Practitioners Should Know

25:11 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jamie Pitlick, Pharm.D., BCPS, BC-ADM
Associate Professor, Pharmacy Practice
Drake University College of Pharmacy and Health Sciences

References and Resources

GlucaGen - Plainsboro, NJ: Novo Nordisk. Revised in March 2021.
Glucagon - Indianapolis, IN. Eli Lily USA.
Zegalogue - Denmark: Zealand Pharma. Revised April 2021.
Baqsimi - Indianapolis, IN: Eli Lily. Revised October, 2020.
GVOKE - Chicago, IL: Xeris Pharmaceuticals. Revised August 2021

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the risk of hypoglycemia for patients with diabetes
2. Describe the differences in the glucagon products on the market in the US

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-402-H01-P
Initial release date: 11/07/2022
Expiration date: 11/07/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The GRADE studies evaluated the pharmacotherapy of diabetes after initiation of metformin – for both micro- and macrovascular outcomes. Join host, Geoff Wall, and guest Jake Galdo as they examine these studies to determine if they are GameChangers in diabetes management.

The GameChanger
Insulin glargine and liraglutide had the biggest decrease in A1c; however, many patients still did not reach goal targets. Minor differences in microvascular and macrovascular outcomes were observed.

Show Segments
00:00 - Introductions

1:40 - The GRADE Studies

12:02 - Glycemic Outcomes

16:08 - Microvascular and Cardiovascular Outcomes

21:10 - The GameChanger: Selecting a Second Medication

27:18 - Connecting to Practice: Realistic Diabetes Care

33:17 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
John A Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Director, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad

References and Resources

Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes
Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Select a second medication after metformin in a patient with type 2 diabetes based on the data from the GRADE studies
2. Discuss the results of the GRADE studies

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-401-H01-P
Initial release date: 10/31/2022
Expiration date: 10/31/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The role of anticoagulant therapy (warfarin) with antiplatelet therapy (aspirin) is a balance of risk versus benefit. However, reducing risk by de-prescribing is often avoided due to hypothetical efficacy reduction. Join host, Geoff Wall, as he evaluates de-prescribing aspirin in patients taking anticoagulants.

The GameChanger
Anticoagulant therapy provides as good or better protection against vascular outcomes as aspirin – creating duplication of therapy. The increased risk of bleeds may not outweigh the negligible efficacy benefit.

Are you looking for a place to network AND get some FREE CE? Download the CEimpact app. The app allows you to connect with pharmacy professionals, get CE, attend events, access product information and so much more - all from your mobile device.

Show Segments
00:00 - Introductions

00:58 - Aspirin Use with Anticoagulants

4:02 - Overview of Schafer et al

11:50 - The Gamechanger: Study Findings

17:48 - Connecting to Practice: DOAC Use

19:52 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss indications for cardioprotective aspirin in patients taking anticoagulants
2. Describe drawbacks to implementing the findings of the Schaefer et al study to a general patient population using anticoagulants

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-381-H01-P
Initial release date: 10/24/2022
Expiration date: 10/24/2023
Additional CPE and CME details can be found here

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

So often, we can fall into the trap of viewing our time with experiential learners as a burden – something that takes time and energy that we feel we don’t have in a busy practice. How can you operationalize and optimize student contribution on-site, build trust among all parties, and overcome challenges and barriers that come along with experiential learning? Tune in to find out how one busy community pharmacist engaged his students to provide an exceptional learning experience that has enhanced their pharmacy-based services and improved care for patients.

HostKathy Schott, PhD
CEimpact

GuestsAnthony Bolus, PharmD
Clinical Coordinator
Family Medicine Services, Inc.
Bessemer, AB

Connect with Anthony Bolus on LinkedIn

Dr. Anthony J. Bolus has worked in community pharmacy for over 10 years since starting as a technician in 2007 in a chain store. Dr. Bolus graduated from Samford University’s McWhorter School of Pharmacy (MSOP) with a Doctor of Pharmacy degree in 2013. Upon graduation, he became a manager at a chain pharmacy in Calera, Alabama, then returned to school in 2014/2015 to complete a postgraduate year one (PGY1) community pharmacy residency with Family Medical Services (FMS), Inc. and Samford University’s MSOP. After completing the residency, Dr. Bolus was hired to be the full time clinical coordinator of FMS, Inc., a position in which he has served for over six years now. Through this position, he helps to oversee, train, and create services beyond dispensing medications at all four of the independent store locations. Dr. Bolus currently serves as a preceptor for Samford University and Auburn University pharmacy students and also in an adjunct faculty capacity at Samford. In addition, Dr. Bolus is the founder and producer of a pharmacy radio show, Healthy Dose, which he began in 2011 and ran for 10 years on Birmingham’s Smooth Jazz Radio Station FM91.1. Healthy Dose® is now a podcast available on all podcast streaming platforms.

Get CEClick here to access the course

CE Information

At the end of this course, preceptors will be able to:

Discuss opportunities and challenges associated with utilizing students in the delivery of patient care services
Describe some strategies for effectively utilizing students as “extenders” of patient care services

UAN: 0107-0000-22-373-H99-P
Release Date: 10/05/2022
Expiration Date: 10/05/2025

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics? Check out these courses:

What is this Wheel?
Tools to Facilitate Success With Your Learning
Managing Time as a Preceptor

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

Studies suggest that patients admitted to the hospital with heart failure are inadequately diuresed before discharge. Join host, Geoff Wall, as he reviews the data on acetazolamide for diuresis in heart failure.

The GameChanger
Augmentation of loop diuretics with acetazolamide significantly increases diuresis in persons with heart failure.

Geoff produces music under the name, Prophets of Jupiter. This is the song he mentions at the end of the episode - Time to Dance - Lola K Remix.

The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist, or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.

Show Segments
00:00 - Introductions

02:15 - Current Use of IV Diuretics

06:15 - Background on Acetazolamide

08:22 - The ADVOR Study

18:38 - Gamechanger: Study Results

20:32 - Connecting to Practice

25:35 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the ADVOR study design
2. Describe the main adverse effects of acetazolamide

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-372-H01-P
Initial release date: 10/17/2022
Expiration date: 10/17/2023
Additional CPE and CME details can be found here

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!

View Details

The current standard of care is to provide a bolus of 30 mL per kg of isotonic fluid for patients with septic shock. Recent retrospective studies question this practice. Join host, Geoff Wall, as he reviewed a NEJM article on the role of fluids in septic shock.

The GameChanger
Large boluses of fluid during septic shock may have unintended adverse events. Some data show that an approach with restrictive fluids may have no difference in death or adverse outcomes.

The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.

Show Segments
00:00 - Introductions

01:38 - Background on Septic Shock and Current Treatment

04:47 - Meyhoff et al Study

15:17 - Gamechanger: Study Findings

22:51 - Connecting to Practice

23:57 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Restriction of Intravenous Fluid in ICU Patients with Septic Shock

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Critique the Meyhoff et al study evaluating restrictive fluids in septic shock
2. Discuss current approaches to fluid resuscitation in patients with septic shock

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-371-H01-P
Initial release date: 10/10/2022
Expiration date: 10/10/2023
Additional CPE and CME details can be found here.

View Details

Get FREE CE for this episode by downloading the CEimpact App (details in the FREE CE section).

The current reality of COVID-19 is reviewed in this episode by Dr. Katelyn Jetelina. Dr. Jetelina is an epidemiologist and author of the wildly popular Newsletter, Your Local Epidemiologist, available via Substack.

We are losing ~400 Americans a day. During the first week of September, we lost 2,299 people. In August 2022 alone, we lost 15,284 Americans to COVID-19. This means COVID-19 remains the third leading cause of death in our repertoire of threats. And it’s largely preventable[1].

Pharmacists continue to support the frontlines of the COVID-19 Pandemic. This episode shares insights on the current reality as well as what you need to know about bivalent boosters, and vaccinating children.

The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.

Show Segments

00:00 - Introductions

03:38 - Is COVID-19 Still a Thing?

10:55 - The GameChanger: Bivalent Booster

17:15 - The Different Boosters

19:40 - Applying to Practice: Dosing

22:48 - Pediatric Considerations

28:35 - Closing Thoughts

References and Resources

400 Americans are dying each day. We cannot accept this reality.
Virtual Immunization Administration Training
Get the CEimpact App

Host
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Guest
Katelyn Jetelina, MPH, PhD
Publisher, Your Local Epidemiologist

Subscribe to Katelyn's substack - Your Local Epidemiologist to receive a direct line of “translated” public health science to the local, national, and international community.

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the current state of COVID-19 pandemic the United States
2. Describe the role of a bivalent vaccine for COVID-19

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-370-H-06-P
Initial release date: 10/3/2022
Expiration date: 10/3/2023
Additional CPE and CME details can be found here.

View Details

Monkeypox is the newest worldwide pandemic and closely mirrors both COVID-19 and HIV pandemics. A large difference is theoretical vaccines and treatments for monkeypox already exist. In this episode of GameChangers, host Geoff Wall, evaluates tecovirimat, a potential monkeypox treatment and the regulations that made it possible.

The GameChanger
Little to no randomized controlled data exist on tecovirimat’s safety and efficacy in monkeypox. A recent case series helps establish the safety of tecovirimat for monkeypox use.

Show Segments
00:00 - Introductions
02:40 - Current Issue of Monkeypox
04:02 - Tecovirimat “Animal Rule”
11:19 - The GameChanger: Tecovirimat Case Series
17:20 - Applying to Practice
20:45 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
References and resources:

Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.
Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection.

Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information:
Learning Objectives:
1. Describe the development and use of tecovirimat under the “Animal Rule”
2. Discuss the latest report of tecovirimat use in US patients with monkeypox

All relevant financial relationships have been mitigated.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-354-H01-P
Initial release date: 09/26/22
Expiration date: 09/26/2023
Additional CPE & CME details can be found here

View Details

Pharmacogenomic testing has been widely available for over a decade to help guide pharmacotherapy including antidepressant selection when treating major depressive disorder. Yet, the data hasn’t substantiated improved safety or efficacy. Host Geoff Wall is joined by Sarah Grady, PharmD to evaluate the PRIME study looking at the role of pharmacogenomic testing in depression.

The GameChanger

Pharmacogenomic testing may help decrease adverse effects at 12 weeks, but not 24 weeks. However, the study did identify a potential confounder with L-methylfolate deficiency.

Show Segments
00:00 – Introductions
02:15 – Background on Pharmacogenomic Testing
05:15 – PRIME Care Study
18:10 – Connecting to Practice
20:55 – Gamechanger
22:12 – L-methylfolate Deficiency Treatment
26:25 – Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Sarah Grady, PharmD
Professor of Pharmacy Practice, Drake University

References and resources:

Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.

Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information:
Learning Objectives:
1. Describe the outcomes and limitations of the PRIME care study
2. Discuss the role of L-methylfolate in the treatment of depression

All relevant financial relationships have been mitigated.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-305-H01-P
Initial release date: 09/05/22
Expiration date: 09/05/2023
Additional CPE & CME details can be found here

View Details

Studies have connected racial and cultural bias in students and how they approach patient cases in their respective PharmD curriculum. How can preceptors identify and address potential bias in pharmacy learners to help ensure healthcare equity?

HostKathy Schott, PhD
CEimpact

GuestLaQuoia Johnson, PharmD, BCPS, DPLA
Pharmacy Consultant
Growing Through It
laquoiajohnson@gmail.com

More about Dr. LaQuoia Johnson

Dr. LaQuoia Johnson is the author of How Rxacism Manifests: Inside the Small World of Pharmacy, a speaker, educator and champion for Diversity, Equity and Inclusion. Her personal mission is to create opportunities for transformational change in leadership from the lens of Grace.

She is a graduate of the UNC Eshelman School of Pharmacy, Board Certified in Pharmacotherapy, and is residency trained in acute-care and pharmacy administration. Dr. Johnson spent the last decade providing patient-centered care and supporting others who do. Today, she leverages her knowledge and skills to educate the next generation of pharmacy technicians as an adjunct professor for Pharmacy Technology programs at two community colleges in North Carolina. Additionally, Dr. Johnson serves the State of North Carolina in partnership with the CDC foundation as a pharmacist consultant, and is the CEO of Growing Through It, LLC offering personal and leadership coaching and EDI-centered workshops for youth groups, corporate conferences, churches, and community-based organizations.

Dr. Johnson resigned from her position in Pharmacy Leadership

Get CEClick here to access the course

CE Information

At the end of this course, preceptors will be able to:

Discuss the possible impact implicit and explicit bias may have on students' ability to support health equity
Describe strategies preceptors can use help students increase their awareness of their own personal bias

UAN: 0107-0000-22-321-H99-P
Release Date: 08/24/2022
Expiration Date: 08/24/2025

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want to connect with Dr. LaQuoia Johnson? Check out her website:

https://drlaquoiajohnson.com/

Want more information on this topic? If you are looking for some more specific guidance relative to implicit bias, health care disparities, and cultural competence, check out these courses:

The Impact of Bias on Health Outcomes
All Preceptors’ Hand On Deck in Breaking the Barriers of Structural Racism
Overcoming Implicit Bias in Healthcare

View Details

The GINA guidelines were updated in 2021, yet providers may not have rolled out the recent changes in practice. JAMA Clinical Guidelines Synopsis highlighted the major recommendations, including SMART therapy (single maintenance and reliever therapy) with an “A” recommendation. Join host Geoff Wall as he talks about implementing new recommendations into practice with community pharmacist and patient, Jake Galdo.

The GameChanger

Single Maintenance and Reliever Therapy (SMART) is the new standard in asthma management. Inhaled Corticosteroid (ICS) plus formoterol is the medication of choice for maintenance and reliever care in asthma.

Show Segments
00:00 – Introductions
3:30 – Background on Asthma
05:06 – GINA Guidelines on Asthma
12:40 – Gamechanger: SMART Therapy
17:08 - Connecting to Practice
29:20 – Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

References and resources:

Therapy for Mild to Moderate Asthma. JAMA.
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes

Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information:
Learning Objectives:
1. Discuss the primary and secondary track of asthma treatment according to the GINA guidelines
2. Discuss with patients why the SMART approach to using inhalers to relieve immediate symptoms is preferred.

All relevant financial relationships have been mitigated.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-350-H01-P
Initial release date: 09/12/22
Expiration date: 09/12/2023
Additional CPE & CME details can be found here

View Details

High-Intensity Statins have been the treatment of choice for ASCVD. However, the recent non-inferiority RACING study evaluates the role of combination moderate-dose statin plus ezetimibe to high-dose statin in ASCVD. Host Geoff Wall breaks down another potential GameChanger in Pharmacotherapy.

The GameChanger
Combination moderate-dose statins plus ezetimibe may be non-inferior to high-dose statins – and have the benefit of better tolerability.

Show Segments
00:00 – Introductions
01:55 – Long-Term Efficacy and Safety of Moderate Intensity Statins with Ezetimibe
02:55 – Statins and Ezetimibe in ASCVD
13:52 – The GameChanger
20:50 – Connecting to Practice
22:01 – Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and resources:

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information:
Learning Objectives:
1. Discuss the RACING study results comparing moderate-dose statin plus ezetimibe to high-dose statins
2. Describe the known ‘nocebo’ effect of muscle-related statin adverse effects.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-310-H01-P
Initial release date: 09/05/22
Expiration date: 09/05/2023
Additional CPE & CME details can be found here

View Details

Vaccine distrust and misinformation is at an all-time high. One claim is that vaccines are responsible for dementias, like Alzheimer’s Disease. A recent database study may show the exact opposite. Join host, Geoff Wall, with guest, Jake Galdo, to discuss the role of vaccines and other therapies in the prevention of Alzheimer’s Disease.

The GameChangerA recent large propensity matched retrospective database study found that the risk of developing Alzheimer’s Disease was LOWER in persons who received regular influenza vaccines compared to unvaccinated individuals.

Show Segments
00:00 – Introductions
01:54 – Alzheimer's Disease
06:00 – Vaccines and Decreasing Risk of Dementia
08:32 – Association Between Influenza Vaccine and Risk of Alzheimer’s Disease
16:11 – The GameChanger
18:35 – Connecting to Practice
22:45 – Mitigating Risk
26:03 – Amyloid Plaque
28:15 – Vaccination Season
29:54 – Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO, Seguridad, Inc
Pharmacist, Ross Bridge Pharmacy
Director, CEimpact

References and resources:

Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.
Faked Beta-Amyloid Data. What Does It Mean?

Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information:
Learning Objectives:
1. Discuss the recent study in the Journal of Alzheimer’s Disease concerning dementia risk and influenza vaccines
2. List potential physiologic pathways for the lowered incidence of Alzheimer’s Disease in persons vaccinated.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-309-H01-P
Initial release date: 08/29/2022
Expiration date: 08/29/2023
Additional CPE & CME details can be found here

View Details

Insomnia is a common medical condition treated with a variety of pharmacologic (Rx or OTC) and non-pharmacologic options. Yet, little data exist on long-term efficacy and safety on these treatment options. Join host Geoff Wall as he discusses a recent meta-analysis comparing treatments for insomnia.
The GameChanger
All treatments for insomnia, including melatonergic agonists, have poor tolerability. Eszopiclone may be the best tolerated and effective “Z” medication for treatment of insomnia.

Show Segments
00:00 - Introductions
01:24 - Insomnia
04:20 - Insomnia Treatment Options
19:25 - The GameChanger
21:36 - Connecting to Practice
24:06 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and resources:
Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.
Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information:
Learning Objectives:
1. Discuss the results of a recent network meta-analysis on treatments of insomnia
2. Compare different pharmacotherapy options for the treatment of insomnia based on a recent meta-analysis

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-304-H01-P
Initial release date: 08/22/22
Expiration date: 08/22/2023
Additional CPE & CME details can be found here

View Details

Irritable Bowel Syndrome (IBS) is a common disorder that greatly affects quality of life. Several medications have been approved for use in IBS – both constipation (IBS-C) and diarrhea (IBS-D). The American Gastroenterological Association just released guidelines provide evidence-based recommendations for patients.

The GameChanger
In the last 10 years several pharmacotherapies have been FDA approved for both constipation IBS-C) and IBS-D. Updated guidelines from the AGA review the literature surrounding these and other therapies for evidenced based guidelines update. For example, secretagogues such as linactolide are now first line treatment after PEG laxatives for IBS-C

Show Segments
00:00 – Introduction
01:28 – Irritable Syndrome (IBS) Bowel Background
04:04 – AGA Evidence-Based Recommendations
06:33 – IBS-D Recommendations
14:29 – IBS – D and IBS – C Recommendations
17:39 – IBS – C Recommendations
26:54 – Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and resources:
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation

Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information:
Learning Objectives:
1. Discuss the pharmacologic and non-pharmacologic therapies for treatment of Irritable Bowel Syndrome-Constipation
2. Discuss the pharmacologic and non-pharmacologic therapies for treatment of Irritable Bowel Syndrome-Diarrhea

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-282-H01-P
Initial release date: 08/15/22
Expiration date: 08/15/2023
Additional CPE & CME details can be found here

View Details

The United States Preventative Services Task Force issued new recommendations for the use of vitamins, minerals, and multivitamins for the prevention of cardiovascular disease and cancer. This is a revision from the 2014 recommendations and is based on recent data. Host Geoff Wall will provide a review of the recommendations – and evidence on these over-the-counter products.

The GameChanger
Based on the new USPSTF recommendations, most vitamins and supplements have insufficient data to determine their benefits versus harm. However, the USPSTF recommends against the use of beta carotene or vitamin E supplementation for the prevention of cancer or cardiovascular disease.

Show Segments
00:00 – Introductions
01:15 – Vitamins, Minerals, and Supplements Regulations and Controversies
06:11 – USPSTF Recommendations
10:07 – Beta Carotene in Cancer and Cardiovascular Disease
11:49 – Vitamin A Supplementation
12:14 – Vitamin E Supplementation
12:52 – Multivitamin Use
15:16 – Vitamin D & Calcium Supplementation
17:40 – Folic Acid Supplementation
18:50 – Vitamin C Supplementation
19:05 – The GameChanger
22:58 – Connecting to Practice
23:40 – Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and resources:
US Preventive Services Task Force. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.

Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information:
Learning Objectives:
1. Discuss the use of vitamin E for cardiovascular disease prevention
2. Describe the USPSTF recommendations for vitamins, minerals, and multivitamins

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-281-H01-P
Initial release date: 08/08/22
Expiration date: 08/08/2023
Additional CPE & CME details can be found here

View Details

A NON-endemic spread of monkeypox has been reported in multiple countries – a phenomenon that has never happened before. The Centers for Disease Control and Prevention and the World Health Organization are developing plans for potential outbreaks – what are the 101s on this disease for healthcare providers?

The GameChanger
Most cases of monkeypox are self-limiting, but death rates up to 10% have been reported, particularly in children and immunosuppressed patients. Treatment options for monkeypox exist but have not been evaluated in large studies to prove efficacy or safety.

Show Segments
00:00 – Introductions
01:24 – Monkeypox Background
08:29 – Monkeypox Presentation
09:32 – Combating & Treating Monkeypox
21:21 – Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and resources:

CDC. Monkeypox and Smallpox Vaccine Guidance.
WHO. Multi-country monkeypox outbreaks in non-endemic countries.
Clinical features and management of human monkeypox: a retrospective observational study in the UK.

Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information:
Learning Objectives:
1. Describe the symptoms and signs of monkeypox
2. Discuss current status of vaccines against monkeypox in the US

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-276-H01-P
Initial release date: 07/25/22
Expiration date: 07/25/2023
Additional CPE & CME details can be found here

View Details

Several large observational studies have suggested metformin has anti-tumor effects and may be beneficial as an adjunctive treatment option for breast cancer. This hypothesis was tested by a randomized clinical trial recently published. Listen to host Geoff Wall discuss if metformin is a miracle drug.

The GameChanger

Metformin can alter insulin signaling which is crucial for the development of certain types of cancer cells. Thus, in various observational and pre-clinical studies, metformin has been associated with better outcomes in breast cancer, usually in patients with diabetes. A recently published RCT found no benefit of taking adjunctive metformin in patients with breast cancer and no diabetes.

Show Segments

00:00 – Introductions
01:19 – Metformin in the Treatment of Breast Cancer
02:21 – Insulin Signaling in Tumor Cell Development
06:54 – Effect of Metformin Vs Placebo on Invasive Disease-Free Survival in Patients with Breast Cancer: The MA.32 Randomized Clinical Trial
17:09 – Connecting to Practice & Further Studies
21:17 – The GameChanger
21:55 – Closing Remarks

Host

Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information
Learning Objectives

Upon successful completion of this knowledge-based activity, participants should be able to:

Describe the potential mechanism(s) of action of metformin as an anti-tumor agent
Discuss the MA.32 study and role of metformin in breast cancer treatment

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-248-H01-P
Initial release date: 7/18/22
Expiration date: 7/18/23
Additional CPE and CME details can be found here.

View Details

Nirmatrelvir-Ritonavir continues to be recommended for outpatient treatment of COVID-19 infections, especially as cases continue to rise. However, this therapy does present clinical challenges – from drug interactions to off-label dosing and rebound COVID-19 infections, therapy is not as easy as it sounds. Listen as host Geoff Wall describes the clinical challenges and guest Jake Galdo describes the public health considerations for nirmatrelvir-ritonavir use.

The GameChanger
Nirmatrelvir-ritonavir has significant clinical challenges including various drug interactions with DOACs, statins, amiodarone, and tacrolimus, for example. It’s also important to note that COVID-19 rebound after nirmatrelvir-ritonavir is not due to resistance based on the latest data.

Show Segments

00:00 – Introductions
01:25 – Nirmatrelvir-Ritonavir Updates
04:27 – Nirmatrelvir-Ritonavir Controversy
06:30 – Drug Interactions
08:05 – DOACs and Nirmatrelvir-Ritonavir
11:44 – Statin and Nirmatrelvir-Ritonavir
13:04 – Amiodarone and Nirmatrelvir-Ritonavir
15:02 – Tacrolimus and Nirmatrelvir-Ritonavir
19:33 – COVID-19 Rebound
23:38 – Equity and Access
31:44 – Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Dr. Galdo have no relevant financial relationships to disclose.

References and Resources

University of Liverpool Drug Interactions
CDC Health Advisory on COVID Rebound Infections
Paxlovid Patient Eligibility Screening Checklist Tool for Prescriber

Redeem your CPE or CME credit

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a Membership
Prescribers: Get a Membership

Continuing Education Information
Learning Objectives:
1. Explain common drug interactions associated with Nirmatrelvir-Ritonavir
2. Discuss COVID ‘rebound’ infections
3. Describe public health and healthcare data considerations for Nirmatrelvir-Ritonavir use

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-247-H01-P
Initial release date: 07/11/22
Expiration date: 07/11/2023
Additional CPE & CME details can be found here

View Details

Curious about tirzepatide and what it means for patients? Tirzepatide, a combination GLP-1 and GIP agonist, was just approved by the Food and Drug Administration for the treatment of diabetes. Tirzepatide has also gained attention for its weight-reducing effects. However, how does tirzepatide compare to other GLP-1 agonists? Is tirzepaide a GameChanger for type 2 diabetes management? Learn more with host, Geoff Wall.

The GameChanger
Tirzepatide is the first in its class to hit the market and has been shown to be as or more effective than semaglutide in glycemic control and weight reduction.

Show Segments
00:00 – Introductions
01:15 – Type 2 Diabetes & Treatment
02:29 – Glucagon-like peptide-1 (GLP-1) Agonists
03:04 – Glucose-dependent insulinotropic polypeptide (GIP) Agonist
03:55 – Tirzepatide vs Semaglutide
14:27 - Tirzepatide vs Insulin
21:15 – Retinopathy & Financial Considerations
22:30 – Closing Remarks

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Once-Weekly Tirzeaptide Versus Once-Daily Insulin Degludec as Add-On to Metformin With or Without SGLT2 Inhibitors in Patients With Type 2 Diabetes (SURPASS-3): A Randomized, Open-Label, Parallel-Group, Phase 3 Trial
Efficacy and Safety of a Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide in Patients With Type 2 Diabetes (SURPASS-1): A Double-Blind, Randomised, Phase 3 Trial
Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information
Learning Objectives

Upon successful completion of this knowledge-based activity, participants should be able to:

Describe the safety and efficacy of tirzepatide compared to GLP-1 agonists
Discuss the use of tirzepatide compared to basal insulin for blood glucose control
Select a patient who may be a candidate for tirzepatide therapy

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-234-H01-P
Initial release date: 06/27/2022
Expiration date: 06/27/2023
Additional CPE and CME details can be found here.

View Details

They are finally here! Covid-19 vaccines for children as young as 6 months. The FDA’s advisory committee unanimously voted to authorize vaccines from Pfizer & BioNTech and Moderna. But now the question, which one is best?

*Note, per the PREP Act, pharmacists, pharmacy technicians, and pharmacy interns may administer Covid-19 vaccines to individuals as young as 3 years.

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Redeem your CPE or CME credit

CPE (Pharmacists)
CME (Physicians)

Get a membership & earn CE for GameChangers Podcast episodes

Pharmacists: Get a membership
Prescribers: Get a membership

References and Resources

Vaccines and Related Biological Products Advisory Committee June 14-15, 2022 Meeting Materials.

Continuing Education Information
Learning Objectives:
1. Describe the efficacy and safety of Covid-19 vaccines in patients under the age of 5
2. Discuss common questions that the potentially vaccine hesitant parent may have about these vaccines

All relevant financial relationships have been mitigated.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-275-H06-P
Initial release date: 6/27/22
Expiration date: 6/27/2023
Additional CPE & CME details can be found here

View Details

Adequate risk assessment and management are crucial in preventing cardiovascular disease. A recent study examined the correlation between common measures of cholesterol concentration versus the number of apolipoprotein B (apo-B)-containing lipoproteins. In other words, should clinicians use different biomarkers for cardiovascular risk assessment? Cardiology Pharmacist, Lindsay Davis, joins Geoff Wall in this discussion.

The GameChanger
Evidence is emerging to suggest apo-B is a more accurate biomarker of MI risk. While not routinely evaluated, apo-B is a GameChanger in that it can be helpful in determining cardiovascular risk in patients with borderline risk factors.

Show Segments

00:00 – Introductions
03:22 – Apolipoprotein B (apo-B)
05:22 – Biomarkers for Cardiovascular Disease
12:58 – The GameChanger
20:37 – Connecting to Practice
28:49 – Closing Remarks

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest:
Lindsay Davis, PharmD, BCPS, BCCP, TTS, ASH-CHC
Professor, Midwestern University

Lindsay Davis has no relevant financial relationships to discuss.

References and resources:

Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis Distinguishing Between Particle Concentration, Type, and Content
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE
Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Redeem your CPE or CME credit

CPE (Pharmacists)
CME (Physicians)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

Continuing Education Information:
Learning Objectives:
1. Describe the role of apolipoprotein B in cardiovascular management
2. Identify patients that may benefit from apolipoprotein B testing

All relevant financial relationships have been mitigated.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-232-H01-P
Initial release date: 06/20/22
Expiration date: 06/20/2023
Additional CPE & CME details can be found here

View Details

Transgender individuals are more likely to receive unequal care and are less likely in general to seek care or preventative services. Often, they are even relied upon to educate their own providers on the basic tenets of transgender care. Healthcare providers can better serve these patients through an interprofessional approach to comprehensive, respectful, and gender-affirming support. Listen in to this week’s episode as Dr. Anisa Hansen describes important steps we can take to have a positive impact on the health of this patient population.

The GameChanger
Just like any other therapy, gender-affirming therapy should be patient-focused, with the patient's goals in mind. Healthcare providers will continue to be called upon to safely monitor these therapies and support their patients. The first and most important step is making a welcoming environment for patients and being both knowledgeable and open to how to best support and treat each patient.

Show Segments
00:00 – Introductions
02:50 – Common Terminology
07:00 – Pronouns
08:00 – Social & Legal Affirmation
09:45 – Issues Surrounding Gender Affirming Care
10:59 – Hormone Therapy for Non-Binary Individuals
13:00 – Masculinizing Gender Affirming Hormone Therapy
18:31 – Feminizing Gender Affirming Hormone Therapy
22:30 – Additional Resources
22:35 – Closing Remarks

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Anisa Hansen, PharmD.
Associate Professor of Pharmacy Practice, Drake University
Mental Health Clinical Pharmacists, Iowa Lutheran Hospital

Anisa Hansen has no relevant financial relationships to discuss.Anisa Hansen has a passion to educate learners on topics in the areas of mental health, LGBTQ health, wellness, and equity and inclusion. Anisa provides clinical service, educates sixth-year pharmacy students, and provides medication education groups in both the outpatient and inpatient setting.
References and ResourcesThe World Professional Association for Transgender Health
The Journal of Clinical Endocrinology & Metabolism
UCSF Transgender Care

Want to learn more about this topic and earn more CE?
Gender Affirming Care for Transgender and Gender Non-Conforming Patients – Pharmacist Gender Affirming Care for Transgender and Gender Non-Conforming Patients – Technician

Redeem your CPE or CME

CPE (Pharmacists)
CME (Prescribers)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information
Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:
1. Define terminology associated with gender-affirming care
2. Discuss masculinizing treatment options

0.05 CEU/0.5 Hr
ACPE UAN: 0107-0000-22-231-H01-P
Initial release date: 06/13/2022
Expiration date: 06/13/2023
Additional CPE and CME details can be found here

View Details

The Centers for Disease Control and Prevention just updated guidelines for sexually transmitted infections (previously sexually transmitted diseases) for everything by HIV. In this multi-part series, host Geoff Wall will break down what’s new and what’s changing in practice.

The GameChangerA 7-day course of doxycycline in the treatment of urogenital chlamydia is preferred and has been shown to be more efficacious compared to azithromycin. Ceftriaxone should be the treatment of choice for gonorrhea as there have been no “resistance”-related treatment failures identified in the United States at any anatomical site.

Show Segments00:00 – Introduction
01:45 – STI Guidelines
02:34 – Chlamydia
14:56 – Gonorrhea
28:57 – Closing Remarks

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

All relevant financial relationships have been mitigated.

References and Resources
CDC Sexually Transmitted Infections Treatment Guidelines, 2021

Redeem your CPE or CME

CPE (Pharmacist)
CME (Physicians)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives

Describe the treatment of Neisseria gonorrhea based on the 2021 recommendations
Discuss pharmacotherapy options for patients with chlamydia with or without concomitant gonorrhea infections

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-224-H01-P
Initial release date: 06/062022
Expiration date: 06/06/2023
Additional CPE and CME details can be found here.

View Details

Twitter for educational purposes? Actually, yes! Listen in to hear how Timothy Gauthier, a social media savvy pharmacist and educator, uses social media in pharmacy education and professional development, and how you and your students can use it as a lifelong learning tool.

Host:
Kathy Schott, PhD
CEimpact

Guests:
Timothy Gauthier, PharmD, BCPS, BCIDPAntimicrobial Stewardship and Infectious Disease Pharmacist
PGY2 Infectious Disease Pharmacy Residency Program Director
Founder & Editor-in-Chief, www.Idstewardship.com
Founder & Editor-in-Chief, www.LearnAntibiotics.com

*Timothy Gauthier reports he is a consultant for DoseMeRx, AntimicrobiaI Therapy, Inc., and Spectrum Mobile Health. Any relevant financial relationships have been mitigated.

The views and opinions expressed in this podcast are that of the interviewee and do not necessarily reflect the policy or position of any former, current, or potential future employer.*

Get CE
Click here to access the course

CPE Information

At the end of this course, preceptors will be able to:

Describe strategies for integrating social media into experiential learning
Avoid common pitfalls associated with social media

UAN: 0107-0000-22-233-H04-P
Release Date: 06/01/2022
Expiration Date: 06/01/2025

Want more education on this and other precepting topics?

Watch for our new course release – Number Needed to Tweet: Using Social Media to Engage Experiential Learners

Check out our Preceptor Library for a full suite of timely and relevant topics for pharmacy preceptors.

Finally, follow our guest, Tim Gauthier, as he continues to engage learners through his social media presence:

LinkedIn
Twitter
Instagram
Blog

View Details

The GameChanger

NAAT testing is the standard of care for genital herpes, although false negatives can occur if lesions are healing. There is no difference in genital outbreaks when comparing episodic treatment and daily prophylaxis in herpes. Finally, one dose of long-acting penicillin IM has been shown to be sufficient in most patients with early syphilis.

Show Segments00:00 – Introduction
01:30 – STI Guidelines
02:14 – Herpes
10:10 – HSV Infections
12:53 – Syphilis
21:30 – Closing Remarks

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

All relevant financial relationships have been mitigated.

References and Resources

CDC Sexually Transmitted Infections Treatment Guidelines, 2021

Redeem your CPE or CME

CPE (Pharmacist)
CME (Physicians)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information
Learning Objectives

Describe approaches to diagnosis and treatment of genital and meningeal herpes
Discuss treatment measures for early primary syphilis

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-223-H01-P
Initial release date: 05/30/2022
Expiration date: 05/30/2023
Additional CPE and CME details can be found here.

View Details

The Centers for Disease Control and Prevention just updated guidelines for sexually transmitted infections (previously sexually transmitted diseases) for everything but HIV. In this multi-part series, host Geoff Wall will break down what’s new and what’s changing in practice.

The GameChanger
Maintenace treatment for recurrent vulvovaginal candidiasis is marginally effective. The standard of care in the treatment of trichomoniasis is now metronidazole for seven days. Current data do not suggest routine treatment of male partners of women with bacterial vaginosis.

Show Segments
00:00 – Introductions
01:20 – STI Guidelines
02:20 – Vaginal Candidiasis
11:12 – Trichomoniasis
19:23 – Bacterial Vaginosis
26:06 – Closing Remarks

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

All relevant financial relationships have been mitigated.

References and Resources

CDC Sexually Transmitted Infections Treatment Guidelines, 2021

Redeem your CPE or CME.

CPE (Pharmacists)
CME (Physicians)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Join for CPE Credit
Join for CME Credit

CE Information

Learning Objectives

Describe the new recommendations for treatment of candidiasis
Discuss changes in duration of therapy for treatment of trichomoniasis
Identify treatment options for bacterial vaginosis

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-222-H01-P
Initial release date: 05/23/2022
Expiration date: 05/23/2023
Additional CPE and CME details can be found here.

View Details

A recent study evaluated the role of metformin in causing birth defects, but when the men are prescribed metformin. This obstetrics study evaluates the role of the partner in risk for birth defects. Does the study change practice? Listen as host Geoff Wall discusses how pregnancy involves both partners.

The GameChangerEmerging data suggest that male metformin use during sperm development may increase the risk of birth defects, specifically among baby boys.

Show Segments00:00 - Introduction
01:23 - Metformin Use in Males & Birth Defects
12:29 - The GameChanger
17:29 - Discussing Risk with Patients
19:39 - Closing Remarks

HostGeoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

All relevant financial relationships have been mitigated.

References and Resources

Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring: A Nationwide Cohort Study

Redeem your CPE or CME

CPE (Pharmacists)
CME (Physicians)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
1. Describe the design for a population health study using a national database
2. Discuss what type of birth defects were associated with male metformin use in the study

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-213-H01-P
Initial release date: 05/16/2022
Expiration date: 05/16/2023
Additional CPE and CME details can be found here.

View Details

A low salt diet can be difficult to maintain, especially in the United States. Multiple guidelines and decades of practice have suggested dietary limitation of sodium for patients with heart failure as an essential lifestyle modification. The recently published SODIUM-HF study evaluates this recommendation and enhances the data.

The GameChanger
While a 20-25% reduction in serum sodium may not improve rates of hospitalization or mortality, it may improve a patient’s quality of life. Patients should be educated on how reducing sodium in their diet may improve their symptoms and increase their quality of life.

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Show Segments
00:00 – Introductions
01:25 – SODIUM-HF Study & Sodium in Diets
20:30 – The GameChanger
22:40 – Closing Remarks

Redeem your CPE or CME credit:
Redeem CPE (Pharmacists)
Redeem CME (Physicians)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membership
Prescribers: Get a membership

References and Resources
Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial

Continuing Education Information:Learning Objectives:
1. Apply the data of the SODIUM-HF study to patients with heart failure
2. Describe the strengths and weaknesses of the SODIUM-HF study

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-193-H01-P
Initial release date: 05/09/22
Expiration date: 05/09/2023
Additional CPE & CME details can be found here

View Details

A nurse was found guilty of gross neglect and negligent homicide in Tennessee. This case has been closely watched by medical professionals, because it may set a new precedent for criminalizing medical mistakes. Guests David Brushwood and Jake Galdo join the podcast to try and make sense of this sensational news.

The GameChanger:

This case may change the way in which medical mistakes are handled internally and at a legal level.

Show Segments:00:00 – Introductions
01:45 – The Case
15:41 – Just Culture & Legality
15:55 – Avoiding & Navigating Errors
26:20 – Closing Remarks

Host:
Geoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guests:
David B. Brushwood, R.Ph, J.D.
Senior Lecturer, The University of Wyoming School of Pharmacy
Pharmacy Law Content Developer, CEimpact

John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Redeem your CPE or CME credit

Redeem CPE (Pharmacists)
Redeem CME (Prescribers)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

References and Resources:

Former nurse found guilty in accidental injection death of 75-year-old patient

Continuing Education Information:

Learning Objectives:
1. Discuss how valid a legal case details from news agencies.
2. Describe how to support a culture of safety within healthcare practice

Drs. Brushwood and Galdo have nothing to disclose.

All relevant financial relationships have been mitigated.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-192-H03-P
Initial release date: 05/02/2022
Expiration date: 05/02/2023
Additional CPE & CME details can be found here

View Details

Reliever Inhaled Glucocorticoid Treatment

Black and Latinx patients are disproportionately impacted by asthma. In fact, asthma mortality rates are twice as high in Black patients compared to White patients. Are there different treatment options to help improve mortality in these populations? Join host Geoff Wall with guest Dr. Matt Trump as they discuss the PREPARE trial.

The GameChangerEmerging data suggests that using a bronchodilator with an inhaled corticosteroid (ICS) may improve asthma exacerbation symptoms in diverse patient populations. This is contrary to current standards of care that encourage the use of a short-acting bronchodilator alone.

Show Segments

00:00 – Introduction
02:05 – Asthma in Diverse Populations
04:25 – Inhaled Corticosteroids in Asthma Management
06:50 – PREPARE Trial
18:33 – The GameChanger
28:11 – Closing Remarks

Host

Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest

Dr. Matt Trump, DO, FACP, FCCPPulmonary & Critical Care Specialist
The Iowa Clinic

Dr. Trump is a consultant for Fishter and Paykel Healthcare and an investigator for Astra Zeneca.

All relevant financial relationships have been mitigated.

References and Resources

Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma

Redeem CPE or CME

Redeem CPE (Pharmacists)
Redeem CME (Prescribers)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives

Upon successful completion of this knowledge-based activity, participants should be able to:

Describe the disparity of outcomes in asthma between different demographics
Discuss the role of reliever inhaled glucocorticoids for persons with asthma

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-176-H01-P
Initial release date: 04/25/2022
Expiration date: 04/25/2023
Additional CPE and CME details can be found here.

View Details

Septic shock is one of the most common causes of deaths in critically ill patients. The updated Surviving Sepsis Campaign Guidelines provide recommendations on the use of adjunct steroids in the treatment of sepsis. However, when to start corticosteroids is still unknown – or is it? This episode of GameChangers evaluates the timing of corticosteroid use in sepsis.

The GameChangerCorticosteroids are now recommended by the Surviving Sepsis Campaign Guidelines in septic shock patients receiving pressors. Early initiation of corticosteroids has now been associated with decreased ICU length of stays and time on pressors.

Show Segments00:00 – Introductions
01:25 – Corticosteroids in Septic Shock
04:47 – Initiation of Corticosteroids
14:57 – The GameChanger
19:24 – Closing Remarks

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Dr. Wall is a member of the Janssen Speaker's Bureau.

References and ResourcesComparison of Early Versus Late Initiation of Hydrocortisone in Patients with Septic Shock in the ICU Setting

Redeem your CPE or CME here!Pharmacist Members
CME

Need a membership?Join for CPE Credit
Join for CME Credit

CE Information

Learning Objectives

Upon successful completion of this knowledge-based activity, participants should be able to:

Identify ideal timing of corticosteroids use in septic shock patients
Discuss the dosing recommendations of corticosteroids in septic shock patients

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-168-H01-P
Initial release date: 04/18/22
Expiration date: 04/18/2023
Additional CPE and CME details can be found here.

View Details

Current guidelines do not recommend switching between different levothyroxine products due to concerns of potential changes in TSH levels. However, getting the same levothyroxine product every time may be difficult for patients due to financial or stocking constraints. Join your host, Geoff Wall, and guest, Dr. Jamie Pitlick to discuss a recent study that examined the consequences of switching between levothyroxine products.

The GameChanger

Based on a recent study, switching between different levothyroxine products may not significantly or clinically impact TSH levels in patients.

Show Segments

00:00 – Introduction
01:12 – Generic Substitution of Generic Levothyroxine Products
03:17 – Bioequivalence of Levothyroxine Products
15:42 – The GameChanger
24:47 – Closing Remarks

Host

Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest

Jamie Pitlick, PharmD, BCPS, PC-ADMAssociate Professor of Pharmacy Practice, Drake University
Diabetes/Endocrinology Care, Iowa Diabetes

References and Resources

Association Between Generic-to-Generic Levothyroxine Switching and Thyrotropin Levels Among US Adults

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

Continuing Education Information:

Learning Objectives:

Describe the outcomes of the study evaluating the impact of switching levothyroxine generic manufacturers
Discuss with patients the results of the study and clinical implications

Dr. Wall is a member of the Janssen Speaker's Bureau.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-144-H01-P
Initial release date: 04/11/22
Expiration date: 04/11/2023
Additional CPE & CME details can be found here!

View Details

Approximately 1 in 5 individuals in the United States alone will experience depression during their lifetime. Current guidelines suggest that monotherapy may be used as initial therapy for major depressive disorder, but what evidence exists suggesting that starting dual anti-depressant therapy may have better outcomes? Join your host, Geoff Wall as he discusses a recent meta-analysis regarding dual therapy in depression.

The GameChanger:

For initial therapy or patients who are non-respondent to previous treatment, dual anti-depressant therapy may have a small, but significant impact on treatment outcomes, specifically treatment efficacy.

Show Segments

00:00 – Introductions

01:19 – Dual Therapy in Depression

11:57 – Which Anti-Depressant Combination?

15:27 – The GameChanger

18:37 – Closing Remarks

Host:
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and resources:

Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression: A Systematic Review and Meta-analysis

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

Continuing Education Information:

Learning Objectives:

Describe which two classes of antidepressants had the highest remission rate when used together in this study
Discuss the pros and cons of this meta-analysis including the studies' heterogeneity

Dr. Wall is a member of the Janssen Speaker's Bureau.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-143-H01-P
Initial release date: 04/4/22
Expiration date: 04/4/2023

For more information https://www.ceimpact.com/podcast

View Details

The world of COVID-19 is always changing. Join Geoff Wall for a rapid fire of updates regarding famotidine, lockdowns, and ivermectin as evaluated for efficacy in COVID-19.

The GameChangersThe use of high-dose famotidine in the treatment of COVID-19 has demonstrated moderate safety, but questionable efficacy. Additionally, a recent meta-analysis examining the efficacy of lockdown on the spread of COVID-19 had several limitations that should be taken into consideration.

Show Segments

00:00 – Introductions
01:56 – Famotidine in the Treatment of COVID-19
10:52 – Effects of Lockdown on COVID-19 Mortality
18:26 – Ivermectin Treatment of COVID-19 in High-Risk Patients
23:45 – Closing Remarks

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources:

References and resources:
Oral Famotidine Versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blind, Data-Intense, Phase 2 Clinical Trial
A Literature Review and Meta-Analysis of the Effects of Lockdowns on COVID-19 Mortality. Pre-Publication.
Efficacy of Ivermectin Treatment on Disease Progression Among Adults with Mild to Moderate COVID-19 and Comorbidities

Continuing Education Information:

Learning Objectives:

1. Describe the latest information on masks and other non-pharmacologic interventions to halt the spread of COVID-19
Discuss the recent randomized controlled trial evaluating famotidine use in early COVID-19 positive patients

Dr. Wall is a member of the Janssen Speaker's Bureau.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-142-H01-P
Initial release date: 03/28/22
Expiration date: 03/28/2023

View Details

Are you still using post-it notes, clips, and stickers to facilitate your Pharmacy's workflow? You aren't alone - many of us are using tactile tools to run our pharmacies. Even if you are leveraging technology, can you confidently say you are maximizing it?

We've come to the point that maximizing technology isn't a choice; it's necessary to save our profession. This episode digs into what pharmacy practice should look like - centering dispensing on the knowledge the pharmacist provides which both maximizes outcomes and ensures safe medication use.

In this episode, Community Pharmacist Joe Williams shares his thoughts on the type of pharmacy practice we need to implement to save our profession. As much as technology supports practice, it doesn't remove the human element. Learn how putting the pharmacist at the center of dispensing can be done through technology.

Segments you don’t want to miss:

5:30 - Pharmacies aren’t just vending machines

9:58 - The biggest mistake our profession has made…and what we need to do

12:25 - Technology – it doesn’t replace a Pharmacist – it allows us to survive

This episode is sponsored by RxSafe, an innovative technology solution designed to accelerate your pharmacy’s success. Learn more about Rxsafe here. Join The Pharmacy Network to continue this conversation and check out RxSafe in the Practice Resource section!

View Details

Perhaps one of the greatest challenges a preceptor has is that of honestly evaluating poor performance in a way that will help get the student either back on track, or connected to the help and support they need, depending on the specific performance issue or issues they are exhibiting. It sounds cold, but in experiential education it has been said more often than once – that sometimes you just have to fail a student for their own benefit and ultimate success. Those conversations are heartbreaking – for the preceptor, for the school’s staff – and most importantly for the students. Listen in as Dr. Lisa Richter and Dr. Kate Newman discuss the evidence and importance of failure in supporting student development.

Host:
Kathy Schott, PhD
CEimpact

Guests:
Lisa Richter, PharmD
Director of Experiential Outreach and Assessment
Assistant Professor of Practice
North Dakota State University

Kate Newman, PharmD
Director of Experiential Education
Clinical Associate Professor, Department of Pharmacy Practice
Southern Illinois University Edwardsville

Get CE
Click here to access the course and claim CE for the episode.

CPE Information

At the end of this course, preceptors will be able to:

Identify barriers to providing accurate assessment of underperforming learners
Discuss strategies to overcome barriers and support accurate assessment of underperforming learners

UAN: 0107-0000-22-148-H04-P
Release Date: 03/23/2022
Expiration Date: 03/23/2025

Want more education on this and other precepting topics? Check out our Preceptor Library for a full suite of timely and relevant topics for pharmacy preceptors here!

View Details

Routine exercise is gamechanging. In this epsiode, Geoff is joined by Keaton Higgins, pharmacy student and certified athletic trainer, to discuss the mortality benefits of regular exercise.

Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Keaton Higgins, ATC
P3 University of Iowa

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources:

Saint-Maurice PF, Graubard BI, Troiano RP, et al. Estimated Number of Deaths Prevented Through Increased Physical Activity Among US Adults. JAMA Intern Med. Published online January 24, 2022. doi:10.1001/jamainternmed.2021.7755

Continuing Education Information:

Learning Objectives:
1. Describe the association of physical activity and mortality
2. Discuss the role of exercise in delaying mortality

Dr. Wall is a member of the Janssen Speaker's Bureau.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-114-H04-P
Initial release date: 03/21/22
Expiration date: 03/21/2023

View Details

Level Up: Is your pharmacy ready for the future and able to handle the present environment?

Listen in to learn how you can strengthen the brick-and-mortar experience in your pharmacy and remain viable in an increasingly online world.

In this episode, Dr. Ben McNabb pharmacist and owner at Love Oak Pharmacy discusses the current and future state of community pharmacy. Oak Love Pharmacy is a local Texas-based Community Pharmacy that provides Point-of-Care testing, Immunizations, Diabetes and Adherence services to the 18,000 members of their county. Ben shares how you can learn from his best practices such as leveraging technology to expand your services.

This episode is sponsored by RxSafe, an innovative technology solutions designed to accelerate your pharmacy’s success. Learn more about RxSafe here and check the RxSafe from the Practice Resources section of The Pharmacy Network.

View Details

Direct to consumer marketing has been a GameChanger in recent years. As new drugs are approved and marketed, healthcare teams must stay ahead of the news and advertisements in order to educate patients and peers on the risks, benefits, and nuances that impact our patients and our practice. Tune into this special, extended 90-minute episode to catch up on recent medications impacting practice.

Host:

John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc.

Dr. Galdo serves in an advisory role and as a member of a speaker’s bureau for Novo Nordisk.

Guest:

Joe Strain Pharm.D
Clinical Faculty
South Dakota State University College of
Pharmacy and Allied Health Professions

Dr. Strain has no relevant financial relationships to disclose.

References and Resources
Dr. Strain prepared slides for this episode with all references and citations, click HERE to download.

Already a member? Redeem your CPE or CME credit here!Pharmacist Members
CME
Pharmacy Technicians

Need a membership?Join for CPE Credit
Join for CME Credit

This episode was made possible by the PharmaCE Expo and the Iowa Pharmacy Association. Register for this year's PharmaCE Expo May 17-18 at the Hilton Des Moines Downtown here! Pharmacists and pharmacy technicians who register receive CPE for this course AND have the opportunity to receive over 14 hours of CE for pharmacists and pharmacy technicians.

Learning Objectives – Pharmacists and Prescribers

Upon successful completion of this knowledge-based CPE activity, participants should be able to:

Summarize therapeutic indications of medications recently approved by the FDA.
Discuss pharmacological properties of the new medications.
List side effects, warnings, precautions, and significant drug interactions associated with the new medications.
Identify the normal dose and dosage forms of the new medications.
Describe limitations to implementing the new medications into clinical practice.

0.15 CEU/1.5 hr

UAN: 0107-0000-22-117-H01-P

Learning Objectives – Pharmacy Technicians

Upon successful completion of this knowledge-based CPE activity, participants should be able to:

Identify new medications recently approved by the FDA.
List the classification for the new medications.
Recall major indications for the new medications.
Locate the usual dose and route of administration information for new medications.
Discuss the cost associated with each of the new medications.

0.15 CEU/1.5 hr

UAN: 0107-0000-22-117-H01-T

Initial release date: 03/14/2022
Planned expiration date: 03/14/2023
Additional CPE and CME details can be found here.

View Details

Up to 69% of #Hospitalizations are caused by Medication Non-Adherence. Think of the impact pharmacists could make on the healthcare spend and patient outcomes if we could have a significant impact on that!

Tooktake is a new medication reminder. This episode explores how you can offer a new, simple and inexpensive wellness tool to help your patients. It's a new medication reminder called “tooktake”.

Find out more about tooktake.

Guest
Leeanna Gantt, Founder tooktake Links to learn more and order tooktake:

Get some samples
Order
Website for Patients
Videos on How to use tooktake

For more information or access to these tools - check out the Practice Resource section of The Pharmacy Network.

Read more about Leeanna's story on how she started tooktake in CEimpact's blog.

The Level Up podcast is where we share tools and resources to help you 'level up' your pharmacy practice.

View Details

Opioids are always in the news for adverse reactions and poor outcomes. Two opioids - tramadol and codeine - are often left out of the fey as potential alternatives. Yet, these medications are not without adverse events. A recent study evaluated the mortality and safety differences in tramadol and codeine.

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources:

Xie J, Strauss VY, Martinez-Laguna D, et al. Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes. JAMA. 2021;326(15):1504–1515. doi:10.1001/jama.2021.15255

Continuing Education Information:

Learning Objectives:

Describe the risks associated with tramadol compared to codeine
Discuss the role of tramadol in managing a patient's pain

Dr. Wall is a member of the Janssen Speaker's Bureau.

0.05 CEU | 0.5 Hrs

ACPE UAN: 0107-0000-22-097-H01-P

Initial release date: 03/7/22

Expiration date: 03/7/2023

Additional CPE & CME details can be found here

View Details

Part 2 of this special two-part series takes a deep dive into the top clinical medicine and healthcare issues that have been true GameChangers this past year. Join us as Geoff Wall and Jake Galdo discuss the latest in practice trends, policy changes, guideline updates, new laws, and much more. Did you miss Part 1? If so, be sure to check out GameChangers Episode #308 for more important GameChangers!

Host:
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc.

Dr. Galdo serves in an advisory role and as a member of a speaker’s bureau for Novo Nordisk.

Guest:
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Dr. Wall is a member of a speaker’s bureau for Janssen.

References and Resources
Dr. Wall prepared slides for this episode with all references and citations, click HERE to download.

Already a member? Redeem your CPE or CME credit here

Pharmacist Members
CME
Pharmacy Technicians

Need a membership?

Join for CPE Credit
Join for CME Credit

CE Information

Learning Objectives – Pharmacists and Prescribers

Upon successful completion of this knowledge-based CPE activity, participants should be able to:

Classify "Gamechangers" by how they affect practice settings.
Discuss the selection of a "Gamechanger" topic and how it will impact the provision of patient care.
Describe possible solutions to clinical problems listed throughout the presentation.
Assess the clinical trials used to support the content for this presentation.
Apply the information presented to influence patient care and outcomes at your specific practice site.

0.075 CEU/0.75 hr
UAN: 0107-0000-22-116-H01-P

Learning Objectives – Pharmacy Technicians

Upon successful completion of this knowledge-based CPE activity, participants should be able to:

Classify "Gamechangers" by how they affect practice settings.
Discuss the selection of a "Gamechanger" topic and how it will impact the provision of patient care.
Describe opportunities for the advancement of pharmacy technician roles based on information presented.
Identify the clinical trials used to support the content for this presentation.
Apply the information presented to influence patient care and at your specific practice site.

0.075 CEU/0.75 hr
UAN: 0107-0000-22-116-H01-T
Initial release date: 02/21/2022
Planned expiration date: 02/21/2022
Additional CPE and CME details can be found here.

View Details

It's easy to focus on the development of clinical skills in our pharmacy learners, but what is our responsibility as preceptors for their personal and professional development? Join us for this episode where Jake Galdo and Josh Kinsey share their thoughts on the importance of developing the whole student, and how this investment will positively impact pharmacy practice. We'll touch on everything from the importance of creating safe space to counseling students on the importance of personal finance.

Host:Kathy Schott, PhD
CEimpact

Guests:
Dr. John (Jake) A. Galdo, PharmD, MBA, BCPS, BCGP
Curriculum Development, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad

Dr. Joshua Davis Kinsey, PharmD
Manager, Client Services
CEimpact

Click here to access the course and claim CE for listening to the episode.

Want more information on this topic? If you are looking for some more specific guidance relative to career mentoring, check out courses on helping students get ready for interviews, how to evaluate a CV, and writing letters of recommendation:

Helping Your Students Get Ready for Interviews
How to Evaluate a CV
Writing Letters of Recommendation that Matter

If you are looking for some guidance on how you approach mentoring and how you might further develop your skills in that aspect of precepting, check out the Eleven Habits of Highlight Effective Preceptors. This course explores the skills and behaviors demonstrated by an effective mentor and will put you on a path toward personal growth in mentoring pharmacy learners.

The Eleven Habits of Highly Effective Preceptors

View Details

Part 1 of this special two-part series takes a deep dive into the top clinical medicine and healthcare issues that have been true GameChangers in 2021. Join us as Geoff Wall and Jake Galdo discuss the latest in practice trends, policy changes, guideline updates, new laws, and much more.

Show Segments:01:38 – SGLT2 Inhibitors in Heart Failure
14:47 – Point of Care Testing
26:32 – Semaglutide for Weight Loss
39:29 – Depo Antipsychotics

John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
Dr. Galdo serves in an advisory role and as a member of a speaker’s bureau for Novo Nordisk.

Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Dr. Wall is a member of a speaker’s bureau for Janssen.

References and Resources
Dr. Wall prepared slides for this episode with all references and citations, click HERE to download.
Redeem your CPE or CME credit

Pharmacist members
CME
Pharmacy Technicians

Need a membership?

Join for CPE Credit
Join for CME Credit

This episode was made possible by the PharmaCE Expo and the Iowa Pharmacy Association. Register for PharmaCE Expo May 17-18 at the Hilton Des Moines Downtown here! Pharmacists and pharmacy technicians who register receive CPE for this course AND have the opportunity to receive over 14 hours of CE.

CE Information
Learning Objectives – Pharmacists and PrescribersUpon successful completion of this knowledge-based CPE activity, participants should be able to:

Classify "Gamechangers" by how they affect practice settings.
Discuss the selection of a "Gamechanger" topic and how it will impact the provision of patient care.
Describe possible solutions to clinical problems listed throughout the presentation.
Assess the clinical trials used to support the content for this presentation.
Apply the information presented to influence patient care and outcomes at your specific practice site.
0.075 CEU/0.75 hr
UAN: 0107-0000-22-115-H01-P

Learning Objectives – Pharmacy TechniciansUpon successful completion of this knowledge-based CPE activity, participants should be able to:

Classify "Gamechangers" by how they affect practice settings.
Discuss the selection of a "Gamechanger" topic and how it will impact the provision of patient care.
Describe opportunities for the advancement of pharmacy technician roles based on information presented.
Identify the clinical trials used to support the content for this presentation.
Apply the information presented to influence patient care and at your specific practice site.

0.075 CEU/0.75 hr
UAN: 0107-0000-22-115-H01-T
Initial release date: 02/21/2022
Planned expiration date: 02/21/2022
Additional CPE and CME details can be found here.

View Details

Weight gain can impact patient’s quality of life and put them at risk for health complications. While weight loss can be an important factor in a patient’s health, it is equally important that it is done safely and effectively. Listen in as host, Geoff Wall compares the safety and efficacy of semaglutide and liraglutide in weight loss.

The GameChanger:

Based on a recent Phase-3 study, semaglutide appears to be more effective in weight loss than liraglutide
Semaglutide also appeared to have modest effects on decreasing systolic blood pressure, blood sugar, lipid concentrations, and serum insulin levels
GLP-1 agonists are expensive medications – patients should be made aware of the of the associated cost as a part of patient centered care

Show Segments:

00:00 – Introductions

01:10 – GLP-1s Agonist (Semaglutide vs Liraglutide) in Weight Management

10:00 – Change in Body Weight

12:02 – Secondary Outcomes – Blood Pressure, Blood Sugar, Lipid Concentrations, & Serum Insulin

12:59 – Safety & Side Effects

14:15 – Cost

14:52 – The GameChanger

17:20 – Closing Remarks

Links to Resources:

Effects of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults with Overweight or Obesity Without Diabetes

How to Claim CE:

CE is available for CEimpact members:

· Click here to claim CPE Credit

· Click here to claim CME Credit

Need a membership?

Join for CPE Credit
Join for CME Credit

Continuing Education Information:Learning Objectives:
1. Describe the inclusion and exclusion criteria of the STEP 8 study
2. Discuss the outcomes of the STEP 8 study

Dr. Wall is a member of the Janssen Speaker's Bureau.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-088-H01-P
Initial release date: 02/14/22
Expiration date: 02/14/2023
Additional CPE & CME details can be found here"

View Details

Every January, the American Diabetes Association updates the Standards of Medical Care in Diabetes. The guidelines cover updates from diabetes advocacy to technology changes. Learn what changed and what matters most for individuals with diabetes.

Time in range was introduced in the 2021 update and is becoming the standard of glycemic targets and control
Metformin may not be the first line option for type 2 diabetes – comorbid conditions and cost to the patient should be considered when determining appropriate treatment
More data is emerging suggesting the SGLT-2 inhibitors slow progression of diabetic neuropathy, CKD, and other comorbid conditions GLP-1 drugs may also aid in neuropathy
In older adults with diabetes, the upper threshold of A1c goal of 8.5% may not be as global as originally thought – glycemic targets should be matched with patient status and factors

00:00 – Introductions

03:25 – Improving Care and Promoting Health

06:07 – Classification of Diabetes

07:55 – Prevention of Diabetes

10:02 – Comprehensive Medication Evaluation

12:05 – Facilitating Behavior Changes

14:14 – Glycemic Targets & DM Technology

17:08 – Obesity

18:15 – Pharmacologic Approach

24:00 – Cardiovascular Disease

25:26 – Chronic Kidney Disease Management

26:06 – Retinopathy, Neuropathy, & Foot Care

28:15 – Diabetes in Older Adults

29:38 – Closing Remarks

John (Jake) A. Galdo, PharmD, MBA, BCPS, BCGP Course Content and Developer, CEimpact Pharmacist, Ross Bridge Pharmacy CEO, Seguridad, Inc

Dr. Galdo received his Doctor of Pharmacy and completed PGY-1 Community Pharmacy Residency training from the University of Georgia, earned a Master of Business Administration from Samford University, and is board certified in both pharmacotherapy and geriatrics. Jake Galdo helps lead content and course development at CEimpact.

Links to Resources:

Standards of Medical Care in Diabetes-2022

Take a deeper dive into glycemic management with Sue Cornell, BS, Pharm.D, CDCES, FAPhA, FADCES: CEimpact

Dr. Cornell currently serves as the associate director of experiential education and professor in the department of pharmacy practice at Midwestern University College of Pharmacy in Downers Gove, Illinois. She is also a certified diabetes care and education specialist.

How to Claim CE:

· Pharmacist

· CME

Need a membership?

Join for CPE Credit
Join for CME Credit

Continuing Education Information:Learning Objectives:

Describe changes to the type 2 diabetes treatment algorithm based on the 2022 guidelines
Identify appropriate first-line therapy for persons with diabetes and cardiovascular disease

Dr. Wall is a member of the Janssen Speaker's Bureau.
Dr. Galdo reports no actual or potential conflicts of interest associated with this episode.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-071-H01-P
Initial release date: 02/07/22
Expiration date: 02/07/23
Additional CPE & CME details can be found here"

View Details

While HIV treatment has come a long way over the decades, it still faces challenges. Specifically, HIV therapy such as integrase inhibitors have been associated with increased weight gain but the mechanism and extent of which has remained largely unknown. Listen in as Dave Hachey, HIV expert, and Geoff Wall discuss this and how it impacts medication selection when caring for patients with HIV.

The Gamechanger:

The risk of weight gain with integrase inhibitor and other potential HIV regimens should be discussed with patients
Patients’ comorbidities should risk factors should be considered when determining an appropriate treatment regimen
Studies suggest that the mechanism of weight gain from integrase inhibitors and older agents such as tenofovir alafenamide is different, although more research is needed

Show Segments:

00:00 – Introductions

04:36 – HIV Treatment & Weight Gain

07:27 – Integrase Inhibitors vs Tenofovir Alafenamide

17:12 – The GameChanger

26:22 – Closing Remarks

Guest Bios:

David Hachey, PharmD, AAHIVP Professor Idaho State University

After graduating from the University of Rhode Island, Dr. Hachey completed a residency and fellowship in Family Medicine at Idaho State University. After, he stayed in Idaho and expanded his role with the College of Pharmacy and the Department of Family Medicine. Dr. Hachey has experience within the community setting and has also served as the director of the regional Ryan White HIV Clinic for the last 15-20 years. His vast experience gives him a unique perspective on the challenges pharmacists and patients face in preventing and managing HIV.

Links to Resources:

Excess Weight Gain with Integrase Inhibitors and Tenofovir Alafenamide Study

How to Claim CE:

CE is available for CEimpact members.

Click here to claim CPE Credit
Click here to claim CME Credit

Get a membership:

Join for CPE Credit
Join for CME Credit

References and resources:

Wood B, Huhn G. Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter?. Open Forum Infectious Diseases, Volume 8, Issue 12, December 2021. https://doi.org/10.1093/ofid/ofab542

Continuing Education Information:Learning Objectives:

Describe the proposed mechanism for weight gain due to integrase inhibitors
Identify co-morbid conditions with HIV that may influence medication selection

Dr. Wall is a member of the Janssen Speaker's Bureau.
Dr. Hachey reports no actual or potential conflicts of interest associated with this episode.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-070-H01-P
Initial release date: 01/03/22
Expiration date: 01/03/2023
Additional CPE & CME details can be found here

View Details

Failure is universal to the human experience. Grit, or the ability to demonstrate tenacity, perseverance, and resilience in the face of failure is a learned skill. Success requires both. Join us in a conversation with Dr. Michael Rupp, failure "master", professor, preceptor, and student mentor. We'll discuss the value of failure, as well as the challenges and opportunities we face as teachers and mentors in creating an environment where failure is an option - or even encouraged.

Host:
Kathy Schott, PhD
CEimpact

Guest:
Dr. Michael Rupp, PhD
Professor
Midwestern University - Glendale

Click here to access the course and claim CE for listening to the episode.

Want more information on this topic? Visit this CE course at www.CEimpact.com:

True Grit: Developing a Philosophy of Failure

Failure may be the single most critical key to student success when balanced with the right structures and supports. And yet, we often expect perfection. Take this course to understand what it means to adopt a "philosophy of failure" and create an environment where pharmacy learners can thrive.

Acknowledgements:
Special thanks to the Northwest Pharmacy Experiential Consortium, who helped conceive the concept for this podcast and assisted it in its launch. Collaboration is one of CEimpact’s core values, and we are grateful for their partnership.

View Details

Studies show that opioids are the number one prescribed medication for peripheral neuropathy contrary to evidence suggesting a lack of efficacy. Despite being a common condition for individuals with diabetes, treatment is often non-evidence based, meaning that creating a care plan can be difficult. With this, the American Academy of Neuropathy (AAN) was urged to re-evaluate treatment recommendations for Diabetic Neuropathy Pain (DNP). Listen in as Dr. John Swegle, a pain management expert, and host Geoff Wall discuss the updates on DNP treatment recommendations.

The GameChanger:

AAN guidelines reaffirmed that opioids should not be used in the treatment of DNP
More appropriate treatments for DNP would include gabapentinoids, TCAs, and SNRIs
SNRI, especially venlafaxine dosing should be targeted to achieve the norepinephrine effects of the drug class
For patients wishing for natural therapy regimens, gingko may be considered

Show Segments:

00:00 – Introductions

02:05 – The American Academy of Neuropathy Guideline Update

05:29 – Treating and Controlling Diabetes

06:27 – Comparing Gabapentinoids, Sodium Channel Blockers, SNRIs, Opioids, and TCAs

12:30 – The GameChanger

19:29 – The American Academy of Neuropathy Recommendations

24:49 – Closing Remarks

Guest Bios:

John Swegle, PharmD, BCPS, BCACP Clinical Associate Professor University of Iowa College of Pharmacy

John received his PharmD degree from the University of Iowa. He currently is a Clinical Associate Professor with the University of Iowa and clinical pharmacist with the Mercy Family Medicine Residency Program. In addition, he works with Hospice of North Iowa serving as a consultant pharmacist and as a faculty member for the Mercy Medical Center – North Iowa Palliative Medicine Fellowship.

Links to Resources:

American Academy of Neuropathy – Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary
Healthcare Claim Study – Opioids in Peripheral Neuropathy

How to Claim CE

CE is available for CEimpact members.

Click here to claim CPE Credit
Click here to claim CME Credit

Need a membership?

Join for CPE Credit
Join for CME Credit

Learning Objectives:

Select an appropriate first line medication for diabetic neuropathic pain (DNP) based on the 2022 guidelines
Describe the treatment effects of the drugs used for DNP in the 2022 guidelines

Dr. Wall is a member of the Janssen Speaker's Bureau.

Dr. John Swegle reports no actual or potential conflicts of interest associated with this episode.

Continuing Education Information:

0.05 CEU | 0.5 Hrs

ACPE UAN: 0107-0000-22-057-H01-P

Initial release date: 01/03/22

Expiration date: 01/03/2023

Additional CPE & CME details can be found here.

View Details

Two oral therapies for COVID-19 were recently approved. Listen in as we discuss who is eligible to receive them, their efficacy, and what this means for the future of COVID-19 treatment.

Guest:
Patrick Kinn, PharmD, MPH, BCPS
Clinical Pharmacy Specialist - Infectious Disease
University of Iowa Health Care

John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Redeem your CPE or CME credit here!
Pharmacist members
CME

Need a membership?
Join for CPE Credit
Join for CME Credit

References and resources:

Jayk BA, Gomes da Silva MM, Musungaie DB, et al. MOVe-OUT Study Group. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. N Engl J Med. 2021 Dec 16:NEJMoa2116044. doi: 10.1056/NEJMoa2116044. Epub ahead of print. PMID: 34914868; PMCID: PMC8693688.
PAXLOVID (nirmatrelvir) [Emergency Use Authorization]. U.S. Food and Drug Administration website. Published December 22, 2021. Accessed January 5, 2021. https://www.fda.gov/media/155050/download
Liverpool COVID-19 Interactions. https://www.covid19-druginteractions.org/
COVID-19 Public Therapeutic Locator. https://healthdata.gov/Health/COVID-19-Public-Therapeutic-Locator/rxn6-qnx8/data

Continuing Education Information:Learning Objectives:

Identify the eligible population for treatment of COVID-19 with oral therapy
Discuss the efficacy of currently available oral therapy treatment options for COVID-19

Dr. Wall is a member of the Janssen Speaker's Bureau.
Dr. Galdo reports no actual or potential conflicts of interest associated with this episode.
Dr. Kinn reports no actual or potential conflicts of interest associated with this episode.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-056-H01-P
Initial release date: 01/17/22
Expiration date: 01/17/2023
Additional CPE & CME details can be found here

View Details

The FDA recently approved the first eyedrop to treat age-related nearsightness due to poor accommodation, a disorder experienced by more than 100 million Americans. Spoiler alert . . . its pilocarpine eye drops - which have been on the market for over 70 years. What does the data say about this new formulation of an old drug and its ability to help with age-related presbyopia? Listen in for a discussion on efficacy and cost.

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources:

https://www.ophthalmologytimes.com/view/fda-approves-eye-drops-for-treatment-of-presbyopia
https://clinicaltrials.gov/ct2/show/NCT04657172

Continuing Education Information:

Learning Objectives:

Describe the evidence that informed the FDA's decision to approve a new formulation of pilocarpine for presbyopia

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-040-H01-P
Initial release date: 01/10/22
Expiration date: 01/10/2023
Additional CPE & CME details can be found here

View Details

Pain is not a game. Chronic non-malignant pain has few effective treatment options, particularly since the adverse effects of opioids have become more known. Many patients with chronic pain also develop mental health issues such as depression and anxiety. A new virtual reality system, designed for at-home self-use, has been approved by the FDA to treat chronic low back pain in adults. Dr. John Swegle, a pain management expert, joins host Geoff Wall to discuss how this potentially gamechanging device gained FDA approval and logistical challenges patients may have in obtaining access.

Guest:
John Swegle, PharmD, BCPS, BCACP
Clinical Associate Professor
University of Iowa College of Pharmacy

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and Resources:FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-virtual-reality-system-chronic-pain-reduction
Virtual Reality Trial Using EaseVRx for Chronic Low Back Pain: https://clinicaltrials.gov/ct2/show/NCT04415177

Continuing Education Information:Learning Objectives:

Describe the purported mechanism of benefit of a virtual reality system in patients with low back pain
Discuss the study that supported a virtual reality device to receive FDA approval for pain management and its implications for patients with low back pain

Dr. John Swegle reports no actual or potential conflicts of interest associated with this episode.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-039-H01-P
Initial release date: 01/03/22
Expiration date: 01/03/2023
Additional CPE & CME details can be found here

View Details

Since the REDUCE study was published in 2013, most guidelines recommend a standard dose of prednisone 40mg for 5 days (or an equivalent dose of another steroid). However, the optimal dose of steroids may be different depending on patient factors. Tune in to explore the concept of personalizing steroid doses in AECOPD using a dosing scale.

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?
Join for CPE Credit
Join for CME Credit

References and resources:
Li Li, MD, Nana Zhao, MS, Xiangyu Ma, MD, et al. Personalized Variable vs Fixed-dose Systemic Corticosteroid Therapy in Hospitalized Paitents with Acute Exacerbations of COPD. Chest Journal, 160(5), 1660-1669, November 1, 2021
https://journal.chestnet.org/article/S0012-3692(21)00951-X/fulltext

Continuing Education Information:Learning Objectives:

Describe the efficacy and safety outcomes of a study investigating the effectiveness of personalized dosing of corticosteroids vs fixed dosing in hospitalized patients with COPD exacerbations
Apply a rubric used to personalize dose of steroid in patients with acute exacerbations of COPD

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-402-H01-P
Initial release date: 12/27/21
Expiration date: 12/27/22
Additional CPE & CME details can be found here (www.ceimpact.com/podcast)

View Details

Pharmacy students change and evolve immensely from the moment they walk into pharmacy school to the moment they graduate. At each step along the way, their educational needs change as well. And of course, each student is uniquely different regardless of where they are on their pharmacy school journey. As a preceptor, you must meet each of them where they are. Join us as we discuss challenges preceptors may face with introductory learners, regardless of where they are on their journey. We will equip you with actionable strategies applicable regardless of pratice environment.

Guest HostHuy Hoang, PharmD
Coordinator for Experiential Advancement|Assistant Professor
Pacific University School of Pharmacy

Guest ExpertJoseph Tran, PharmD, RPh
Lead Pharmacist Consultant
Geneva Woods Pharmacy, Anchorage, AK

Want more education on this topic? Visit these courses at www.CEimpact.com

Teaching the Science of Safety to APPE and IPPE Students

Identify opportunities for "teaching moments" and turn students pharmacists into resources for patient safety initiatives.

Tools to Facilitate Student Success with Your Learning Experience

Preceptors often don’t feel they have time or know how to go about creating an appropriate amount of structure within the experiences they provide for student pharmacists. In this CPE course, preceptors have the opportunity to learn and apply simple quality improvement techniques to maintain and enhance their learning experience.

Topic Discussion to Promote Learner Growth

This course provides preceptors with rationale for utilizing topic discussions as well as methods for incorporating topic discussions into their rotations. Seasoned preceptors will also gain insight on how to take their existing topic discussions to the next level through practical ways to revitalize and revamp these learning experiences.

AcknowledgementsSpecial thanks to the Northwest Pharmacy Experiential Consortium, who helped conceive the concept for this podcast and assisted it in its launch. Collaboration is one of CEimpact’s core values, and we are grateful for their partnership.

View Details

A recent study calls into question the safety of mirtazapine in the elderly, an antidepressant often recommended in the elderly for treatment of senile cachexia due to the medication’s appetite stimulation properties. This episode reviews the SYMBAD trial with guest Sarah Grady, PharmD.

Guest:
Sarah Grady, PharmD
Drake University

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources: Banerjee S, High J, Stirling S, et al. Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1. PMID: 34688369; PMCID: PMC8546216.

Continuing Education Information:Learning Objectives:

Describe the results of the SYMBAD study and its implications in the care of geriatric patients
Discuss the adverse effects found in the SYMBAD study

Dr. Sarah Grady reports no actual or potential conflicts of interest associated with this episode.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-401-H01-P
Initial release date: 12/20/21
Expiration date: 12/20/22
Additional CPE & CME details can be found here (www.ceimpact.com/podcast)

View Details

In the past several weeks, there have been news reports about pharmacies, health care clinics, and remote vaccination clinics giving the wrong dose of a vaccine. Before these reports, there were also stories of health care providers inappropriately diluting the Pfizer vaccine resulting in a wrong dose delivered to adult patients. Whenever we hear about these news reports, it causes most health care providers to become concerned, stressed, and anxious as to how to mitigate these types of errors.

This week’s Level Up episode offers you concrete tools to mitigate your risk, regardless of your practice setting.

Host
Suzanne Feeney, PharmD
VP, Business Development, CEimpact

GuestRandy P. McDonough, BS, MS, PharmD, BCGP, BCPS
CEO, Towncrest Pharmacy Corp
CIO, Seguridad, Inc

We’ll address 3 specific measures you can take to minimize your risk:

Online Scheduling
Appointment procedures
Pediatric Considerations

Links to Resources

Towncrest Pharmacy’s Vaccine Scheduler
Scheduling tool
Level Up Column: Risk Mitigation

View Details

Hyperkalemia is a potentially fatal condition, yet no real guidelines for treatment exist and evidence to guide treatment is limited. Listen in for a rapid review of the evidence both for and against standard treatments of hyperkalemia.

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources: N/A

Continuing Education Information:

Learning Objectives:

Discuss treatment options for hyperkalemia that remove potassium from the body as opposed to shifting the electrolyte into other body areas.
Describe which intravenous fluids should be used when treating hyperkalemia.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-396-H01-P
Initial release date: 12/13/21
Expiration date: 12/13/22
Additional CPE & CME details can be found here!

View Details

COVID-19 has brought on many challenges within our healthcare systems. CVS recently announced the closure of pharmacies across the nation causing thousands of workers to lose their jobs. Other healthcare systems are scrambling to keep up due to shortages of workers. And at the same time, they are trying to stay afloat and to meet business needs. This has caused a decrease in empathy within patient care. In this week's conversation, Jake Galdo discusses with Randy McDonough, co-owner of Towncrest Pharmacy Corp, how to bring empathy back to your practice.

HostJake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Clinical Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Guest

Randy P. McDonough, BS, MS, PharmD, BCGP, BCPS
CEO, Towncrest Pharmacy Corp
CIO, Seguridad, Inc

Takeaways

The circumstances within healthcare, especially in pharmacy, are trying to meet high demands. Systems are short-staffed and struggling to maintain their business. Pharmacists are unable to display patient care with empathy as they are overworked and feeling depleted.
Healthcare systems need to be disrupted in order to change what is happening. Our healthcare systems are going down a path that cannot be sustained.
Place yourself in your patient's shoes. How would you view your practice? Start making changes now and return your focus on empathy with your patient care.

View Details

Repost Episode: A degree is pharmacy is incredibly versatile - from health-systems and long-term care facilities to community pharmacies and managed care - pharmacists are an integral part of healthcare. Sometimes, students may pursue additional training through residency programs.

How can you prepare your students?

Pearl 1: Preparing for an interview.
Pearl 2: How to quickly evaluate a resume/CV
Pearl 3: Finding the first career step.

Want more education on this topic? Visit these courses at www.CEimpact.com

Helping Your Students Get Ready for Interviews

Help your students and residents shine during the interview process. Learn how to coach your students to success, including tips on etiquette and preparation. Additionally, you'll hear from both an experienced Residency Director and Student Preceptor about what's worked well for them.

How to Evaluate a CV

How can you help your students and residents prepare for their future? This brief course provides tips on how to critically review a CV. We spend time reviewing an example CV so you can learn what to look for and how to constructively share feedback. Leave this session with a tool to guide you through the process of CV evaluation.

Rotations and Residencies and Jobs, Oh My! Helping Your Students Decide What's Next

This continuing pharmacy education course provides tools and guidance to preceptors and mentors on how to help students navigate their next steps into the profession. Participate in this course to discuss advanced pharmacy practice experience selection, position application preparation, and residency recruitment; as well as how to have meaningful discussions with students on how to manage these stressful processes and decisions.

Writing Letters of Recommendation that Matter

It’s a common scenario: an APPE student is applying to residency programs and asks you as a preceptor to write a letter of recommendation. How do you write a letter that stands out? This course offers practical strategies for writing a letter that is personalized and impactful. Hear tips on what to ask from the student requesting a letter as well as how to handle a situation where you don’t feel comfortable writing a letter of recommendation.

Become a member with our CEimpact Membership here!

View Details

Fluoroquinolone antibiotics are widely prescribed in the US despite a growing number of serious adverse effects associated with their use. One of these adverse effects is QTc prolongation which can lead to lethal arrhythmias. A recent study evaluates in patients on hemodialysis are at an even higher risk.

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources: Assimon MM, Pun PH, Wang L, et al. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. Published online October 20, 2021. doi:10.1001/jamacardio.2021.4234

Continuing Education Information:Learning Objectives:

Describe the design and outcomes of a recent study that examines sudden cardiac death in a cohort of hemodialysis patients receiving quinolones
Apply the results of this study to a specific patient case

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-389-H01-P
Initial release date: 12/06/21
Expiration date: 12/06/21
Additional CPE & CME details can be found here

View Details

As a pharmacist, you need to think on your feet, yet it can be difficult if you are burned out. How can you be freed up to perform to the best of your abilities? How can you bring more revenue to the business so you can provide a healthier pharmacy? In this week's conversation, Jake Galdo talks with Randy McDonough, co-owner of Towncrest Pharmacy Corp, about they've brought revenue into their pharmacies through 1) being an interventionist; 2) documenting clinical services on their 10K sheets; and 3) hiring candidates who demonstrate the pharmacy of the future and provide a safer environment.

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Clinical Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Guest
Randy P. McDonough, BS, MS, PharmD, BCGP, BCPS
CEO, Towncrest Pharmacy Corp
CIO, Seguridad, Inc

Takeaways

"On the Run" allows pharmacists to become interventionists by thinking on their feet and elevating important information that is presented to them.
Hiring pharmacists and pharmacy technicians who are passionate about the future of pharmacy, and who care about others, provides a safe environment to your pharmacy.
10K reports that document clinical services, including immunizations, show value and bring profit to your pharmacy.

Looking for more? Take these courses!

Feeling the Burn? The Impact of Burnout in the Pharmacy Profession
Leadership: A Pharmacist's Action Plan
What's Your Big Idea?
Alert Fatigue and Pharmacists' Liability

View Details

How can you prepare your students?

Pearl 1: Preparing for an interview.
Pearl 2: How to quickly evaluate a resume/CV
Pearl 3: Finding the first career step.

Want more education on this topic? Visit these courses at www.CEimpact.com!

Helping Your Students Get Ready for Interviews

Help your students and residents shine during the interview process. Learn how to coach your students to success, including tips on etiquette and preparation. Additionally, you'll hear from both an experienced Residency Director and Student Preceptor about what's worked well for them.

How to Evaluate a CV

How can you help your students and residents prepare for their future? This brief course provides tips on how to critically review a CV. We spend time reviewing an example CV so you can learn what to look for and how to constructively share feedback. Leave this session with a tool to guide you through the process of CV evaluation.

Rotations and Residencies and Jobs, Oh My! Helping Your Students Decide What's Next

This continuing pharmacy education course provides tools and guidance to preceptors and mentors on how to help students navigate their next steps into the profession. Participate in this course to discuss advanced pharmacy practice experience selection, position application preparation, and residency recruitment; as well as how to have meaningful discussions with students on how to manage these stressful processes and decisions.

Writing Letters of Recommendation that Matter

It’s a common scenario: an APPE student is applying to residency programs and asks you as a preceptor to write a letter of recommendation. How do you write a letter that stands out? This course offers practical strategies for writing a letter that is personalized and impactful. Hear tips on what to ask from the student requesting a letter as well as how to handle a situation where you don’t feel comfortable writing a letter of recommendation.

Become a subscriber to our premium CE Service here!

View Details

The United States Preventative Services Task Force has another update - this time focused on low-dose aspirin and primary prevention. Is your heart healthier WITHOUT a daily aspirin?

Guest:
John A Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad

Redeem your CPE or CME credit here!

Pharmacist members
CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources:

Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication

Continuing Education Information:
Learning Objectives:

Describe the new USPSTF guidelines for primary use of low dose aspirin in patients over age 60
Apply the guidelines to an individual patient and counsel on the risks and benefits of low dose aspirin

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-388-H01-P
Initial release date: 11/29/21
Expiration date: 11/29/22
Complete CPE & CME details can be found here

View Details

Pharmacists currently fill multiple roles within the pharmacy. This can foster burnout and cause errors. As pharmacists, we should be focusing on patient interaction and drug therapy. But how do you take control of your environment so this can happen? In this week's conversation, Jake Galdo talks with Randy McDonough, co-owner of Towncrest Pharmacy Corp, about the future of pharmacy through incremental change.

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Clinical Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Guest
Randy P. McDonough, BS, MS, PharmD, BCGP, BCPS
CEO, Towncrest Pharmacy Corp
CIO, Seguridad, Inc

Takeaways

Pharmacists fill multiple roles within the pharmacy. This can foster burnout and cause errors.
The pharmacist of the future is away from the counter and focused on patient interaction and the patient's drug therapy.
Start by taking control of your environment and determining which structural change needs to happen. This can feel like more work but in the long run and with small incremental changes, you will see success faster.

Looking for more education on incremental change? Take these courses!

Technician Product Verification
Technician Immunization
Point of Care Testing

View Details

Burnout in healthcare is very real, now perhaps more than ever. And while giving back to the profession through precepting sounds noble, it can often be seen as just one more challenge on a long list. Tune into this episode to explore how to better balance work, life, and teaching in a way that is fulfilling for both you and your students.

Guest
Jennifer Chang, PharmD, BCPS
Clinical Associate Professor | Director of Preceptor Development
University of Washington School of Pharmacy

Guest Experts:

Caitlin Blomquist, M.Ed.
Director of Advising and Student Success
Office of Professional Pharmacy Education
UW School of Pharmacy

Todd Winkler, PharmD
Clinical Assistant Professor, University of Washington
Clinical Pharmacist, Family Medicine Clinic and General Medicine at Swedish Medical Center (Cherry Hill)

Want more education on this topic? Visit these courses at CEimpact.com!

It's Time to Be Thriving: Starting with the Whole You

Many pharmacists are facing professional burnout due to increasing workload in practice and demands in their role as preceptors. Listen in to start transitioning your mindset from a survival mentality to experiencing a thriving pharmacy career by promoting a culture of well-being through precepting.

Feeling the Burn? The Impact of Burnout in the Pharmacy Profession

Explore the research on causes, risk factors, and prevention of burnout in order to be more effective in your work.

Managing Time as a Preceptor

Does precepting take time? Sure it does. But students can also be a great asset and contribute in significant ways to practice site initiatives and improvements when provided the right amount of structure, guidance, and autonomy.

Acknowledgements
Special thanks to the Northwest Pharmacy Experiential Consortium, who helped conceive the concept for this podcast and assisted it in its launch. Collaboration is one of CEimpact’s core values, and we are grateful for their partnership.

View Details

A recent case control study evaluated adverse effects on glycemic control secondary to cholesterol lowering statin medications. Listen in as we evaluate the risk versus benefit of statin therapy in persons with diabetes.

Redeem your CPE or CME credit here!

Claim CPE (Pharmacist Members)
Claim CME

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources: Mansi IA, Chansard M, Lingvay I, et al. Association of Statin Therapy Initiation With Diabetes Progression: A Retrospective Matched-Cohort Study. JAMA Intern Med. Published online October 04, 2021. doi:10.1001/jamainternmed.2021.5714

Learning Objectives:

Describe the proposed mechanism by which statins would worsen blood glucose control
Discuss confounders in the study that examined the association of statin use and worsening diabetes control.

Continuing Education Information:
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-365-H01-P
Initial release date: 11/22/21
Expiration date: 11/22/22

Complete CPE & CME details can be found here

View Details

With each patient who comes through your pharmacy, you want to give them the quality of care they deserve. Knowing a patient's serum creatinine allows you to ensure your patient's kidneys are fully functioning and helps you evaluate treatment plans to provide the best care. In this week's conversation, Jake Galdo talks with Courtney Tigges, a Clinical Pharmacist at Towncrest Pharmacy and PGY-1 Resident at The University of Iowa about the importance of documenting your patient's serum creatinine to provide quality care in your pharmacy.

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Clinical Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Guest
Courtney Tigges, PharmD
Clinical Pharmacist, Towncrest Pharmacy
PGY-1 Resident, The University of Iowa

Takeaways

Courtney's residency project is gathering serum creatinine for patients over 50 to ensure it is within range and documenting it in the patient record.
This provides collaborative care by building trust and relationship with both physicians and patients in your practice.
You can start by having these conversations with your patients and documenting their serum creatinine.

Looking for more on improving patient care?
Take this course, It's Time to Deprescribe!

Pharmacist
Technician

Check out Choose My Pharmacy to begin bringing back quality to your patient care. Choose My Pharmacy™ is about you, a stakeholder in healthcare, becoming empowered to understand community pharmacy quality.

View Details

Repost Episode: Teaching is hard. Learn the what, why, and how of the Socratic Method and how using this process may aid preceptors in understanding what a student truly knows - and where more focus needs to be placed. Help your students think better with Socratic questioning!

Click here to download the Socratic Questioning handout!

Pearl 1: Describe the Socratic Method
Pearl 2: Identify reasons the Socratic Method is a useful precepting tool
Pearl 3: Implement the Socratic Method while precepting students

Guests:
Tracy Pettinger, PharmD
Clinical Associate Professor
Idaho State University

Lindsay Davis, PharmD, BCPS, BCCP, ASH-CHC, TTS
Professor
Midwestern University

Want more education on this topic? Visit these courses at www.CEimpact.com:

Learn to Teach in Practice: A Curriculum for the Clinician Educator
Do you want to advance your role as an educator in your practice setting?
Learn to Teach in Practice provides a pathway to explore, describe, apply, analyze and reflect on the role of the pharmacist as an educator in the pharmacy profession.

The Eleven Habits of Highly Effective Preceptors
Why is self-assessment important for preceptors, and how does it improve teaching? The Habits of Preceptors Rubric was designed to provide a robust assessment of an individual preceptor's habits. This course offers an introduction to this rubric as well as guidance on completing a self-assessment exercise which will create an actionable, impactful plan for continuous preceptor development.

Become a member today with our CEimpact Membership!

View Details

The TOGETHER Study, published in Lancet, evaluated the role of fluvoxamine in the treatment of COVID-19. Is this a real GameChanger, or just another dud? Lay media has been picking up the study - listen to Geoff and Jake break down the article to help healthcare providers give evidence-based recommendations.

Guest
John A Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad

Redeem your CPE or CME credit here!

Claim CPE Credit
Claim CME Credit

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources: Reis G, Dos Santos Moreira-Silva EA, Silva DCM, et al. TOGETHER investigators. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2021 Oct 27:S2214-109X(21)00448-4. doi: 10.1016/S2214-109X(21)00448-4. Epub ahead of print. PMID: 34717820; PMCID: PMC8550952.

Additional Resources:
WSJ Opinion on Fluvoxamine
WSJ Letter-to-Editor

Continuing Education Information:
Learning Objectives:
1. Describe the inclusion and exclusion criteria for the TOGETHER study
2. Discuss the role of Drug-Drug Interactions with fluvoxamine

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-394-H01-P
Initial release date: 11/15/21
Expiration date: 11/15/22
Dr. Galdo reports that he is on a speaker's bureau for Novo Nordisk.
Complete CPE & CME details can be found here

View Details

A critical part of a pharmacist's job is ensuring the proper dose of a medication is provided to patients. They can do this by checking the dose with the patient's weight, especially with pediatric patients. If the dose is incorrect, it can cause adverse effects of an overdose or not work effectively because it is under-dosed. In this week's conversation, Jake Galdo talks with Kelsey Holder, a Clinical Pharmacist at SEMO Rx Pharmacies and PGY-1 Resident with the University of Missouri - Kansas City about the importance of collecting pediatric weight to ensure better patient care.

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Clinical Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Guest
Kelsey Holder, PharmD
Clinical Pharmacist, SEMO Rx Pharmacies
PGY-1 Resident, University of Missouri - Kansas City

Takeaways

Kelsey's project is implementing a workflow change for her pharmacy staff to focus on pediatric weight to ensure prescriptions can be processed accurately.
Checking pediatric weight and verifying a dose is important because an overdose or under-dose can cause harm to the patient.
You can start this in your pharmacy by educating yourself and your pharmacy staff on the importance of having patient weight on file and ensuring the dose is correct based on weight

How to Start

Look at the patient's profile to determine if the patient's weight is on file
Talk to your pharmacy staff on the importance of having patient weight on files + making sure that dosing is correct based on weight

Looking for more education on pediatric patients and using pediatric weight base skills? Take these courses!

Pediatric Pearls for Pharmacy Technicians
Test and Treat: Group A Streptococcus (Pharmacist)
Test and Treat: Group A Streptococcus (Technician)

View Details

Repost Episode: 2020 will forever be remembered as the year of COVID-19. The pandemic impacted all aspects of the world, including experiential education. Listen as Taylor and Megan provide pearls on how to precept during a pandemic.

Pearl 1: What has changed due to the pandemic for precepting.
Pearl 2: Practical advice to help maximize student learning.
Pearl 3: Innovate precepting with ideas like "Fresh Air Fridays."

Want more education on this topic? Visit these courses at www.CEimpact.com:

Guests:
Taylor Bertsch, PharmD
Washington State University College of Pharmacy and Pharmaceutical Science

Megan Undeberg, PharmD, BCACP
Washington State University College of Pharmacy and Pharmaceutical Science

The New Normal: How to Develop and Deliver Remote Experiential Training
In light of the COVID-19 pandemic, many preceptors and APPE students were caught off guard with shelter in place requirements and safety concerns related to on-site experiential learning. In this course, we will provide preceptors with tools to successfully transition to a remote learning environment in a manner that supports the goals of the student, preceptor, and experiential site.

COVID-19: Safe Practices for Pharmacy Learners
This course is designed to provide pharmacy learners with a background on COVID-19 and its implications for patients, themselves, and other health care professionals. Risk factors, symptoms, clinical presentation of COVID-19, as well as appropriate use of personal protective equipment (PPE) will be discussed.

Become a member today with our CEimpact Membership!

View Details

The Surviving Sepsis Campaign Guidelines have been updated! It's been over five years since the last update and many new studies have redefined the role of several therapies for sepsis.

Redeem your CPE or CME credit here!

Claim CPE Credit
Claim CME Credit

Need a membership?

Join for CPE Credit
Join for CME Credit

References and resources:
Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021, Critical Care Medicine: November 2021 - Volume 49 - Issue 11 - p e1063-e1143 doi: 10.1097/CCM.0000000000005337

Continuing Education Information:
Learning Objectives:
1. Discuss the role of corticosteroids in septic shock patients requiring vasopressors
2. Discuss laboratory and screening tools to aid in treating septic shock patients

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-360-H01-P
Initial release date: 11/08/21
Expiration date: 11/08/22
Complete CPE & CME details can be found here

View Details

With so many pharmacies part of performance networks, quality measures become critically important to many aspects of business, including reimbursement. In this week's conversation, Jake Galdo talks with Randy McDonough, co-owner of Towncrest Pharmacy Corp, about utilizing pharmacy technicians and technology to provide the pharmacist time to devote to quality patient care.

Takeaways

Pharmacies are measured by a number of metrics based on patient outcomes, but there are flaws because pharmacies are often penalized for patients not following treatment plans. Other issues include:
The level of analysis - a measure designed for plans using health-plan data applied to a pharmacy that doesn't have the same data set
The cutoffs (or threshold of performance) - when you are in the percentile of performance and finding that it is relative to how everyone is doing
Looking at different metrics gives a holistic view of the pharmacy for both better quality of the pharmacy and patients
What kind of medication related problems can you find?
What are your interventions?
What kind of recommendations can you make to change therapy?
What are the clinical outcomes?
Community Pharmacies should strive for quality of the patient care over quantity of prescriptions that go out the door.

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Clinical Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Guest
Randy P. McDonough, BS, MS, PharmD, BCGP, BCPS
CEO, Towncrest Pharmacy Corp
CIO, Seguridad, Inc

Looking for more education on the quality of patient care in your pharmacy? Check out What's Your Big Idea?

View Details

Repost Episode: Preceptors play a crucial role in helping students identify and mitigate cognitive biases in medicine. But you might be wondering, how do I actually accomplish this? Tune in to Part 2 of Uncovering Cognitive Biases to learn practical tips and tricks to help students mitigate their cognitive biases!

Pearl 1: Describe the factors that predispose an individual to biases
Pearl 2: List strategies to help mitigate the influence of biases in decision-making.

Guests:
Tracy Pettinger, PharmD
Clinical Associate Professor
Idaho State University

Kasidy McKay, PharmD, BCPS
Clinical Assistant Professor
Idaho State University

Want more education on this topic? Visit these courses at www.CEimpact.com:

Leading with G.R.A.C.E.: Leveraging Diversity, Inclusion and Equity in your Pharmacy Practice
Understanding the clash between culture, class, and race is more important now than ever before. This course will provide you with the knowledge, skills, and resources to gain a deeper understanding of systemic racism, its impact on the Black, Indigenous, and People of Color (BIPOC) community, and how to leverage your role in the pharmacy profession to impact sustainable change.

All Preceptors' Hands on Deck in Breaking the Barriers of Structural Racism
There are different types of racism, and most individuals do not know the difference among them. Structural racism is the root cause of unequal distribution of resources, services, and healthcare. A lot of practicing pharmacists do not fully understand the concept of structural racism in relation to not only patients' medication adherence but also students' success during experiential education. This course is designed to educate preceptors on the impacts of structural racism on patients' clinical, economic, and humanistic outcomes; and learners’ professional growth and success.

Become a member today with our CEimpact Membership!

View Details

Hypertension is often managed by treating to a target blood pressure goal. But what if this is wrong? A recent meta-analysis found benefits of blood pressure lowering regardless of age. Host Geoff Wall is joined by Lindsay Davis, a cardiovascular pharmacist and educator, to make heads or tails of this article.

Guest:
Lindsay Davis, PharmD, BCPS, BCCP, ASH-CHC, TTS
Cardiology Pharmacist and Professor, Midwestern University

Redeem your CPE or CME credit here!

Claim CPE Credit
Claim CME Credit

Need a membership?

Join here for CPE Credit
Join here for CME Credit

References and resources: Blood Pressure Lowering Treatment Trialists' Collaboration. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet. 2021 Sep 18;398(10305):1053-1064. doi: 10.1016/S0140-6736(21)01921-8. Epub 2021 Aug 27. PMID: 34461040.

Continuing Education Information:
Learning Objectives:
1. Describe the methodology of a recent meta-analysis on blood pressure
2. Identify appropriate blood pressure targets for patients regardless of age

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-359-H01-P
Initial release date: 11/01/21
Expiration date: 11/01/22
Dr. Davis reports no actual or potential conflicts of interest associated with this activity.
Complete CPE & CME details can be found here!

View Details

Many of us are experiencing burnout from the pandemic. When you're stressed it can be difficult to see your way out of it. Randy McDonough, co-owner of Towncrest Pharmacy Corp, created a pharmacy business model that combats burnout and integrates a new mindset for everyday work life. Listen in as Jake Galdo asks Randy how to adopt this model by making small but incremental change to bring happiness - and safety - back to everyday work life.

Takeaways

Burnout is real… but we can engage our patients differently if we change our conversations with them.
Towncrest's business model combats burnout and brings happiness back into everyday work life by making changes to the way we interact with patients in the pharmacy.
This process takes small, incremental changes that accumulate to greater change.

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Clinical Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

Guest
Randy P. McDonough, BS, MS, PharmD, BCGP, BCPS
CEO, Towncrest Pharmacy Corp
CIO, Seguridad, Inc

Looking for more to combat burnout? Take these courses! Get a CEimpact membership today and get them for free here!

Feeling the Burn? The Impact of Burnout in the Pharmacy Profession
It's Time to be Thriving: Starting with the Whole You
Meditation for Medication Safety and Well-Being (Pharmacist)

View Details

New Episode! Statistics are scary. Pharmacists must leverage statistical methods on a routine basis when evaluating clinical studies and providing patient care. As preceptors, they must also develop evidence-based practice in their students. Join us on this episode to explore some practical approaches to incorporating the literature into your teaching with our guest, Dr. Geoff Wall. Check out the great resources listed below in this episode's show notes!

Host:
Kathy Schott, PhD
CEimpact

Guest:
Geoff Wall, PharmD, PharmD, FCCP, BCPS, CGP
Professor of Pharmacy Practice
Drake University

Want more education and ideas on this topic? Check out these resources + education:

Biostatistics Refresher
Take the fear out of using primary literature in your teaching!

CEimpact Journal Club
Join this monthly, live journal club with your student to stay current and practice your literature evaluation skills together!

GameChangers Pharmacotherapy
Listen every Monday to stay up-to-date on pharmacotherapy advances that are changing the game! Prescribers and Pharmacists learn from each other about best practices related to drug therapy for patients.

Join The Preceptor Academy within The Pharmacy Network to access resources and engage with other preceptors on topics that matter to you as a teacher and mentor!

Acknowledgments:
Special thanks to the Northwest Pharmacy Experiential Consortium, who helped conceive the concept for this podcast and assisted it in its launch. Collaboration is one of CEimpact’s core values, and we are grateful for their partnership.

Become a member today with our CEimpact Membership!

View Details

The recent Quartet Study evaluated initial hypertension pharmacotherapy - specifically, the role of using four antihypertensives at a low dose compared to usual step therapy. Does a small dose of multiple medications work better than one high dose medication?

Redeem your CPE or CME credit here!
Claim CPE Credit here!
Claim CME Credit here!

Need a membership?
Join for CPE Credit here!
Join for CME Credit here!

References and resources: Chow CK, Atkins ER, Hillis GS, et al. QUARTET Investigators. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomized, double-blind, active-controlled trial. Lancet. 2021 Sep 18;398(10305):1043-1052. doi: 10.1016/S0140-6736(21)01922-X. Epub 2021 Aug 29. PMID: 34469767.

Continuing Education Information:
Learning Objectives:
1. Describe the medications used in the QUARTET study
2. Apply the results of the QUARTET study to a patient with hypertension

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-356-H01-P
Initial release date: 10/25/21
Expiration date: 10/25/22
Complete CPE and CME details can be found here

View Details

What happens when pharmacy law and patient care don’t align? As a pharmacist during the COVID-19 pandemic, you are dealing with balancing legal liability and vaccine administration daily through ever-changing rules and regulations. This week’s episode shares hypothetical patient cases that David Brushwood, pharmacist attorney, and Jake Galdo, clinical pharmacist review. Together, they'll address the legal and clinical considerations for common COVID-19 vaccine scenarios you face in practice – which can often be in conflict.

For access to the full CE Course that includes ACIP recommendations, workplace legal liability and PREP Act discussion get a CEimpact Membership.

The following patient scenarios are discussed; David and Jake address what the right thing to do is from both a practice perspective and a regulatory perspective.

**This debate was recorded in September. FDA and CDC continue to update and change the COVID-19 vaccine recommendations, which may affect the legal and clinical considerations presented in this episode. However, this materials helps providers triage the next patient care conundrum

Hypothetical Scenario #1

A pregnant pharmacist refuses to be vaccinated despite mandates from the state and from the pharmacy.

Hypothetical Scenario #2

A pharmacist has become burned out from the long hours, stress of the pandemic, and staffing shortages. The pharmacist administered the J&J COVID-19 vaccine to a patient as closing. When billing after hours, the DUR showed “do not mix vaccines.” The pharmacist refuses to do further vaccines in the current conditions out of concern for patient welfare.

Hypothetical Scenario #3

A pharmacist decided to “take a break” when COVID immunizations began, saying “I have heard that the vaccine is worse than the disease, and I can’t do harm to patients.” The pharmacist has now requested a return to work and is claiming a religious exemption from administering immunizations.

Hypothetical Scenario #4

A new patient comes to the pharmacy and states they previously received ChAdOx1 nCov-19 in the UK but would like to get a dose of BNT162b2 now.

Hypothetical Scenario #5

A regular patient presents a ‘prescription’ to the pharmacy, and it states the following: “‘Patient’ has previously received J&J Covid vaccine. Unfortunately, she was a chemotherapy patient at that time. She has no measurable antibodies. I have recommended that she be vaccinated as is she’d never been vaccinated before. She should receive 2 doses of either the Pfizer or Moderna vaccine. Thank you.”

Hypothetical Scenario #6

A pharmacy’s staff all have young children (ages 5 - 7 years old). The staff conduct their own research, and they conclude that the mRNA vaccines are safe for young children. They consider using leftover doses of vaccine for their own children, as opposed to wasting these valuable doses.

Hypothetical Scenario #7

Your neighbor, a physician, has been caring for her elderly parents and children as her fulltime job. She was fully vaccinated in January during the first phase and comes in the pharmacy for a booster on mRNA1793. You know she is not immunocompromised.

Interested in the learning more? Get a CEimpact membership for access to the full course and CPE Credit for The Great COVID Debate.

View Details

Repost Episode: Cognitive biases are pervasive and particularly troublesome in medicine. And guess what...we are all susceptible to cognitive biases! However, it is possible to learn to identify our biases and mitigate them. The decisions clinicians make in medicine can significantly impact an individual's life, morbidity, and mortality. And precepting is the perfect time to help students learn to identify their own cognitive biases. However, to help a student identify their own cognitive biases, we have to be able to identify our own. Tune in to this episode of Precept2Practice to discover your own cognitive biases.

Pearl 1: Identify cognitive biases.
Pearl 2: Describe the types of cognitive biases most common in medical settings

Guests:
Tracy Pettinger, PharmD
Clinical Associate Professor
Idaho State University

Kasidy McKay, PharmD, BCPS
Clinical Assistant Professor
Idaho State University

Want more education on this topic? Visit these courses at www.CEimpact.com!

Become a member today with our CEimpact Membership!

View Details

Pseudogout, or Calcium Pyrophosphate Deposition Disease (CPDD), is more common than you think – plus the treatment is even murkier. In this episode, we discuss its presentation, diagnosis, and treatment.

Continuing Education Credit

Have a membership?

Claim CPE Credit here!

Claim CME Credit here!

Need a membership?

Join for CPE Credit here!

Join for CME Credit here!

References and resources: https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Diseases-Conditions/Calcium-Pyrophosphate-Deposition-CPPD

Continuing Education Information:

Learning Objectives:

List risk factors for developing pseudogout and common joints the disease effects
Describe an evidence-based approach to the treatment of pseudogout.

Click HERE for complete CPE & CME details

0.05 CEU | 0.5 Hrs

ACPE UAN: 0107-0000-21-340-H01-P

Initial release date: 10/18/21

Expiration date: 10/18/2022

View Details

For over 50 years, the standard has been that Staph aureus bacteremia and endovascular infections must be treated with a bactericidal antibiotic, like beta lactams or vancomycin. A new study suggests that bacteriostatic antibiotic, like clindamycin, could be used to treat MRSA bacteremia.

Redeem your CPE or CME credit here!

References and resources: Guthridge I, Smith S, Law M, et al. Efficacy and Safety of Intravenous Lincosamide Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0034321. doi: 10.1128/AAC.00343-21. Epub 2021 Aug 17. PMID: 34125589.

Continuing Education Information:
Learning Objectives:
1. Identify if an uncomplicated patient with MRSA bacteremia may be eligible for bacteriostatic medications
2. Describe some of the advantages of using drugs like clindamycin in these patients

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-339-H01-P
Initial release date: 10/12/21
Expiration date: 10/12/2022
Complete CPE & CME details can be found here !

What's new?

GameChangers Pharmacotherapy Podcast will release new episodes on Mondays starting 10/18/2021
We are making it easier to claim CE Credit for listening each week! This October - we'll launch a simple, one membership option so you can get one-click CE redemption for GameChangers episodes.
Name changes! You'll notice the podcast show will change to CEimpact - you'll still get new GameChangers episodes released each week on Mondays. Keep listening here and your feed will automatically switch over to CEimpact on 10/18.

View Details

Can a ‘report card' tame excessive prescriptions of antibiotics in outpatient settings? In this episode Dr. Wall with guest Josh Yost, MD, FACP will evaluate a paper that looked at using 'report cards' on antibiotic use and its impact on outpatient prescribing.

Guest:
W. John Yost, MD, FACP
UnityPoint Health

Earn CME or CPE credit here!

References and resources: Schwartz KL, Ivers N, Langford BJ, et al. Effect of Antibiotic-Prescribing Feedback to High-Volume Primary Care Physicians on Number of Antibiotic Prescriptions: A Randomized Clinical Trial. JAMA Intern Med. Published online July 06, 2021. doi:10.1001/jamainternmed.2021.2790

Continuing Education Information:
Learning Objectives:
1. Discuss the implementation of a report card to educate primary care providers on overuse of antibiotics
2. Discuss issues related to implementation of the study methods to other health systems and the potential costs that could be saved in doing so

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-306-H01-P
Initial release date: 9/7/21
Expiration date: 9/7/22
Dr. Yost reports no actual or potential conflicts of interest associated with this activity.
Complete CPE & CME details can be found here.
What's new?

GameChangers Pharmacotherapy Podcast will release new episodes on Mondays starting 10/18/2021
We are making it easier to claim CE Credit for listening each week! This October - we'll launch a simple, one membership option so you can get one-click CE redemption for GameChangers episodes.
Name changes! You'll notice the podcast show will change to CEimpact - you'll still get new GameChangers episodes released each week on Mondays. Keep listening here and your feed will automatically switch over to CEimpact on 10/18.

View Details

Anti-mask and anti-vaccine fervor are causing an overload of the healthcare system and leading to increased mortality and morbidity. Three publications recently released, including a randomized controlled trial, evaluate community masking on COVID-19 spread.

Guest
Michael Hogue, PharmD, FAPhA, FNAP
Dean, Loma Linda University

Redeem your CPE or CME credit here!

References and resources: Abaluck J, Kwong L, Styczynski A, et al. The Impact of Community Masking on COVID-19: A Cluster-Randomized Trial in Bangladesh. Available at: https://www.poverty-action.org/publication/impact-community-masking-covid-19-cluster-randomized-trial-bangladesh. Bazant M, Bush J. A guideline to limit indoor airborne transmission of COVID-19. Proceedings of the National Academy of Sciences Apr 2021, 118 (17) e2018995118; DOI: 10.1073/pnas.2018995118. Center for Disease Control. Morbidity and mortality weekly report: MMWR. [Atlanta, GA]: US Dept of Health, Education, and Welfare, Public Health Service, Center for Disease Control. Sept 10, 2021.

Continuing Education Information:
Learning Objectives:
1. Describe the Abaluck et al trial, including benefits and applications
2. Describe the evidence base for public health interventions, including difficulties for randomized controlled studies

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-338-H01-P
Initial release date: 09/28/21
Expiration date: 09/28/22
Dr. Hogue reports no actual or potential conflicts of interest associated with this activity.
Complete CPE & CME details can be found here!

View Details

The recent ESCAPED study examines the treatment of Vaso-occlusive Crisis (VOC) in persons with Sickle Cell Disease (SCD). Many patients have difficulty receiving treatment due to a myriad of factors, including structural racism. Listen as Geoff examines if the ESCAPED study can shine a light on how to treat VOC in patients with SCD.

Redeem your CPE or CME credit here!

References and resources:
Lanzkron S, Little J, Wang H, et al. Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study. Ann Intern Med. 2021 Jul 6. doi: 10.7326/M20-7171. Epub ahead of print. PMID: 34224261.

Continuing Education Information:
Learning Objectives:
1. Describe the guideline goals for treatment of Vaso-occlusive Crisis (VOC) to a specific patient
2. Discuss the results of the ESCAPED study in relation to outcomes

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-286-H01-P
Initial release date: 8/24/21
Expiration date: 8/24/22
Complete CPE & CME details can be found here.

View Details

Recent studies have suggested that a short course of antibiotics, compared to longer durations, are just as efficacious for many common infections. The appropriate duration of urinary tract infections for men, by definition complicated, is uncertain due to the risk of developing secondary prostatitis. A new study evaluates 7 vs 14 days of antibiotic treatment of UTIs in men without fever.

Redeem your CPE or CME credit here!

References and resources: Drekonja DM, Trautner B, Amundson C, Kuskowski M, Johnson JR. Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial. JAMA. 2021;326(4):324–331. doi:10.1001/jama.2021.9899

Continuing Education Information:
Learning Objectives:
1. Describe the potential complications of urinary tract infections in men that are different than women
2. Implement the findings of this study into a clinical practice

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-316-H01-P
Initial release date: 9/14/21
Expiration date: 9/14/22
Complete CPE & CME details can be found here!

View Details

The United States Preventative Services Task Force (USPSTF) announced new recommendations for diabetes screening. Approximately 34.5% of the US population has pre-diabetes – frequently attributed to the 75% of US adults with an overweight or obese body mass index. What makes 35 years old the new test screening age for diabetes compared to 40?

Guest:
John A Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad

Redeem your CPE or CME credit here!

References and resources: US Preventive Services Task Force. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;326(8):736–743. doi:10.1001/jama.2021.12531

Continuing Education Information:
Learning Objectives:
1. Identify individuals who should be screened for diabetes
2. Describe the role of racial and ethnic disparities in diabetes

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-323-H01-P
Initial release date: 9/07/21
Expiration date: 9/07/22
John A. Galdo reports that he is on a speaker's bureau for Novo Nordisk.
Complete CPE & CME details can be found here

View Details

Proton Pump Inhibitors (PPIs), like all drugs, cause adverse drug events. Given the sheer number of patients prescribed, or using over-the-counter, PPIs, many practitioners may question continued use. Hear as Geoff examines a recent study from Ann Arbor which looked at the effects of a deprescribing program to step down from PPIs.

Redeem your CPE or CME credit here by getting a GameChangers Subscription!

References and resources:
N/A

Continuing Education Information:
Learning Objectives:
1. Discuss a recent study evaluating the risks of proton pump inhibitors
2. Identify potential patients that could benefit from proton pump inhibitor discontinuation

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-232-H01-P
Initial release date: 8/10/21
Expiration date: 8/10/22
Complete CPE & CME details can be found here.

View Details

The Delta variant has made it clear the COVID pandemic is far from over. Recent studies have suggested that immunocompromised patients may have a reduced or no antibody response to the currently available COVID-19 vaccines. On August 13th, the CDC and FDA recommended that patients receive an additional vaccination. Hear Dr. Geoff Wall and guest, Dr. Nicole Alvey, on how immunocompromised patients need an additional dose, and how to prioritize their care. Drs. Wall and Alvey also share preliminary thoughts on booster vaccines based on the U.S. Surgeon General’s announcement on 8.18.21 recommending booster shots available at 8 months; however, the Biden administration announced on 8.25.21 that booster shots should be available after 6 months of the last dose, pending ACIP review.

Guest:
Nicole Alvey, PharmD, BCPS, FAST
Associate Professor, Roosevelt University

Earn CME or CPE credit with a GameChangers Subscription!

Want more? Head over to The Pharmacy Network to watch our Expert in Residence discuss all things COVID-19 boosters + additional shots titled All About Boosters.

References and resources:

Continuing Education Information:
Learning Objectives:
1. Describe risk factors for having a poor antibody response to currently available COVID-19 vaccines
2. Implement new recommendations for an additional vaccination of COVID-19 in eligible patients

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-XXX-H06-P
Initial release date: 8/24/21
Expiration date: 9/7/22
Dr. Alvey reports no actual or potential conflicts of interest associated with this activity.
Complete CPE & CME details can be found here.

View Details

A landmark paper published in 2002 set the standard for Targeted Temperature Management (TTM) by having hospitals use TTM protocols to "cool" patients for a period of time after cardiac arrest to improve neurologic outcomes. On June 17th, 2021, the TTM-2 study was published and changed this standard. What is the future of the TTM modality in cardiac arrest patients?

Redeem your CPE or CME credit here!

References and resources:
Dankiewicz J, Cronberg T, Lilja G, et al. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. N Engl J Med. 2021 Jun 17;384(24):2283-2294. doi: 10.1056/NEJMoa2100591. PMID: 34133859.

Continuing Education Information:
Learning Objectives:
1. Describe the TTM-2 study
2. Discuss the theoretical benefits of maintaining a normal or low body temperature immediately following cardiac arrest.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-263-H01-P
Initial release date: 8/17/21
Expiration date: 8/17/22
Complete CPE & CME details can be found here.

View Details

Do psychedelics treat mental illness? In this GameChanger episode host, Geoff Wall and guest, Sarah Grady, a psychiatric pharmacist, discuss a recent NEJM article comparing psilocybin (magic mushrooms) to escitalopram.

Guest:
Sarah Grady, PharmD
Drake University

Redeem your CPE or CME credit here with your GameChangers Subscription!

We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964

References and resources:
Carhart-Harris R, Giribaldi B, Watts R, et al. Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021 Apr 15;384(15):1402-1411. doi: 10.1056/NEJMoa2032994. PMID: 33852780.

Continuing Education Information:
Learning Objectives:
1. Discuss a recent study comparing psilocybin to escitalopram in depression
2. Identify potential patients that could benefit from psilocybin based on the study

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-231-H01-P
Initial release date: 8/3/21
Expiration date: 8/3/22
Dr. Sarah Grady reports no actual or potential conflicts of interest associated with this activity.
Complete CPE & CME details can be found here.

View Details

The delta variant of COVID-19 has put the US in the precarious position of a fourth wave of the disease -- how efficacious are our vaccines against this variant? Also, are any new treatments for early COVID-19 being studied to help continue the fight? Find out more in this episode!

Redeem your CPE or CME credit here!

We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964

References and resources:
Thompson MG, Burgess JL, Naleway AL, et al. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. N Engl J Med. 2021 Jul 22;385(4):320-329. doi: 10.1056/NEJMoa2107058. Epub 2021 Jun 30. PMID: 34192428; PMCID: PMC8262622.

Rossignol J, Matthew C, Oaks J, et al. Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization. medRxiv 2021.04.19.21255441; doi: https://doi.org/10.1101/2021.04.19.21255441

Continuing Education Information:
Learning Objectives:
1. Discuss the differences in effectiveness between the mRNA and adenovirus vaccines for the delta variant of COVID-19
2. Describe the use of nitazoxanide in mild to moderate COVID-19 and barriers to its use

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-XXX-H01-P
Initial release date: 8/31/21
Expiration date: 8/24/22
Complete CPE & CME details can be found here.

View Details

The first new treatment for Alzheimer's, aducanumab, was approved by the Food and Drug Administration on June 7, 2021. This approval did not come without controversy. Learn what the available data show for efficacy and safety and whether or not the current list price of $56,000 per year meets cost-effectiveness thresholds.

Guest
John A Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad

Redeem your CPE or CME credit here!

We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964

References and resources:
Aducanumab for Alzheimer's Disease: Effectiveness and Value. Institute for Clinical and Economic Review. June 30, 2021. https://icer.org/wp-content/uploads/2020/10/ICER_ALZ_Revised_Evidence_Report_06302021.pdf

Continuing Education Information:
Learning Objectives:
1. Discuss the outcomes for phase III trials of aducanumab
2. Define the cost-effectiveness of aducanumab

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-265-H01-P
Initial release date: 7/27/21
Expiration date: 7/27/22
John A. Galdo reports that he is on a speaker's bureau for Novo Nordisk.
Complete CPE & CME details can be found here.

View Details

A new study evaluates the cost-effectiveness of dapagliflozin in heart failure. Geoff and Jake continue the conversation from "Home Sweet Home (It's Where the Heart Is)" [Previous Episode] about the role of SGLT-2is in heart failure. This time the conversation is focused on the cost-effectiveness and QALYs. Is the price right for improved care?

Redeem your CPE or CME credit here!

We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964

References and resources:
Parizo JT, Goldhaber-Fiebert JD, Salomon JA, et al. Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction. JAMA Cardiol. Published online May 26, 2021. doi:10.1001/jamacardio.2021.1437

Continuing Education Information:
Learning Objectives:
1. Define QALY
2. Discuss the cost-effectiveness of dapagliflozin in heart failure

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-264-H01-P
Initial release date: 7/20/21
Expiration date: 7/20/2022
Complete CPE & CME details can be found here.

View Details

New asthma guidelines came out in 2020, yet the answer to triple or dual inhaler therapy wasn't explicitly answered. In this episode host, Geoff Wall and guest, Jake Galdo discuss the role of triple inhaler (ICS-LABA-LAMA) in the management of severe persistent and uncontrolled asthma.

Redeem your CPE or CME credit with a GameChangers Subscription here!

We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964

References and resources:
Kim LHY, Saleh C, Whalen-Browne A, et al. Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma: A Systematic Review and Meta-analysis. JAMA. 2021 May 19:e217872. doi: 10.1001/jama.2021.7872. Epub ahead of print. PMID: 34009257; PMCID: PMC8135065.

Continuing Education Information:
Learning Objectives:
1. Discuss a recent study comparing triple to dual inhaler therapy in asthma
2. Describe the adverse drug events associated with triple inhaler therapy in asthma
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-230-H01-P
Initial release date: 7/13/21
Expiration date: 7/13/22
Complete CPE & CME details can be found here.

View Details

The recently published ADAPTABLE study seeks to answer, definitively, a long held question: What is the correct dose of aspirin to improve outcomes in secondary prevention of cardiovascular disease? Also, more information about PCORnet, which is referenced in the article and during the episode, may be found here: https://pcornet.org/

Redeem your CPE or CME credit here!

We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964

References and resources:
Jones WS, Mulder H, Wruck LM, et al. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 May 15. doi: 10.1056/NEJMoa2102137. Epub ahead of print. PMID: 33999548.

Continuing Education Information:
Learning Objectives:
1. Describe the outcomes and design of the ADAPTABLE study
2. Discuss some of the limitations of this trial in its application to specific patients

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-229-H01-P
0.50 AMA PRA Category 1 Credits™
Initial release date: 7/6/21
Expiration date: 7/6/22
Complete CPE & CME details can be found here.

View Details

Vaccines are the mainstay of care in the COVID-19 pandemic. However, patients may still become infected and need treatment options. Two studies have evaluated the role of inhaled budesonide for the early treatment of outpatient COVID-19 infections. Can budesonide hasten the resolution of symptoms or prevent hospitalizations?

Redeem your CPE or CME credit here!

References and resources:
Ramakrishnan S, Nicolau DV, Langford B, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. The Lancet Respiratory Medicine. April 2021. doi:10.1016/s2213-2600(21)00160-0

Yu L-M, Bafadhel M, Dorward J, et al. Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial. medRxiv. Published online January 1, 2021:2021.04.10.21254672. doi:10.1101/2021.04.10.21254672

Continuing Education Information:
Learning Objective: Identify the appropriate patient population for inhaled budesonide in the treatment of COVID-19
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-228-H01-P
0.50 AMA PRA Category 1 CreditsTM.(the TM needs to be super scripted)
Initial release date: 6/29/21
Expiration date: 6/29/22
Complete CPE & CME details can be found here.

View Details

Diuretics, thiazide, and loop are critical medications for a number of disease states. Yet, they are often used inappropriately, either on the wrong dose or schedule or prescribed in patients who may not benefit from diuretics. This episode takes a look at diuretic pearls and how to get the most out of these medications.

Resources:
Ali S, Jung S, Nandkeolyar S, Stoletniy L, Sakr A, Verbrugge FH, Hilliard A, Abramov D. Inpatient Diuretic Management of Acute Heart Failure: A Practical Review. Am J Cardiovasc Drugs. 2021 Mar 12. doi: 10.1007/s40256-020-00463-5.

Sinha AD, Agarwal R. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD. Clin J Am Soc Nephrol. 2019 May 7;14(5):757-764. doi: 10.2215/CJN.04330418.

Continuing Education Information:
Learning Objective: Identify an appropriate dose and schedule for loop diuretics.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-211-H01-P
0.50 AMA PRA Category 1 Credits™.
Initial release date: 6/8/21
Expiration date: 6/8/22
Complete CPE & CME details can be found at: https://network.ceimpact.com/plans/142054?bundle_token=2c8f01a0dd5d1a330a87ed726ba0af93

View Details

Longer antibiotics are associated with increased costs and adverse effects and increase the potential for bacterial resistance. A recent paper in the Lancet describes a study conducted in France comparing the outcomes of patients with community-acquired pneumonia (CAP) who are hospitalized but not critically ill with a short course of antibiotics (3 days) compared to standard treatment (8 days). The study found that the short course was non-inferior to the longer course of antibiotics and may have implications for treating the common infection.

References and resources:
Dinh A, Ropers J, Duran C, et al. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203. doi: 10.1016/S0140-6736(21)00313-5. PMID: 33773631.

Continuing Education Information:
Learning Objective: Discuss the difference between 3-day and 8-day antibiotic use in patients with community-acquired pneumonia.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-210-H01-P
0.50 AMA PRA Category 1 CreditsTM
Initial release date: 6/1/21
Expiration date: 6/1/22
Complete CPE & CME details can be found at here

View Details

Replay of our Live Event Podcast on the Pharmacy Network. Host of GameChangers, Geoff Wall, PharmD, FCCP, BCPS, CGP and Jake Galdo, PharmD talked about season 1 recap, and season 2 new happenings! Season 2 officially launches early June! If you want to watch the live replay, check it out here.

View Details

It's the GameChangers' Birthday! This episode is a rapid review of a few subjects to celebrate the first year of GameChangers. From oral iron administration to the use of metronidazole with alcohol or serotonin syndrome, this episode has all the ingredients for a celebration!GameChangers' host, Geoff Wall, just released new music! Check out his latest EP here: https://open.spotify.com/artist/0J26ngHZz2cf6mQR3UiEHW?827= or wherever you listen to music!Reference: Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017 Nov;4(11):e524-e533. doi: 10.1016/S2352-3026(17)30182-5. Epub 2017 Oct 9. PMID: 29032957.Kaundal R, Bhatia P, Jain A, et al. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol. 2020 Jan;99(1):57-63. doi: 10.1007/s00277-019-03871-z. Epub 2019 Dec 6. PMID: 31811360.Visapää JP, Tillonen JS, Kaihovaara PS, et al. Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother. 2002 Jun;36(6):971-4. doi: 10.1345/aph.1A066. PMID: 12022894.Orlova Y, Rizzoli P, Loder E. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol. 2018 May 1;75(5):566-572. doi: 10.1001/jamaneurol.2017.5144. PMID: 29482205; PMCID: PMC5885255.CPE details for GameChangers Podcast April 2021Learning Objective: Discuss the evidence-based dosing of oral iron supplementation.0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

Alzheimer's Disease and Related Dementias are a terrible disease on individuals, caregivers, and communities. There are no cures. However, new data has come out discussing the risk factors, polypharmacy, and a potential early detection opportunity. It's time to de-prescribe and follow the money.Reference: Nicholas LH, Langa KM, Bynum JPW, Hsu JW. Financial Presentation of Alzheimer Disease and Related Dementias. JAMA Intern Med. 2021;181(2):220–227. doi:10.1001/jamainternmed.2020.6432Maust DT, Strominger J, Kim HM, et al. Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021;325(10):952–961. doi:10.1001/jama.2021.1195CPE details for GameChangers Podcast April 2021Learning Objective: Discuss if adverse financial outcomes may be a risk factor for future dementia diagnosis.0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast Disclosure: Dr. Galdo is a member of the Board of Directors for the Alabama Chapter of the Alzheimer's Association.See omnystudio.com/listener for privacy information.

View Details

More and more vaccines are getting authorization in the United States to prevent COVID-19. However, sometimes a vaccine trial is not always effective. But even failure can provide new insights. Learn about the Janssen COVID-19 vaccine and what happened with the recent Hepatitis C vaccine candidate.This podcast was recorded prior to the joint CDC and FDA statement on the Johnson & Johnson/Janssen COVID-19 vaccine on April 13th. On April 13th, 2021, the CDC and FDA issued a joint statement recommending a pause on the use of the Johnson & Johnson/Janssen COVID-19 vaccine until further notice. Click here for the full statement.Reference: Page K, Melia M, Veenhuis R, et al. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. N Engl J Med 2021; 384:541-549. DOI: 10.1056/NEJMoa2023345Fact Sheet for Healthcare Providers Administering Vaccine Emergency Use Authorization of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019. https://www.fda.gov/media/146304/download CPE details for GameChangers Podcast April 2021Learning Objective: Describe the outcomes of a recently published trial on hepatitis C vaccine candidates.0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

The battle against the COVID-19 pandemic has continued for over a year. The evidence continues to update and change, and more and more people are becoming vaccinated. This episode provides a review of the newest literature including guidance on vaccinated individuals. But, remember, don't stop wearing a mask now!Reference: Interim Public Health Recommendations for Fully Vaccinated People. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html.CPE details for GameChangers Podcast April 2021Learning Objective: Describe evidence-based recommendations to mitigate SARS-CoV-2 infections0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

Recently the American Gastroenterological Society updated their guidelines for treatment for a true medical emergency: gastric and esophageal bleeding. This episode reviews the guidelines and highlights the importance of several changes to management. Today's episode is sponsored by a special CEimpact FREE Law focused webinar:Make sure to save your spot for FREE LIVE LAW CE April 1st. 7PM. https://ceimpact.com/law Reference: Henry Z, Patel K, Patton H, et al. AGA Clinical Practice Update on Management of Bleeding Gastric Varices: Expert Review. Clinical Gastroenterology and Hepatology. 2021. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S154235652100077X?returnurl=null&referrer=null CPE details for GameChangers Podcast March 2021Learning Objective: Identify appropriate therapy for individuals with variceal bleeds based on the new guidelines0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

Aspirgillosis is a deadly fungal infection that is a major cause of mortality in patients with impaired immune systems. The current standard of care has been voriconazole due to the favorable side effect profile compared to amphotericin. However, posaconazole may not have there adverse effects and be a reasonable course of therapy. Is voriconazole just just a phase?Today's episode is sponsored by a special CEimpact FREE Law focused webinar: Save your spot - FREE LIVE LAW CEwebinar on April 1st. SPOTS ARE LIMITED!https://ceimpact.com/law Reference: Maertens JA, Rahav G, Lee DG, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140- 6736(21)00219-1. PMID: 33549194.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 63, Issue 4, 15 August 2016, Pages e1–e60, hMps://doi.org/10.1093/cid/ciw326CPE details for GameChangers Podcast March 2021Learning Objective: Develop appropriate treatment of aspergillosis infections based on clinical studies.0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcastSee omnystudio.com/listener for privacy information.

View Details

The recently published STEP trial showed a dramatic effect on weight loss with the weekly injectable semaglutide versus placebo. Lay media picked up the headlines from this potential "GameChanger" medication for weight loss. With this one shot will patient lose themselves?Reference: Wilding J, Batterham R, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. February 10, 2021. DOI: 10.1056/NEJMoa2032183CPE details for GameChangers Podcast March 2021Learning Objective: Discuss the design of the STEP trial0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

The endocannabinoid system is influenced by compounds found the Cannabis genus of plants and involves two compounds: cannabidiol (CBD) and tetrahydrocannabinol (THC). Federal and state regulation is changing, so the medicinal and recreatoinal use of cannabis-related prodcuts continues to increase. Although not life-threatening, some patients may experience Cannabis Hyperemesis Syndrome. Fortunately, a narrative review outlines the causes and treatment to help get out the weeds of treatment.Reference: Perisetti A, Gajendran M, Dasari C, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Annals of Gastroenterology (2020) 33, 1-8. http://www.annalsgastro.gr/files/journals/1/earlyview/2020/ev-09-2020-01-AG_5230-0528.pdf CPE details for GameChangers Podcast March 2021Learning Objective: Describe the potential mechanisms and treatment options for Cannabis Hyperemesis Syndrome.0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

The recently published (in a pre-print server) COLCORONA study, sponsored by the Montreal Heart institute and conducted in 6 countries aimed to show if using colchicine would decrease risk of hospitalization and death in outpatients with COVID-19. Will it work? How's the study design? Learn the facts.Reference: Tardif J, Bouabdallaoui N, L'Allier P, et al. Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19. Pre-Print. https://www.medrxiv.org/content/10.1101/2021.01.26.21250494v1CPE details for GameChangers Podcast March 2021Learning Objective: Apply the results of the CORCORONA study to patients with COVID-19 disease.0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

The United States Preventative Services Task Force (USPSTF) recommendations for tobacco cessation have been recently updated. While no major changes to pharmacotherapy recommendations are in the new guidelines, the paper does emphasize that all health care providers can work with patients to help them achieve tobacco freedom. Learn how to support patients in your community.Reference: USPSTF Recommendation: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions CPE details for GameChangers Podcast February 2021Learning Objective: Discuss the rates of tobacco cessation and adverse effects of current Food and Drug Administration approved therapy for tobacco cessation.0107-0000-21-083-H01-P0.2 CEU/2.0 Hrs (Knowledge)Initial Release Date: 02/23/21Expiration Date: 02/23/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

The National Asthma Education and Prevention Program released the 2020 Asthma Guideline Update in December 2020. This guideline, published in JAMA, is different from the internal Global Initative for Asthma (GINA) guidelines and represents the first update since 2007. Learn about what makes these guidelines unique and how healthcare providers can maintain breaths.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!Reference: Commentary: Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF, Pace W, Schatz M. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program. JAMA. 2020;324(22):2301–2317. doi:10.1001/jama.2020.21974 Guidelines: 2020 Focused Updates to the Asthma Management Guidelines. https://www.nhlbi.nih.gov/health-topics/all-publications-and-resources/2020-focused-updates-asthma-management-guidelines CPE details for GameChangers Podcast February 2021Learning Objective: Describe recommended therapy based on the staging on asthma in individuals 12 years or olderGuest Faculty: Kelli Cunningham, PharmD, BCPSDr. Cunningham reports no actual or potential conflicts of interest in relation to this episode of GameChangers.0107-0000-21-083-H01-P0.2 CEU/2.0 Hrs (Knowledge)Initial Release Date: 02/23/21Expiration Date: 02/23/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

Irritable bowel syndrome is a common disorder that exacts a significant toll on quality of life. For the first time, the American College of Gastroenterology has published guidelines on the diagnosis and treatment for this disorder.This episode is accredited for CPE. Subscribe at CEimpact( https://www.ceimpact.com/pharmacist ) and claim your CE today!Reference: Lacy, Brian E. PhD, MD, FACG1; Pimentel, Mark MD, FACG2; Brenner, Darren M. MD, FACG3; Chey, William D. MD, FACG4; Keefer, Laurie A. PhD5; Long, Millie D. MDMPH, FACG (GRADE Methodologist)6; Moshiree, Baha MD, MSc, FACG7 ACG Clinical Guideline: Management of Irritable Bowel Syndrome, The American Journal of Gastroenterology: January 2021 - Volume 116 - Issue 1 - p 17-44 doi: 10.14309/ajg.0000000000001036.Accessed at https://journals.lww.com/ajg/Fulltext/2021/01000/ACG_Clinical_Guideline__Management_of_Irritable.11.aspx Bristol stool scale (recommend tertiary references): Lewis, SJ; Heaton, KW (September 1997). "Stool form scale as a useful guide to intestinal transit time". Scand. J. Gastroenterol. 32 (9): 920–4. doi:10.3109/00365529709011203. PMID 9299672.CPE details for GameChangers Podcast February 2021Learning Objective: Discuss appropriate treatments for irritable bowel syndrome0107-0000-21-083-H01-P0.2 CEU/2.0 Hrs (Knowledge)Initial Release Date: 02/23/21Expiration Date: 02/23/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

Lyme disease is a complex infection and post infection syndrome can lead to serious outcomes, including death. A new guideline was developed for the diagnosis and treatment of this infection. Spoon!This episode is accredited for CPE. Subscribe at CEimpact( https://www.ceimpact.com/pharmacist ) and claim your CE today!Reference: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clinical Infectious Diseases, November 30, 2020. https://doi.org/10.1093/cid/ciaa1215. Accessed athttps://www.idsociety.org/practice-guideline/lyme-disease/ CPE details for GameChangers Podcast February 2021Learning Objective: Discuss treatment for different forms of lyme disease infections depending on the severity of symptoms0107-0000-21-XXX-H01-P0.2 CEU/2.0 Hrs (Knowledge)Initial Release Date: 02/23/21Expiration Date: 02/23/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information.

View Details

In December 2020, the American College of Cardiology published an Expert Consensus Decision Pathway for Antithrombotic Therapy in Patients undergoing Percutaneous Coronary Intervention. This guideline addresses a timely problem of patients on anticoagulation and antiplatelet therapy.This episode is accredited for CPE. Subscribe at CEimpact ( https://www.ceimpact.com/pharmacist ) and claim your CE today!Reference: 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. Dec 18, 2020. Epublished DOI: 10.1016/j.jacc.2020.09.011. Accessed at https://www.jacc.org/doi/10.1016/j.jacc.2020.09.011CPE details for GameChangers Podcast January 2021Learning Objective: Recommend an appropriate antithrombotic/anticoagulant regimen in a patient who has received percutaneous coronary intervention with stenting0107-0000-21-079-H01-P0.2 CEU/2.0 Hrs (Knowledge)Initial Release Date: 01/25/21Expiration Date: 01/26/24Additional CPE information is located at https://www.ceimpact.com/podcastSee omnystudio.com/listener for privacy information.

View Details

The unbelievable happened in 2020 - a vaccine was developed with high efficacy within 12 months for a novel virus! In December two vaccines for the prevention of the SARS-CoV-2 virus were approved through Emergency Use Authorization in the US. Is it time to get a shot?This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!Reference: Polack F, Thomas S, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. NEJM. Dec 10, 2020. DOI: 10.1056/NEJM2034577Baden L, El Sahly H, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. NEJM. Dec 30, 2020. DOI: 10.1056/NEHMoa2035389ACIP Recommendations: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html See omnystudio.com/listener for privacy information.

View Details

Every December, the American Diabetes Association updates the Standards of Medical Care in Diabetes. The guidelines cover sixteen sections from diabetes advocacy to technology updates. Start 2021 off right - learn what changed and what matters most for individuals with diabetes.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!Reference: American Diabetes Association. Standards of Medical Care in Diabetes - 2021. Diabetes Cares. January 01, 2021; volume 44, issue supplement 1. https://care.diabetesjournals.org/content/44/Supplement_1 Disclosure: Dr. Jake Galdo is a speaker for Novo Nordisk in 2021.See omnystudio.com/listener for privacy information.

View Details

Myopathy is a common reason for discontinuation of statin medications. The recent SAMSON study examined the nocebo effect and how this may bias patients towards treatment failure. How can clinicians overcome the nocebo effect?This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!Reference: Wood F, Howard J, Finegold J, et al. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects. N Engl J Med 2020; 383:2182-2184. DOI: 10.1056/NEJMc2031173See omnystudio.com/listener for privacy information.

View Details

The efficacy of antiretroviral therapy has led to persons with HIV living a near-normal lifespan. But medications only work when used appropriately. The International Antiviral Society-USA Panel published updated recommendations for the treatment and prevention of HIV infections. Treatment of HIV may be distilled into a simple idea - two "nucs" and something else. Learn how to optimize care for your patients.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!Reference: Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel. JAMA. 2020;324(16):1651-1669. Available at: https://www.iasusa.org/2020/11/12/antiretroviral-drugs-treatment-prevention-hiv-infection-adults-2020-recommendations-of-the-international-antiviral-society-usa-panel/ The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information.

View Details

Clostridioides difficile is an important cause of morbidity and mortality in the United States with over 500,000 infections annually. The Infectious Disease Society of America released a clinical quality measure focused on treatment of c diff in March 2020. A review of the diagnosis and treatment will help providers improve quality.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information.

View Details

The question of acetaminophen versus ibuprofen may finally be laid to rest. A recent meta-analysis compared the efficacy and safety of ibuprofen versus acetaminophen for the treatment of fever or pain in children younger than 2 years. Is there a drug of choice?Reference: Tan E, Braithwaite I, McKinlay CJD, Dalziel SR. Comparison of Acetaminophen (Paracetamol) With Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(10):e2022398. doi:10.1001/jamanetworkopen.2020.22398This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information.

View Details

In the never ending battle with COVID-19, new studies have demonstrated a role for IVIG in the treatment of acute COVID-19 pneumonia, the potential benefit of honey and black seed in mild to moderate COVID-19, and the efficacy of an mRNA vaccine. What does this all mean for current practice?Additional References:IVIG: Gharebaghi, N., Nejadrahim, R., Mousavi, S.J. et al. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial. BMC Infect Dis 20, 786 (2020). https://doi.org/10.1186/s12879-020-05507-4 Honey: Ashraf S, Ashraf S, Imran M, et al. Efficacy of honey and Nigella sativa against COVID-19: HNS-COVID-PK Trial. medRxiv 2020.10.30.20217364; doi: https://doi.org/10.1101/2020.10.30.20217364 Cleveland Clinic Hospitalization Risk for COVID-19 Positive Calculator: https://riskcalc.org/COVID19Hospitalization/ Cleveland Clinic Predict COVID-19 test result Calculator: https://riskcalc.org/COVID19/ This episode is accredited for CPE. Subscribe at CEimpact https://www.ceimpact.com/pharmacist and claim your CE today!The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information.

View Details

Atopic Dermatitis is not extensively taught in pharmacy curriculum. With several international medical societies publishing updated guidelines and newly approved medications, it's time for a review. Clinicians can learn ways to help treat patients under the skin.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information.

View Details

The opioid epidemic is helping reduce prescriptions for opioid-based pharmacotherapy. However, parallel to this drop has been an increase in gabapentin and pregabalin prescriptions. Why has this occurred and what should the clinician know about this phenomenon?Additional Resources/References: Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016. Zhou L, Bhattacharjee S, Kwoh CK, Tighe PJ, Malone DC, Slack M, Wilson DL, Brown JD, Lo-Ciganic WH. J Clin Med. 2019 Dec 29;9(1):83. doi:10.3390/jcm9010083.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

Sodium Glucose Co-Transporter-2 Inhibitors, a medication class for the treatment of diabetes, is now showing benefits in other medical conditions, like heart failure and kidney disease. Is this a class effect?Additional Resources/References: McGuire DK, Shih WJ, Cosentino F, et al. Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis . JAMA Cardiol. Published online October 07, 2020. doi:10.1001/jamacardio.2020.4511This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! See omnystudio.com/listener for privacy information.

View Details

Vancomycin, despite being around for decades, keeps having updates to dosing, formulations, and monitoring. It's important to stay updated on this vital medication for hospital and infusion center practitioners. Are you ready for the changes?Additional Resources/References: https://www.idsociety.org/practice-guideline/vancomycin/This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information.

View Details

A recently published Serial cross-sectional analysis of National Health and Nutrition Examination Survey data has been published suggesting that overall blood pressure control in adults with hypertension over the last 4 years has declined.Why is this? What tips can the pharmacist and prescriber use to improve control? Can these professionals work together to improve BP control? Can we survive under pressure?Additional Resources/References: Muntner P, Hardy ST, Fine LJ, et al. Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018. JAMA. 2020;324(12):1190–1200. doi:10.1001/jama.2020.14545This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

The LoDoCo2 Trial suggested that colchicine may improve outcomes in patients with cardiovascular disease. Can a 3,000 year old drug still be a miracle?Additional Resources/References: Nidorf SM, Fiolet ATL, Mosterd A, et al; LoDoCo2 Trial Investigators. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020 Aug 31. doi: 10.1056/NEJMoa2021372. Epub ahead of print. PMID: 32865380.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

The fear of a "Twindemic," an influenza and COVID-19, double pandemic is starting to rise. But what does the data say about this fear? Is the US in double trouble with BOGO viral infections?This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

Updated osteoporosis guidelines have arrived from the American Association of Clinical Endocrinology. The AACE guidelines include different recommendations from the 2017 National Osteoporosis Foundation guidelines, primarily due to new anabolic agents. Learn about a newly created a new patient risk stratified category, the role of bisphosphonates, and how to approach patient care.Additional Resources/References:FRAX calculator: US version https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9; AACE osteoporosis guidelineshttps://www.aace.com/disease-stateresources/reproductive-and-gonad/clinical-practiceguidelines-recent-news-and-updatesThis episode is accredited for CPE. Subscribe at CEimpact(https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

Medications are only 10 percent of total US healthcare expenditure, yet remain a focus of healthcare costs. In this Gamechangers episode, Geoff Wall and guest, Jake Galdo, will discuss two articles evaluating generic utilization on Medicare costs. By giving up brands, can we lower costs?Additional Resource/Reference: https://jamanetwork.com/journals/jamacardiology/article-abstract/2770174 and https://jamanetwork.com/journals/jama/fullarticle/2697695This episode is accredited for CPE. Subscribe at CEimpact https://www.ceimpact.com/pharmacist and claim your CE today! See omnystudio.com/listener for privacy information.

View Details

Antibiotics are a risk factor for Clostridium difficile infections. Combining a review of the 2017 Infectious Diseases Society of America and recent literature for prophylactic therapies, learn how to care for patients between a rock and a hard place.Additional Resource/Reference: https://learn.ceimpact.com/library/group/12/course/2313 This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

The TAILOR-PCI Trial evaluates the outcomes between genotype-guided P2Y12 inhibitor selection versus conventional prescribing on ischemic outcomes. Listen to Geoff Wall and guest, Jake Galdo, discuss the role of pharmacogenomics in patient care.Additional Resource/Reference:https://jamanetwork.com/journals/jama/article-abstract/2769725 This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

New guidelines from American College of Physicians suggest that first-line treatment of non-low back musculoskeletal injuries are topical therapies. Topical non-steroidal anti-inflammatory drugs, like diclofenac, are available as over-the-counter products in the US. Learn about the preferred route of care when treating pain.Additional Resource/Reference: https://www.acpjournals.org/doi/10.7326/M19-3602 This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

Community Pharmacies are vital members of neighborhoods and the healthcare community. A major social determinant of health is access to healthcare - both providers and medications. Recently, Berenbrok and colleagues published research that showed community pharmacies are visited almost twice as much compared to primary care providers by Medicare beneficiaries annually. Guest Jake Galdo will be joining our host Geoff Wall to discuss how community pharmacists provide care.Additional Resource/Reference: https://jamanetwork.com/journals/jamanetworkopen/fullarUcle/2768247 This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

The COVID-19 pandemic continues to rage on worldwide. Data surrounding the treatment of patients with COVID-19 respiratory failure is moving at lightning pace, so for this week's episode we will discuss the latest (as of 8/13/20) information surrounding two modalities for COVID-19 treatment: convalescent plasma and tocilizumab. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information.

View Details

A recent retrospective database study found that in patients on new oral anticoagulants prescribed clarithromycin, compared to azithromycin, were assocated with an increased risk of major beeding. We will discuss this paper and other common drug interactions the practicing pharmacists should be vigilant about.This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/3gvDKKA See omnystudio.com/listener for privacy information.

View Details

A recent study suggests that SGLT2 drugs - now shown to dramatically improve cardiovascular and renal outcomes in a wide variety of patients - have a higher incidence of euglycemic DKA than previously thought. If pharmacists see more of this ADR, how do we treat appropriately - especially when a patient's sugars may not be very high?This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/3gy7F4O See omnystudio.com/listener for privacy information.

View Details

Most prescribers believe that short course of steroids have no serious adverse effects, but a recent study from the Annals of Internal Medicine challenges that notion. What does the pharmacist need to know about the short and long term adverse effects of steroids and how to proactively prevent them?Additional Resources/ReferencesAssociation between Oral Corticosteroid Bursts and Severe Adverse Events: https://www.acpjournals.org/doi/pdf/10.7326/M20-0432 This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/2XxYr0T See omnystudio.com/listener for privacy information.

View Details

Ethanol use disorder continues to be a major problem in the U.S. The stress and anxiety related to the COVID-19 pandemic may exacerbate alcohol use disorder. Tune in to this episode to learn the latest in guideline updates relative to the management of ethanol withdrawal.Additional Resources/ReferencesAlcohol Withdrawal Management Guideline: https://www.asam.org/Quality-Science/quality/guideline-on-alcohol-withdrawal-managementThis episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/2OB3RDi See omnystudio.com/listener for privacy information.

View Details

Geoff Wall, PharmD delivers another great podcast. Pharmacists see skeletal muscle relaxant prescriptions daily but how much real experience do we have with these drugs? Do they work? Are they safe? This episode covers what should every pharmacist know about these medications.This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/2CEy161 See omnystudio.com/listener for privacy information.

View Details

Overinflamation or cytokine storm is said to be the driver of acute respiratory disorder disease (ARDS) in COVID patients. A recent study conducted in the United Kingdom suggests that the steroid dexamethasone may be a weapon for prevention. In this episode, we discuss the study that caused the National Health Service in the U.K. and the CDC to change their recommendations for steroids and severe COVID.Additional Resources/ReferencesRamdomised Evaluation of COVID-19 Therapy: https://www.recoverytrial.net/ This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/3h8OfTR See omnystudio.com/listener for privacy information.

View Details

The COVID-19 pandemic has disproportionally affected Latinx Americans. Learn how pharmacists can optimize patient care for Latinx patients by discussing how to overcome economic and language barriers. In this episode, we'll talk with Dr. Sally Haack who cares for Latinx patients on a daily basis in her pharmacy practice.Special guest: Sally Haack, PharmD, BCPS Associate Professor Drake UniversityThis episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2YogiIp See omnystudio.com/listener for privacy information.

View Details

Many patients over age 65 take daily medications that have anticholinergic properties. We know the addition of these drugs can affect quality of life and cognition. In this episode, we talk with Dr. Kristin Meyer, an expert in geriatrics to explore the latest data and discuss what Pharmacists can do to promote the appropriate use of anticholinergics.Additional Resources/ReferencesBeers Criteria:By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674-694. doi:10.1111/jgs.15767Anticholinergic Risk Scale:Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons. Arch Intern Med. 2008;168(5):508–513. doi:10.1001/archinternmed.2007.106Recent arge study associating anticholinergics with dementia:Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019;179(8):1084–1093. doi:10.1001/jamainternmed.2019.0677This episode is accredited for CPE. See omnystudio.com/listener for privacy information.

View Details

The American College of Rheumatology recently published new guidelines for the treatment of Gout. While gout is well understood and the medications to treat gout are both effective and affordable, implementation of the new ARC guidelines will, ideally, lead to improved quality of care for patients with gout. In this episode, Dr. Wall discusses guideline changes and important pearls so pharmacists may optimize medication therapy for patients suffering from gout.This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2YchMVZ See omnystudio.com/listener for privacy information.

View Details

Racism is a public health emergency and a root cause of social determinants of health. If we are to practice patient-centered care, and education our pharmacists to better serve their patients, we ought to act to dismantle structural racism and start by having some honest conversations. In this episode, we'll talk with Dr. Vibhuti Arya about our role as pharmacists in addressing this public health emergency.Special Guest: Vibhuti Arya, PharmDAssociate Clinical Professor, St. John's UniversityClinical Advisor, New York City Department of Health and Mental HygieneView Dr. Arya's Tedx Talk here: https://www.youtube.com/watch?v=vnYE0n7Tx_o This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2BgRwRs Racism, SDOH, social determinants of health, anti-racist See omnystudio.com/listener for privacy information.

View Details

Recently news suggests low vitamin D levels have been associated with increased risk of COVID-related morbidity and mortality. We know that vitamin D is a safe fat soluable vitamin that is difficult to "overdose" on. What should the pharmacist know in terms of repletion dose and signs of toxicity? Since many patients do not get enough vitamin D in their diets, large medical societies and organizations recommend daily vitamin D for this reason. This episode will focus not on the claims of efficacy of Vitamin D in COVID, but will instead discuss how your patients can replete vitamin D levels and the risks of toxicity in overrepletion.This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2N87PCD See omnystudio.com/listener for privacy information.

View Details

Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in COVID based on a heretofore unpublished study. The study, conducted by NIAID, is the subject of this episode.This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/3hn191p See omnystudio.com/listener for privacy information.

View Details

Buprenorphine has been shown in numerous studies to be safe and effective in opioid use disorder, yet

View Details

Geoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. Recently SGLTs, which are currently indicated for Type 2 diabetes, have been investigated and received FDA approval for Heart failure with reduced ejection fraction (HFrEF). Listen in to this episode to discover more about how these drugs work in this (HFrEF) disease state.This episode is accredited for CPE. This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2ApMvWw See omnystudio.com/listener for privacy information.

View Details

GameChangers: In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection. In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection. Emerging evidence suggests that patients with COVID infection may be hypercoagulable and prone to clotting. Listen in as we discuss the evidence surrounding this issue and how to address therapeutic issues in anticoagulation in this population.This episode is accredited for CPE. This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/3he73SF See omnystudio.com/listener for privacy information.

CEimpact Podcast: Recent Episodes

CEimpact